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The Green Fluorescent Protein has gained significant attention and the 2008 
Nobel Prize as a non-invasive fluorescent marker that has revolutionized molecular 
biology.  Within the 11-stranded -barrel of the protein is protectively housed an 
arylideneimidazolidinone (AMI) chromophore formed via a post-translational cyclization 
that is responsible for the fluorescent properties of the protein.  Following removal from 
the protective -barrel, the chromophore exhibits remarkably different spectroscopic 
properties with a 10
4
 diminished emission quantum yield.  This observation has been 
attributed to torsional motions that allow for rapid internal conversion.  These motions 
are a function of the structure of the AMI chromophore where cis/trans isomerization can 
occur about the benzylidene double bond as well as the formal single aryl bond.  From 
this, the question arises:  if these torsional motions are inhibited, can the fluorescence of 
the chromophore be restored? 
In order to study these chromophores, AMI’s were synthesized with a variety of 
functional groups.  Synthesis of these chromophores is afforded through a 2+3 
cycloaddition providing a combinatorial synthetic protocol contrary to the commonly 
cited synthetic procedure of the Erlenmeyer azalactone synthesis.  The combinatorial 
cycloaddition provides tolerance for a myriad of functional groups and the relative 
synthetic ease has readily allowed for the synthesis of hundreds of AMIs to date.  With an 
arsenal of AMI chromophores a number of studies can be accomplished researching the 
photophysical questions surrounding these chromophores.   
 xx 
It is rationalized that inhibition of conformational freedom should provide for the 
restoration of the emission quantum yield.  This study was undertaken through the 
transformation of the AMI chromophore to a bidentate ligand where upon metal binding 
torsional motions are inhibited.  This was further explored through the encapsulation of 
hydrophobic chromophores within octa acid cavitands that provide a restrictive 
environment similar to what is found within the -barrel.  Results from these studies 
show the topological effects experienced by these chromophores and how restrictive 
environments provide for an enhancement in the emission quantum yield.   
Using the encapsulation studies as motivation additional studies were motivated 
to use these compounds as fluorescent probes.  Collaborating with Dr. Young-Tae Chang, 
these chromophores can be screened against a myriad of analytes to determine 
interactions through emission response in an efficient fashion.  This led to the use of 
these chromophores, and coupled with rational design, as a human serum albumin probe.  
Further collaborative studies show that these chromophores can be used as agonists for 
nuclear receptors where binding the ligand binding domain provides for a restrictive 
environment as well as a fluorescent probe.   
In addition to these interesting applications, the photochemistry of specific 
chromophores shows an interesting photochemical reaction of dimerization resulting in 
mechanical motion.  Synthetic modifications also allow for these chromophores to act as 
liquid crystalline materials.  As shown from this summary the chromophore of GFP 
characterized as an AMI chromophore show interesting properties and applications as 
well as great potential in a number of fields. 




INTRODUCTION AND OVERVIEW 




Motivation and Dissertation Overview 
As multiple literature sources have shown, a great amount of interest surrounds 
GFP and the chromophore responsible for its fluorescent properties.  Simply put, GFP 
has revolutionized molecular biology by providing a non-evasive, post-translational 
biological marker that can be added to various systems without the use of co-factors to 
study various biological processes and interactions.  From a spectroscopic standpoint 
GFP has favorable spectral characteristics as well as an astounding quantum yield, 
contributing even more to its expansive use.  Noting these characteristics, removal of the 
chromophore from the protein system responsible for these spectral features does not 
produce similar results.  Upon removal from the protective -barrel, the chromophore of 
GFP becomes essentially non-fluorescent showing sharp contrast to the =0.79 noted 
within the protein.  At the center of these studies lies the question:  what mechanism is 
responsible for this phenomenon attributed to rapid internal conversion experienced by 
the chromophore?  With this in mind another question that becomes significant is:  can 
the emission properties be restored or altered without the -barrel?  As highlighted 
below, this consequence arises from the non-radiative decay pathways that quench the 
fluorescence.  Modifications to this system allow for the idea that hindering or stopping 
these radiationless pathways could restore a portion or the entire emission quantum yield 
noted with the natural protein.  This restoration could provide important information 
toward the mechanisms noted with GFP allowing for the engineering of superior or 
spectroscopically different proteins.  Additionally, the chromophore could be used 
 2 
without the protein eliminating the variable of steric bulk that the 238-amino acid residue 
protein presents to a system, especially with kinetics studies. 
 Motivation for the work has evolved with additional data.  Initially, the idea of 
hindering cis/trans isomerization through complexation to a metal cation provided for 
early studies into the various deactivation pathways.  This idea was a function of the 
notion that hindering both the single aryl bond rotation as well as the formal double 
rotation should provide a restoration of the emission quantum yield.  Following work 
with Dr. V. Ramamurthy’s group, the importance of the rotation about the single aryl 
bond became a significant contributor to the overall photophysical picture through the 
idea that inclusion within cavities restored a significant, but not the entire, portion of the 
emission quantum yield.  Results from this work provided a foundation into the inclusion 
of these chromophores into various environments whereby inclusion “turns-on” the 





 For any and all of the studies highlighted, synthesis of model chromophores is a 
necessity.  From the high demand of a myriad of chromophores with differing 
substitution patterns, an efficient synthesis tolerant of various functional groups is also a 
necessity.  Motivation to develop a synthetic protocol that is more robust as well as less-
time intensive as the Erlenmeyer azalactone synthesis is of vital importance. 
Overview  
Taking into account the knowledge and challenges presented within this 
introductory portion, a number of projects were undertaken to answer some of the key 
questions and obstacles surrounding studies involving the GFP chromophore.  These 
studies are highlighted within this work and an overview of the chapters as well as the 
work contained within includes: 
Chapter 2 
Chapter 2 reports synthetic progress of various fluorescent protein chromophores, 
termed AMIs, for arylidenemethylimidazolinones, using a new method for synthesis via a 
 3 
2+3 cycloaddition.  This combinatorial synthetic protocol has allowed for the efficient 
synthesis of hundreds of different AMIs unnoted in the literature up to this point.  The 
compounds and synthetic protocol highlighted in this chapter will provide the molecules 
used for studies in subsequent chapters (Copyright by Georg Thieme Verlag Stuttgart).   
Chapter 3 
Chapter 3 reports the modification of the para-hydroxy AMI derivative with a 2-
pyridyl moiety allowing the creation of bidentate ligand capable of binding metal cations.  
Upon binding, a 100-fold emission enhancement is noted for Zn
2+
 showing the possibility 
of hindering torsional motions within AMI chromophores and the implication of such 
(Copyright of the Royal Chemistry Society, 2010).   
Chapter 4 
Chapter 4 reports an interesting photochemical mechanism within the solid state 
of specific AMI derivatives.  Upon irradiation, certain AMIs undergo a dimerization 
reaction based upon their crystal packing pattern.  Additionally, polymorphs, meaning 
different forms of crystals within the same sample, were noted for the meta-hydroxy AMI 
analog (Copyright of the American Chemical Society). 
Chapter 5 
Chapter 5 reports the results upon encapsulation of AMIs within supramolecular 
hosts, in this case octa acid cavitands and cholate salt aggregates.  The consequences of 
this study are significant in that upon inclusion, rotation about the single aryl bond is 
hindered but irradiation still produces the trans isomer within these hosts.  This data 
shows the significance of the single bond toward internal conversion while at the same 
time provides a proof of concept for use as these AMI chromophores as small molecule 
probes (Copyright of the American Chemical Society). 
Chapter 6 
Chapter 6 highlights a combinatorial screening method to test the photophysical 
consequence of the interaction of various AMI derivatives with biologically relevant 
 4 
analytes.  These screening results can readily be used toward the discovery of small 
molecule probes using the AMI core as a structural motif (Copyright of the American 
Chemical Society). 
 Chapter 7 
Chapter 7 discusses the interaction of various AMI chromophore analogs with 
nuclear receptors, primarily the estrogen receptor  and the pregnane X receptor.  
Chromophores were discovered to interact with nuclear receptors through modeling 
calculations as well as combinatorial screening of the wild type nuclear receptors.  Initial 
results show these specific AMI chromophores readily interact as antagonists for the 
nuclear receptors presented.  
Chapter 8 
Chapter 8 highlights a successful outcome of the screening process discussed 
within chapter 6.  Initial results showed a dramatic interaction with specific AMIs and 
human serum albumin (HSA).  Using rational design of the chromophores a new probe 
for HSA was realized showing great sensitivity and selectivity toward HSA compared to 
other homologous and competing analytes within an aqueous environment (Copyright of 
the American Chemical Society). 
Chapter 9 
Chapter 9 discusses some preliminary work toward the use of AMI chromophores 
as liquid crystals.  The general structural motif of an electron-withdrawing group, 
realized through the imidazolinone heterocycle, coupled with use of a biphenyl 
substitution commonly noted in commercial liquid crystals, allows for the creation of 
liquid crystal candidates.  Preliminary results of this study are presented. 
Chapter 10 
Chapter 10 highlights some general conclusions of this work and provides some 
ideas concerning future work that arises from the success and published results of this 
dissertation.   
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Overview of the GFP Chromophore 
 Housed within the 11-stranded -barrel, the arylideneimidazolidinone (AMI) 
chromophore of the green fluorescent protein (GFP), the component responsible for the 
green fluorescence, has drawn significant attention for its interesting photophysical and 
photochemical properties both within the natural protein and upon denaturation.  
Formation of the chromophore p-hydroxybenzylideneimidazolidinone (p-HOBDI) in the 
green fluorescent protein (GFP) of the jellyfish Aequorea victoria
2
 occurs via a post-
translational autocatalytic cyclization followed by autoxidation within a tripeptide unit  
(Ser-65, Tyr-66, Gly-67) of the polypeptide sequence consisting of 238 amino acids (see 
Figure 1.2).
3
  X-ray diffraction studies reveal that the chromophore is protectively housed 
and covalently anchored along a coaxial helix threaded through the center of an 11-
stranded -barrel that secludes it from the aqueous solvent surrounding the protein.
4,5
 
Additional non-covalent coupling of the chromophore to the protein backbone is 
facilitated via an extended hydrogen-bonded network.
6
   
Studies involving the chromophore devoid of the protective -barrel reveal significantly 
different behavior.  These studies are made possible through the synthesis of the 
chromophore carried out using Tonge’s modification
7
 of the Niwa synthesis,
8
 often 
referred to as the Erlenmeyer azalactone synthesis.  Additionally, as highlighted within 
Figure 1.1. Green fluorescent protein -barrel showing chromophore (p-HOBDI) 
encapsulated within the structure. 
 6 
this work, other synthetic protocols are available including a Knoevenagel condensation 
and a 2+3 cycloaddition.   
 Chapter 2 provides an overview of these synthetic protocols for AMI 
chromophores as well as the advances made within our laboratory regarding the 2+3 
cycloaddition that have allowed the synthesis of hundreds of new chromophores. 
Additional fluorescent protein chromophores 
 All proteins with visible light fluorescence isolated to date contain an AMI 
chromophore.  Since the discovery of GFP, multiple other fluorescent proteins have been 
noted either in nature or through protein modifications.  A general overview of these 
proteins provided in Figure 1.3
9
 shows the structural modifications between the different 
classes of chromophores including a substitution of the Tyr-66 residue of GFP for a Trp 
or His residue in the cases of the blue and cyan fluorescent proteins, respectively.  
Contrary to a sequence substitution, the yellow fluorescent protein is achieved through 
the placement of an additional Tyr residue within close proximity of the chromophore 
allowing for - stacking interactions that bathochromically shift the spectral 
characteristics.  Missing from this table is the red fluorescent protein whose chromophore 
occurs via an additional post-translational modification.   This is achieved through an 
additional oxidation step, as highlighted in Figure 1.2, of the C-terminus of the 
imidazolinone ring resulting in an extension of the conjugation thus allowing for a 40-50 






















































Figure 1.2.  Autocatalytic cyclization and subsequent oxidation to yield GFP and 
additional oxidation to yield RFP. 
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Photophysics of the GFP Chromophore 
Following removal from the protective -barrel, the GFP chromophore exhibits several 
spectral changes including a 10
4
 decrease in emission quantum yield. Stark differences 
between the bound chromophore compared to the natural chromophore allude to complex 
photophysical mechanisms.  Within wild-type GFP (wt-GFP) the chromophore exhibits 
two forms with absorbance bands at 398 nm and 477 nm corresponding to the neutral 
form and the anionic form, respectively and an emission band at 508 nm.  Upon 
denaturation, a hypsochromic shift is noted with an absorbance band at 370 nm and an 
emission band at 440 nm.  The mechanism of radiationless decay has been established as 
internal conversion, promoted by motion along a volume conserving mechanism, perhaps 
invoking a “hula twist”,
10
 nearly barrierless coordinate, which is disputed within the 
literature in favor of a phenyl rotation.
11
  These various torsional motions are depicted in 
Figure 1.4, but one of the most significant consequences gained is that within the 
restrictive -barrel these torsional motions are prohibited providing strong circumstantial 
support of the mechanism of radiationless decay.  These motions of the chromophore 
have great implications within the protein as well.  Fluorescent proteins are characterized 
Figure 1.3.  Variety of fluorescent proteins exhibiting different spectroscopic 
properties with their respective chromophores. 
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by “blinking”, which is the temporary conversion to a non-fluorescent form, which has 




 or cis/trans 
isomerization, for which the trans form is non-fluorescent.  Strong support for cis/trans 
isomerization as the origin of blinking is provided by the behavior of kindling fluorescent 
proteins,
14
 which, upon irradiation into the long-wavelength band, are “kindled” to the 
fluorescent form.  The idea of cis/trans isomerization will prove to be a significant issue 
within the multiple projects highlighted throughout this dissertation.  The next section 
highlights this important photophysical mechanism of the GFP chromophore. 
Cis/trans isomerization 
One of the main arguments in favor of rapid internal conversion of the 
chromophore is cis/trans isomerization.  These studies expand to address a key 
unresolved issue in the photophysics of fluorescent proteins at to whether the cis/trans 
isomerization is responsible for the blinking phenomenon, which, in addition to 
isomerization, has been attributed to protonation and to triplet formation.  The work of 
many groups including the Tolbert group,
15
 suggests that formal isomerization from the 
resting cis form to the trans form resulting from the decay of the twisted intermediate to 



































 and corresponds in unexceptional ways to the mechanisms of other AMI 
chromophores.   
Within the literature, the mechanism of photoisomerization has been the subject of 
several studies, but the mechanism of the thermal reverse isomerization is more 
problematic.  The blinking phenomenon requires that isomerization, if involved, be 
thermally reversible.  The results we have observed are consistent with the 
addition/elimination mechanism shown as Path b in Figure 1.5.
17
  Although a plausible 



























































Figure 1.5.  Proposed pathways for the ground-state E-XBDI to Z-XBDI isomerization 
showing (a) Direct (traditional); (b) Addition/elimination mechanism; (c) Isomerization 
by tautomerization.  
 
 An extensive body of work highlighting the mechanism of cis/trans isomerization 
within AMI chromophores exists within the literature.  A variety of ultrafast optical 
techniques have been employed to study the photophysics and photochemistry of GFP 
chromophores.  Using time-resolved infrared spectroscopy (TRIR) spectroscopy, a 
bleaching of the carbonyl band at 1696 cm
-1
, and a new band at 1746─1780 cm
-1 
was 
noted for HOBDI. 
18,19
  Interestingly, the decay rate of this band coincides with the 
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fluorescence lifetime, which allows for the conclusion that this new band is the excited-
state carbonyl stretch and some twisting about the formal double bond is occurring.  The 
orientation of the transition moment of the IR-active carbonyl stretching vibration of 
HOBDI relative to that of the electronic transition dipole moment indicates that the C=O 
vibration acts in a “spectator mode” for the relative orientation of the phenolate and 
imidazolindinone groups, which allows the derivation of an effective near complete 
twisting around the ethylenic bridging bond upon electronic excitation of HOBDI 
providing indirect evidence of cis/trans isomerization.  In addition to this work, Tolbert 
and coworkers demonstrated a direct relation between the degree of HOBDI twisting and 
the rate of deactivation by comparing the decays of HOBDI and 2,6-dimethyl-HOBDI.
20
  
In the latter the highly twisted structure with a 45
o
 DFT-calculated dihedral angle 
between the phenyl and imidazolinone planes resulted in an unprecedented short S1 
lifetime (110 fs for anion) as compared to 530 fs for HOBDI anion in ethanol.  In an 
attempt to decouple the two possible rotational coordinates involving the free rotation 
about the single aryl bond and the cis/trans isomerization about the formal double bond, a 














Figure 1.6.  Depiction of “unlocked” (left) and “locked” (right) Z m-MeOBDI. 
 
Interestingly, a counterintuitive result that the locked m-MeOBDI decays much faster 
than the unlocked one, with lifetimes of 260 fs and 1.4 ps
21
 in methanol, respectively was 
observed.  Single-crystal X-ray measurements demonstrate a dihedral angle increase from 
3.90
o




 for the locked m-MeOBDI.  These results demonstrate 
that the rotation around the double bond is indeed a major coordinate leading to the 
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conical intersection point; however, the twisted ground-state geometry appears to place 
the Franck-Condon state closer to conical intersection.  
While the mechanism of cis/trans isomerization remains a debate both for the free 
chromophore as well as the sequestered chromophore, recent work within our groups 
have alluded to the importance of additional modes of deactivation as well as the 
presence of cis/trans isomerization.  Highlighted within the multiple chapters of this 
dissertation, work within the Tolbert group has shown that inclusion/encapsulation of 
these AMI chromophores leads to fluorescence turn-on but fails to prevent cis/trans 
isomerization form occurring leading to the emission deactivation commonly noted in the 
studies presented above.  
 
Terminology and Methodology 
General overview of photophysics 
The interaction of a molecule with light can lead to a number of processes.  These 
processes can lead to the chemical modification of a molecule defined as photochemistry 
or to a change the energetics of a molecule without a modification to the chemical 
structure of a molecule defined as photophysics.  Throughout this dissertation, references 
will be made to the photophysics of GFP chromophore analogs thus providing motivation 
for an overview of photophysical processes presented here. 
The absorption of a photon of light by a molecule can initiate a number of 
different atomic movements.  Molecules that contain a specific arrangement of atoms 
and/or functional groups that absorb light within the UV/Vis range are termed 
chromophores.  Prior to interaction with light, molecules are said to be in the ground 
state.  That is, the electronic structure obeys quantum mechanical calculations including 
Hund’s rule, Pauli’s exclusion principle, and Aufbau’s principle.  Within this context, the 
valence electrons located at the highest energy level occupy a molecular orbital termed 
the HOMO or highest occupied molecular orbital.  By default the next molecular orbital 
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is termed the LUMO or lowest unoccupied molecular orbital.  A number of simple and 
complex actions can occur following the absorption of a photon of light by a molecule.  
A comprehensive visual depiction of photophysical processes is given by the Jablonski 
diagram provided as Figure 1.7.
23
   
 
 Within the Jablonski diagram, states describing the molecular orbitals are given as 
singlet -Sn- (meaning electrons within orbitals have opposite spins) and triplets -Tn- 
(meaning electrons within orbitals have the same spin).  Upon absorbing a photon, a 
molecule is promoted from the S0 state to a higher state most commonly S1.  A 
chromophore will only absorb light that brings about a single electronic transition, termed 
as the Stark-Einstein law.  This has an exception in multi-photon absorption studies 
where special conditions allow for this law to be relaxed.  Following the absorption of 
light and promotion to a higher energy state, which occurs on a very fast time-scale, the 
molecule is considered to be in the excited state.  Promotion to higher energy states other 
Figure 1.7.  Jablonski diagram depicting range of photophysical process for a 
chromophore. 
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than the first singlet excited state (S1) does occur but movement from higher energy states 
(S2, S3, etc.) to S1 is extremely fast.  This vibrational relaxation occurs so fast and 
provides the observation that all photochemistry and general photophysical studies are 
done with respect to the S1 state, termed Kasha’s rule.  An additional consequence of the 
speed of electronic transitions lies in the fact that the lines as well as the depicted energy 
levels are vertical.  This arises from the fact that these processes occur on such small time 
scales that nuclear motions do not occur thus the initial and final states of the 
chromophore remain the same.  
Principles of light absorption 
The interaction of a molecule with light is governed by the type and arrangement 
of atoms within a molecule, especially functional groups.  Common functional groups 
including alkenes, conjugated alkenes, carbonyls, and aromatic compounds all readily 
absorb light in the UV/Vis range.  Taking note of these examples it is observed that 
molecules containing pi-bonds as a rule of thumb make excellent candidates for 
chromophores.  This does not go to say that single bonds do not absorb light, in fact they 
readily absorb light at <200nm, but these wavelengths are out of the typical UV/Vis 
range thus providing some complications in their use.  Since absorbance of light is a 
process, a way to measure it and its efficiency is a necessity.  This process is done using a 
spectrophotometer whereby incident light of a certain wavelength is introduced to a 
sample and the amount of light transmitted through the sample is measured Figure 1.8. 
This process will be elaborated upon further in the following section within this 
introduction.  The amount of light transmitted through a sample is inversely proportional 
to the amount of light absorbed by the sample thus providing the absorption spectrum.    
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Figure 1.8.  Typical schematic of absorption measuring process. 
 
To measure the efficiency at which a chromophore absorbs light, the employment of the 
Beer-Lambert Law, primarily the molar extinction coefficient (), is necessary.  The 
Beer-Lambert Law is given by: 
    
  
 
         
where Io is the intensity of the incident light, I the intensity of the transmitted light, A is 




), b is the path 
length (typically 1 cm) that the light travels through the sample, and c is the concentration 
of the sample in molarity.  Compounds are often characterized by their molar 
absorbtivity, used interchangeably with molar extinction coefficient.  From this, 
absorbance provides some fundamental characteristics of molecules.  The principle of 
absorbance of visible light is one that has great implications within chemistry and leads to 
significant processes afterward including the important concept of fluorescence.    
Fluorescence and other photophysical processes occurring after absorption 
 Following the absorbance of light, a number of photophysical processes can 
follow as highlighted in the Jablonski diagram.  One of the most significant processes is 
termed fluorescence, which is the emission of a photon of light following the absorption 
of a photon.  If a compound emits light following absorption of light it is termed a 
fluorophore.  While this process is intuitively expected from the diagram, many 
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additional processes compete with fluorescence and can result in a chromophore not 
emitting light.  These processes that do not produce light are termed non-radiative decay 
processes and can take many forms.  
 Fluorescence as shown can readily be measured using a spectrofluorometer.  
Following the gathering of absorption data, a molecule can be promoted to the excited 
state and the subsequent relaxation to the ground state can be measured as a fluorescence 
spectrum commonly called an emission spectrum since fluorescence is not guaranteed.  




Figure 1.9.  Example absorbance and emission spectrum of quinine.   
 
 A couple of spectral features to take into account arise from Figure 1.9.  First, the 
energy maximum of emission is less than that of absorbance.  This is a direct result of the 
non-radiative processes that occur that are in direct competition with fluorescence hence 
lowering the overall energy for fluorescence.  The term given for the difference between 
the absorbance maxima and the emission maxima of the same transition (in this and most 
cases the transitions involving S0 and S1) is called the Stokes shift.  Since fluorescence is 
a process that is readily measured, it becomes a necessity to measure its efficiency.  The 
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overall efficiency of fluorescence is measured as the fluorescence quantum yield given 
by: 
  
                        
                          
 
This calculation is readily achieved by the comparison of a given fluorophore with a 
known standard providing for an emission quantum yield.  Mathematically, a quantum 
yield of 1.00 implies the same numbers of photons were emitted as absorbed.  This is not 
readily the case given the competing process often found in flurophores, thus quantum 
yields are commonly reported as decimal values between 0 and 1.  For general reference, 




 sec.  
Fluorescence lifetimes are measured through instrumentation involving “pumping” a 
molecule into the excited state and using a detector to measure the amount of time 
between pumping and emission.  An important consequence of fluorescence lifetimes is 
achieved that relates lifetime to rate constants.  That relationship is defined as: 
 
  
     
where kf is the rate constant of fluorescence and f is the fluorescence lifetime. 
 A short overview of processes that readily compete with fluorescence is needed.  
Within the Jablonski diagram, note that three other main processes can occur:  internal 
conversion, intersystem crossing, and phosphorescence.  Internal conversion occurs 
within the same multiplicity (meaning singlet and triplet) and is noted when relaxation 
occurs from a higher state to a lower state.  This readily competes with fluorescence since 
internal conversion from S1 to S0 can occur without the necessary emission of a photon.  
This is commonly associated with another energy releasing pathway including molecular 
movements (vibrations) or heat.  This represents one of the key competitors of photon 
emission.  Additionally, intersystem crossing can occur which involves the conversion of 
the electron from the singlet state to the triplet state requiring a spin-flip of the electron.  
Following conversion to the triplet state, the molecule can relax to the ground state via 
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phosphorescence.  This process is much lengthier than emission from S1 to S0 at times 
achieving rates of minutes!  It is important to note that multiple other processes can 
readily compete with fluorescence.  These processes can include quenching which is due 
to the excited molecule’s interaction with another molecule causing a radiationless 
relaxation of the excited molecule. Additional energy transfer can also occur and the 
interested reader is referred to the source cited for this section as well as a plethora of 
other sources that exist on these topics.     
 
General overview of steady-state spectroscopy 
 The gathering of an absorbance spectrum or emission spectrum is an example of 
steady-state spectroscopy.  Absorption spectroscopy makes use of a spectrophotometer 
given as a simple schematic in Figure 1.10.   
 
Figure 1.10.  Simplified schematic of a spectrophotometer. 
 
where incident light is generated by either a tungsten lamp (visible light) or a deuterium 
lamp (UV light) and passed through a monochrometer to determine the wavelengths of 
light that are absorbed by the sample (chromophore).  This result is processed by the 
detector and given as an absorbance spectrum (highlighted earlier).  For the purposes of 
this research, absorption spectra were recorded on a Perkin-Elmer Lambda 19 
UV/Vis/NIR spectrophotometer.   
 The gathering of an emission spectrum shares some commonalities to the 
spectrophotometer.  Emission spectra are taken using a spectrofluorometer given as the 





Figure 1.11.  Simplified schematic of a spectrofluorometer. 
 
Light is produced from a lamp source and passed through a monochrometer.  Detection 
of light is done at 90
o
 after being subjected to a photomultiplier tube that produces the 
radiation measured by the detector providing an emission spectrum.  For the purposes of 
this research, emission spectra were recorded using a Horiba Jobin Yvon Flurolog 
spectrofluorometer.  Data from the spectrofluorometer was corrected using the correction 
file provided for the given light source and conditions. 
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SYNTHESIS OF NOVEL FLUORESCENT PROTEIN 
CHROMOPHORE ANALOGS 





 The chromophore of the green fluorescent protein (GFP) has gained significant 
attention in the literature due to its unusual photophysical and photochemical properties.
2
  
Denaturation of the protein -barrel leads to a loss in emission quantum yield, and 
numerous studies have sought to regain that brightness by incorporation into rings
3,4
 or 
restriction in hydrophobic capsules.
5
 In order to study the mechanisms by which these 
phenomena arise, convenient access to a wide spectrum of substituted 
arylideneimidazolinones (AMI) is required. Thus a high-yield, functional group-tolerant 
methodology adaptable to a combinatorial approach is motivated in order to provide 
materials to study this interesting class of molecules.  
The Plöchl-Erlenmeyer synthesis,
6
 an over a century old classic reaction in 
organic chemistry provides access to AMI’s
7
 and continues to dominate the literature 
concerning the synthesis of GFP chromophores as well as supplement more recent 
methods
8
 (Figure 2.1). 
Figure 2.1.  Synthetic scheme of the Erlenmeyer azalactone synthesis. 
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 This two-step methodology requires initial preparation of an arylideneoxazolone 
followed by reaction with amines to yield respective imidazolinones and continues to 
dominate the synthesis of GFP chromophores as well as supplement more recent 
methods.
9
  Alternative methods include the de novo formation of the imidazolinone ring
10
 
or interconversions of imidazolinones.
11




Despite this progress, the need for reliable, quick and convenient access to a 
variety of substituted imidazolinones with varying substitution patterns remains, since 
such chromophores are of increasing interest in other disciplines,
13
 including biosciences 
and medicine.
14
 Such synthetic methods must provide efficiency, directness and a 
diversity of functional groups. We have found that the methodology proposed by 
Bazureau et al, a very clever adaptation of earlier chemistry developed by Grigg et al.
15
 
and other authors, is most adaptable for our purposes. In this paper we expand upon that 
synthesis to provide a general approach to arbitrary substituted AMIs. 
Imines of -aminoacid esters owe their synthetic versatility to easy equilibration 
(self-enolization) to a bipolar nitrogen ylide via facile 1,2 prototropic shift. The resulting 
stabilized imine ylide is an adaptable component of a 2+3 cycloaddition leading to an 
assortment of heterocycles, including arylideneimidazolinones.
16
 The required 
iminoglycine methyl ester is readily produced from the reaction of ethyl acetimidate 
Figure 2.2.  Synthetic scheme of the modified Knoevenagel condensation for AMI 
synthesis. 
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hydrochloride with glycine methyl ester hydrochloride (Figure 2.3). The accompanying 
Schiff base, acting as a dipolarophile, is conveniently synthesized in high yields by a 
condensation of aromatic aldehydes and primary amines (Figure 2.3).  In the resulting 4-
arylideneimidazolin-5-one, the Schiff base provides the aromatic substituent as well as 
the amide nitrogen of the imidazolinone with its substituent, while the other reagent, (1-
ethoxyethylideneamino) acetate, common for all reactions, contributes all other atoms in  
 
 
the imidazolinone ring (Figure 2.3). Since both aromatic aldehydes and aliphatic amines 
are commercially available, and the synthetic method is tolerant of functional groups, it is 
readily adaptable and provides convenient access to a variety of substituted 
imidazolinones.  
 The synthesis is carried out by mixing 1 equiv of the corresponding Schiff base 
with 1.1 equiv of the imidate.  In cases where the Schiff base contains acidic groups, a 
spontaneous reaction takes place with considerable generation of heat.  The exothermic 
nature of this reaction is not as sizable when acidic groups are absent. For better control 
of the reaction, minimal amounts of ethanol were used as solvent.  Magnetic stirring 
overnight under ambient conditions generally resulted in precipitation of a pure reaction 
Figure 2.3.  Synthetic scheme of the 2+3 cycloaddition. 
 24 
product. In cases where no solid was obtained, the reaction product was isolated and 
purified by column chromatography. 
 Through a different synthetic protocol, Lukyanov, et.al. proposed the 
functionalization of the C-terminus of the imidazolinone through the allylic oxidation of 
the methyl group to an aldehyde proving significant reactivity as a consequence of the 
aldehyde group.  This oxidation is accomplished using SeO2.  Coupled with the imine 
chemistry extensively used in the 2+3 cycloaddition, a variety of substituted 
imidazolinones can be readily synthesized in quantitative yields.  It is also significant to 
note that the synthesized analogs mimic the chromophore of the red fluorescent protein 
due to the extended conjugation provided by the imine bond. 
 Extension of the 2+3 cycloaddition can be realized through the reaction of 
aromatic ketones with primary amines under similar conditions.  These reactions are not 
as well documented within the literature and require modified conditions compared to the 
condensation of the aldehydes with the primary amines due to sterics of the aromatic 








































Figure 2.4.  Synthetic scheme of 2+3 cycloaddition employing a SeO2 oxidation to 
allow for additional combinatorial substitution. 
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molecular sieves within the reaction as well as TiCl4 in some cases as a catalyst.  The 
ketimine products can subsequently be reacted with the synthesized imidate to form the 
imidazolinone final product (Figure 2.4).  It is important to note that this represents the 
first time that a substitution on the bridging methine carbon, whose substitution is 
determined by the aromatic carbonyl compound initially used.  The synthetic breadth of 
this substitution is somewhat limited compared to the aldehyde imine synthesis route 
resulting from a significantly fewer number of aromatic ketones available through 
commercial sources.  The use of this new synthetic protocol coupled with all previous 




Melting points were measured on an Electrothermal melting appoint apparatus and are 
uncorrected.  1H NMR spectra were determined with a Varian Mercury Vx 300 
spectrometer operating at 300 MHz (1H) and at 75 MHz (13C), in appropriate solvents, 
as indicated within the text.  Chemical shifts were referenced to TMS.  Low-resolution 
Figure 2.5.  Synthetic scheme of AMI’s using aromatic ketones providing bridging 
methine substitution. 
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MS spectra (EI 70 eV) were measured on a Micromass AutoSpec spectrometer.  
Elemental analyses were performed by the Atlantic Microlab, Inc., Norcross, Georgia 
(USA).  TLC studies were carried out on Analtech Uniplate Silica Gel GF plates.  
Column chromatography was performed using Sorbent Technologies 40-63 M standard 
grade silica gel.  The organic solvents and reagents used to synthesize the compounds 
were used as received from commercial sources without further purification. 
Imine synthesis 
Synthesis of the various Schiff bases was carried out according to the literature by 
combining the given aromatic aldehyde (1 mmol) with the corresponding amine (1.1 
mmol).  In cases where the aldehyde or amine was solid, ~3mL of EtOH was used to 
solubilize the reagents.  The reaction was allowed to stir under ambient conditions for 12 
hours.  In cases where a precipitate was noted, the product was isolated by filtration and 
washed with ~2mL of cold EtOH to afford pure product.  In cases where both reagents 
were initially liquids, the solvents and excess amine were removed in vacuo.  All Schiff 




Synthesis of the imidate was carried out according to the literature.
18
  Potassium 
carbonate (50 mmol) and methyl glycinate hydrochloride (50 mmol) were suspended in 
125 mL of ether followed by addition of 20 mL of water then addition of ethyl 
acetimidate hydrochloride (50 mmol).  The mixture was shaken for 6 min followed by 
decanting of the ether.  An additional 75 mL portion of ether was added and the mixture 
shaken for 6 min and ether decanted.  The two ether portions were dried over anhydrous 
MgSO4.  The ether was removed in vacuo to afford 4.30 g (yield: 54%) of the pure 
imidate as confirmed by NMR.    
Imidazolinone synthesis 
The required aromatic Schiff base (1 mmol) was combined with the imidate (1.1 
mmol) in ~1 mL of absolute EtOH and allowed to stir in a capped vial overnight under 
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ambient conditions (Figure 2.3).  In cases where the Schiff base was solid additional 
EtOH was used to solubilize the reactants.  In some cases, as indicated in Table 2.3, the 
precipitated product was filtered and washed sequentially with ~2mL Et2O and ~1mL 
EtOH to yield pure product.  In the cases where precipitation did not occur at room 
temperature, the reaction mixture was placed at 0 
o
C for 1-4 days allowing precipitation 
to occur.  Following this, the product was filtered and washed sequentially with ~2mL 
cold Et2O and ~1mL cold EtOH.  If precipitation did not occur by either method, flash 
column chromatography on silica gel was carried out using CHCl3 as the elution solvent.  
Characterization of all purified imidazolinones is provided in Appendix A. 
Allylic Oxidation 
The imidazolinone product (1eq) was dissolved in anhydrous dioxane (50 mL) 
followed by addition of selenium dioxide (1.2 equiv).  The suspension was stirred under 
reflux for 1 h followed by carefully decanting the red solid from the mixture while hot. 






 Combinatorial approaches, as alluded to in the introduction, were exploited on the 
phenyl substitution as well as the N-terminus of the imidazolinone.  This is readily 
realized through the combinatorial reaction of the corresponding aldehyde with a given 
primary amine forming the imine precursor for the final 2+3 cycloaddition step.  Due to 
the quantitative nature and general synthetic robustness of the imine synthesis, as 
highlighted in the literature, an overarching combinatorial approach was adopted with the 
imine synthesis providing large quantities of starting materials for the cyclization step.  
To expedite this process and in collaboration with Dr. Andy Cooper at the University of 
Liverpool in Liverpool, England, robotics were used to combinatorially react 32 
aldehydes with 16 amines yielding 512 different imines.  With all starting materials 
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considered, there are greater than 1,000 different combinations of imines that can be 
synthesized for use with this synthesis.  Table 2.1 lists the available aromatic aldehydes 
and primary amines currently available within the Tolbert laboratory and highlights the 
compounds sent to Liverpool for combinatorial synthesis.  It is important to note that 
others on the list were excluded from the list due to high cost coupled with difficultly in 
shipment to international locations.  If either of these were the case, the compounds were 
excluded from the robotic combinatorial synthesis. 
 







4-Me 2-OMe 2-OH 2-Br 2-OH, 4-N(Et)2 4-N(Et)2 2,4-Me 
3-Me 1-naphthyl 3-OH 4-NO2 3,5-t-Bu, 4-OH 4-CN 2-quinoline 
2-Me 2-naphthyl 4-OH 3-NO2 2-OH, 3-OEt 2-CF3 4-i-Pr 
4-OMe 4-t-Bu 2,3-OMe 4-CO2H 2,6-Me, 4-OH 3-CF3 4-i-Bu 
3-OMe Indole 2,5-OMe 2-F 2,4,5-OMe 4-CF3 2,6-Me 
2-Et 3-Et 4-Et benzyl 2-imidazole 3-F 
 
4-Cl 3-Cl 2-Cl 4-Br 2-OH, 4-OMe 4-OBz 
 
2,4-Cl 3,4-Me 2,4-OH 3,4-OH Me4-Tetralin 4-N(Me)2 
 
4-OAc 3,5-Me 4-F 3-Br 3,5-Me, 4-OH 
  
       
R3 components 
Me Et n-Pr i-Pr n-Bu n-hexyl n-heptyl 
n-octyl C2H4OH C3H6OH C3H6CO2H C5H10CO2H C10H20CO2H C4H8CO2H 




 Synthesis of the AMIs using the 2+3 cycloaddition provided a robust synthesis 
that yielded products with a myriad of functional groups located on both the phenyl ring 
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as well as the nitrogen of the imidazolinone ring.  Compounds synthesized to the date of 
this dissertation are summarized in Table 2.2 with characterization data of these 
compounds provided in Appendix A. 
Table 2.2.  Imidazolinone library of compounds synthesized to date of dissertation 
publication. (sym indicates a “di-imidazolinone” where two compounds are joined by a 
methylene linker). 
 
# R1 R2 R3 R4 # R1 R2 R3 R4 
1 4-Me H Me Me 89 
3,5-Me 
4-OH 
H Me Me 
2 3-OMe H Me Me 90 3-F H Me Me 
3 3-OH H Me Me 91 3-OH H C3CO2H Me 
4 2,3-OMe H Me Me 92 4-OC12H25 H Me Me 
5 4-NO2 H Me Me 93 4-OMe H Me Me 




H Me Me 95 4-OMe H n-Pr Me 
8 4-CO2H H Me Me 96 4-Cl H n-Pr Me 
9 4-N(Me)2 H Me Me 97 4-Br H Me Me 
10 2-F H Me Me 98 2-OMe H n-Pr Me 
11 4-OBz H Me Me 99 2-Br H Me Me 




H Me Me 101 4-Br H n-Pr Me 
14 4-OH H Me Me 102 2-Br H n-Pr Me 
15 2-Me H Me Me 103 3-F H n-Pr Me 
16 4-CN H Me Me 104 3-Cl H Me Me 
17 4-N(Et)2 H Me Me 105 3-OMe H n-Pr Me 
18 4-OH H n-Pr Me 106 Benzyl H n-Pr Me 
19 4-OH H n-Pn Me 107 3-OH H C3CO2H Me 
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20 4-OH H n-Bu Me 108 Benzyl H C3CO2H Me 
21 4-Me H n-Pr Me 109 4-PhC5H11 H Me Me 
22 4-N(Me)2 H n-Pr Me 110 4-i-Pr H Me Me 
Table 2.3.  Continued 
23 4-OH H C3CO2H Me 111 3,4-Me H Me Me 
24 4-OH H C5CO2H Me 112 
2-OH 
4-N(Et)2 
H n-Pn Me 
25 1-naphthyl H Me Me 113 
2-OH 
4-N(Et)2 
H n-heptyl Me 
26 4-Et H Me Me 114 
2-OH 
4-N(Et)2 
H n-Pr Me 
27 3-Me H Me Me 115 4-N(Et)2 H n-hexyl Me 
28 2,4-Me H Me Me 116 
2-OH 
4-N(Et)2 




H Me Me 117 2-OH H n-Pr Me 
30 2,5-Me H Me Me 118 3-Cl H n-Pr Me 
31 1-naphthyl H Et Me 119 
2-OH 
4-N(Et)2 
H Dodecyl Me 
32 4-i-Pr H n-Pr Me 120 
2-OH 
4-N(Et)2 
H Octyl Me 
33 4-N(Me)2 H n-Bu Me 121 4-i-Bu H C3CO2H Me 
34 2-CF3 H Me Me 122 4-i-Bu H n-heptyl Me 
35 2-naphthyl H Me Me 123 3,4-Me H C3CO2H Me 
36 4-N(Et)2 H i-Pr Me 124 3-pyridyl H Me Me 
37 4-OH H EtOH Me 125 3-Br H n-Pr Me 
38 4-OH H 
CH2(CF2)7 
CF3 
Me 126 2,4-Cl H Me Me 
39 4-Et H n-Pr Me 127 2-OH H Me Me 
40 2-Et H Me Me 128 3-Br H Me Me 
41 2-Me H n-Pr Me 129 4-PhC3H7 H Me Me 
42 2-Me H CH2CF3 Me 130 
3,5-t-Bu 
4-OH 
H n-Pr Me 
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43 4-OH H PrOH Me 131 
3,5-t-Bu 
4-OH 
H n-Pn Me 
44 2-Et H n-Pr Me 132 
3,5-t-Bu 
4-OH 
H n-hexyl Me 
45 3-NO2 H Me Me 133 4-OMe H EtOH Me 
Table 2.4.  Continued 
46 4-N(Et)2 H n-Pr Me 134 3,4-OMe H n-Pr Me 
47 2,6-Me H Me Me 135 
2-OH 
3-OEt 
H 2-phenol Me 
48 4-i-Pr H Me Me 136 4-OH H C2N(Me)2 Me 
49 4-t-Bu H Me Me 137 3-OH H C2N(Me)2 Me 
50 3-indole H Me Me 138 2-OH Me Me Me 
51 2-F H n-Pr Me 139 4-N(Et)2 H C2-sym Me 
52 4-N(Me)2 H i-Pr Me 140 Benzyl H C2N(Me)2 Me 
53 4-tetralin H Me Me 141 
3,5-t-Bu 
4-OH 
H EtOH Me 
54 2-Me H Et Me 142 
2-OH 
4-OMe 
H n-Pr Me 
55 4-N(Et)2 H n-Pn Me 143 2,4-Cl H n-Pr Me 




H Me Me 145 
2-OH 
4-OMe 
H Me Me 








H Me Me 148 4-OH H Allyl Me 
61 2-Et H Et Me 149 2,5-OMe H n-Pr Me 
62 3-Me H n-Pr Me 150 4-N(Me)2 H PrOH Me 
63 2-Me H n-Bu Me 151 
3-OH 
4-Br 
H Me Me 
64 2-Me H n-Pn Me 152 4-OH H 2-heptyl Me 




H C3CO2H Me 154 4-OMe H Allyl Me 
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67 4-Me H Et Me 155 
2-OH 
4-OMe 
H PrOH Me 
68 2,3-OMe H C3CO2H Me 156 4-N(Me)2 H 2-heptyl Me 
69 4-N(Et)2 H C3CO2H Me 157 4-OC4H9 H Me Me 
Table 2.5.  Continued 
70 4-Cl H Me Me 158 4-N(Me)2 H C3N(Me)2 Me 
71 3-CF3 H n-Pr Me 159 4-N(Me)2 H C2CN Me 
72 4-CF3 H Me Me 160 
2-OH 
4-N(Et)2 
H C2-sym Me 
73 4-OH H C3N(Me)2 Me 161 4-Me H C2H4CN Me 
74 3-CF3 H Me Me 162 2-Indole H n-Pn Me 
75 2,4-OH H C3CO2H Me 163 3-OH H 2-heptyl Me 
76 3,4-OH H C3CO2H Me 164 3-OH H 3-Pn Me 
77 2-Cl H Me Me 165 2-Indole H C3N(Me)2 Me 
78 2-Cl H n-Pr Me 166 4-N(Me)2 H EtOH Me 
79 4-CF3 H n-Pr Me 167 4-N(Et)2 H C6-sym Me 
80 3,5-Me H Me Me 168 2-Indole H n-Pr Me 
81 4-tetralin H C3CO2H Me 169 3-OH H 2-heptyl Me 




H C3CO2H Me 171 4-OBu H n-Pn Me 
84 4-N(Me)2 H C3CO2H Me 172 4-OH H 3-Pn Me 








H Benzyl Me 175 4-OH H C2H4CN Me 
88 4-OH H Benzyl Me      
 
  
 It is important to note that the compound numbers provided Table 2.2 will be used 
throughout this thesis to identify compounds unless a coding system of compounds is 
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developed as a consequence of the publication respective of each chapter or unless 
otherwise noted in the introductory paragraph.  Additionally, full characterization data for 




C NMR, mass spectrometry, and melting 
points is provided in the appendix verifying the purity of these compounds. 
  
Table 2.3. Yields of synthesized compounds following respective purification methods 
where (
a
) indicates precipitation with overnight stirring, (
b





) indicates purified by column chromatography.   
 
# Yield % # Yield % # Yield % 
1 81 
a
 31 90 
a





 32 70 
b





 33 30 
b





 34 50 
a





 35 69 
a





 36 62 
a





 37 67 
a
 67 50 b 
8 65 
a
 38 30 
a
 68 85 b 
9 64 
a
 39 63 
b





 40 59 
a





 41 72 
b
 71 35 b 
12 80 
a
 42 38 
b
 72 76 
a
 
13 50 a 43 30 
b
 73 84 b 
14 69 
a
 44 60 
b
 74 59 a 
15 49 
a
 45 75 
a
 75 79 a 
16 96 
a
 46 72 
a
 76 75 a 
17 49 
a
 47 45 
a
 77 25 a 
18 50 
a
 48 66 
b
 78 20 a 
19 44 
a
 49 66 
a





 50 71 
a
 80 63 a 
21 84 
a
 51 40 
a
 81 96 a 
22 48 
b
 52 46 
b
 82 80 a 
23 74 
a
 53 42 
a
 83 70 a 
24 78 b 54 57 
b
 84 94 a 
25 95 
a
 55 50 
b
 85 70 c 
26 55 
a
 56 64 
a
 86 51 a 
27 70 
a
 57 95 
a
 87 89 a 
28 70 
a
 58 60 
a
 88 67 a 
29 75 
a
 59 85 
a
 89 66 a 
30 55 
a
 60 37 
a






In addition to the robust nature of the synthesis, the yields were good to very 
good, which made the process amenable to a combinatorial approach.  The reaction 
outcomes and yields are noted in Table 2.3.  The purification method of each of the 
compounds is also noted in Table 2.3, showing that with the combinatorial approach that 
is adopted using this synthetic protocol, the ease of purification vial washing and/or 
simple extraction is coupled with this overall synthetic ease. 
 
Conclusions 
 As shown, the 2+3 cycloaddition can readily be used to synthesize a variety of 
substituted AMI’s in good to excellent yields.  Prior to the application of the 2+3 
cycloaddition synthetic protocol, synthesis of fluorescent protein chromophores was 
commonly accomplished through the Erlenmeyer azalactone synthesis.  This synthesis, 
while versatile in terms of available compounds, requires harsh conditions as well as 
purification via column chromatography not providing for a combinatorial approach to be 
adopted.  Contrary to the Erlenmeyer azalactone synthesis, as well as other synthetic 
protocols, the combinatorial approach of imine chemistry that can be extended from 
aromatic aldehydes to include aromatic ketones provides thousands of starting materials 
for cyclization and the overall synthetic breadth of the cycloaddition presents possibilities 
to synthesize AMI’s for a range of studies in a very efficient manner.  Even with the wide 
synthetic applicability of the cycloaddition, a number of factors exist that limit its use.  
The main deficiency of the cycloaddition is the lack of synthetic ease to readily 
functionalize the R4 position of the imidazolinone resulting from the sparse commercial 
availability of available imidates used to make the amino imidate.  While this presents a 
real challenge, the cycloaddition can be used to provide a wide range of synthetic options 
and allow the study of these chromophores from the substitution of the R1, R2, and R3.  
The remainder of this dissertation details the applications and advanced studies these 
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compounds are being used to study as well as the possibility of these compounds to be 
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UNDERSTANDING THE PHOTOPHYSICS OF FLUORESCENT 
PROTEIN CHROMOPHORES:  INHIBITION OF TWISTING USING 
METAL COMPLEXATION 





  One of the remarkable features of the Green Fluorescent Protein (GFP) is that 
when the chromophore is removed from the -barrel by denaturation or by 
independent synthesis (p-hydroxybenzylideneimidazolinone, p-HBDI, Figure 3.1), the 
fluorescence is almost abolished.  This extraordinary 10
4
 decrease in fluorescence 
intensity is noteworthy even among structurally analogous chromophores, e.g., trans-
stilbene, which show considerable emission quenching in solution associated with an 
internal conversion mechanism induced by twisting in the excited state, similar to a 
Z/E isomerization pathway.  This phenomenon has been put to use in imaging, for 
instance in stilbene-modified antibodies that exhibit increased fluorescence upon 
binding,
2
 and Katzenellenbogen’s use of a stilbene-like analog of diethylstilbestrol,
3
 
to image estrogen receptors.
4
  In this case, the rigidity of the aliphatic rings maintains 
a higher emission quantum yield as compared to the linear chromophore.  Li et al. 
have used the inhibition of twisting in styryl chromophores as an assay for amyloid 
plaques.
5
  In a similar fashion, Prodhomme et al.
6
 and Armitage et al.
7
 have developed 
thiazole orange and related fluorophores as convenient site-specific assays for RNA 
and DNA through intercalative inhibition of double-bond isomerizations.  Such 
observations provide motivation for the use of the GFP chromophore to act as probes.  
Following these motivations, the idea arises that metal complexation could serve one 
 38 
pathway to such inhibition. 
The nitrogen lone pair of the imidazolidinone provides a basic moiety for 
interaction with the adjacent ring.  One possibility for inhibition of twisting has been 
reported by Chen et al. through intramolecular hydrogen bonding using, o-
hydroxybenzylideneimidazolinone (o-HBDI) such that the adjacent hydroxyl group 
forms a weak hydrogen bond, and further allows for intramolecular excited-state 
proton transfer.
8
  An alternate approach developed by Wu and Burgess involves the 
use of another Lewis acid, a BF2 group, to restrain twisting.
9
  In this study, the aryl 
moiety is replaced with by a pyrrole (structure 1, Fig. 3.1), and the conformation 
becomes irreversibly fixed.  In a very elegant way Barondeau et al. synthesized the 
Blue Fluorescent Protein mutant BFPms1 (Fig. 3.1) and demonstrated Zn(II) binding 
by its chromophore.
10
  X-ray data revealed the 5-coordinate Zn(II) cite that included 
the bidentate chromophore, Thr65 and Glu222 moieties, and the water molecule.  
However, Zn(II) binding increased fluorescence intensity only 2-fold.  It was 
reasoned that replacement of the benzyl moiety in p-HBDI by a 2-pyridyl moiety 
would provide a bidentate ligand which, upon complexation should result in a 
fluorescence “turn on”, but in a reversible fashion. 
 
Experimental Protocols 
Synthesis of PyMDI 
Figure 3.1.  GFP synthetic chromophores and the chromophoric moiety of the BFP 
variant BFPms1.
10
  For the latter only three out of five binding sites are shown.    
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The title compound (PyMDI) was conveniently obtained in a 76% yield via a 
Knoevenagel-type condensation of 2-pyridinecarbaldehyde with 1,2-dimethyl-1H-
imidazol-5(4H)-one.
11
 The reaction was catalyzed using 3-butyl-1,2-dimethyl-1H-
imidazol-3-ium hydroxide, a recently developed ionic liquid with literature precedence 




 and Knoevenagel 
condensations.
14
 It is critical that the reaction product, (Z)-1,2-dimethyl-4-(pyridin-2-
ylmethylene)-1H-imidazol-5(4H)-one immediately be purified, flushed with nitrogen, 
and stored at 0
o
C in the dark.  For purification, column chromatography on alumina was 
used with ethyl acetate as the eluent. 
 
Results 
 The requisite 2-pyridylmethylene-dimethylimidazolinone (PyMDI, Fig. 3.1) 
was conveniently obtained in a 76% yield via a Knoevenagel-type condensation of 2-
pyridinecarbaldehyde with 1,2-dimethyl-1H-imidazol-5(4H)-one.
15
 The reaction was 
catalyzed with 3-butyl-1,2-dimethyl-1H-imidazol-3-ium hydroxide, a recently 
developed ionic liquid with literatature precedence for use with aldol condensation 
reactions (Fig. 3.2).
16
   
  The chromophore was readily soluble in methanol/water mixtures at 
concentrations suitable for fluorimetric analysis.  In methanol/water (1/1 vol) 
solutions, absorption/emission maxima were 344/440 nm.  In the absence of metals, 
the chromophore was very weakly fluorescent (Φf<0.001) presumably due to internal 
conversion caused by Z/E photoisomerization.
17,18
  This phenomenon is common for 
the wide array of synthetic analogs of fluorescent proteins chromophores.
19
  Upon 




 M solutions of PyMDI with a variety of metal salts, either no 
fluorescene response was observed, the weak fluorescence was quenched,  or the 
fluorescence was significantly enhanced.   
































































































Figure 3.3.  Absorption and fluorescence spectra of PyMDI in the presence of various 
concentrations of Zn(II) and hydrogen ions in methanol/water (1/1 vol) solutions. 
 
The increase in fluorescence was particularly dramatic in the presence of Zn(II) salts 
(Zn(NO3)2.∙6H2O was used, see Fig. 3.3) reaching 150-fold at saturation in the 
presence of 15 mM zinc ions.  A similiar but less dramatic response was noted for 
Cd(II) salts as well.  Analysis of Zn(II) binding using the Job plot and Benesi-
Hildebrand methods resulted in a 1:1 metal/ligand stochiometry,
16
 with an Zn-PyMDI 
formation constant (Kf) of 1900 M
-1
, the absorption/emission maxima of the complex 
were 360/424 nm,with a lifetime of 1.3 ns. 
Stoichiometry of Zn(II) binding to PyMDI in solution. 
The stoichiometry of complexation in solution was determined using a Job plot 
according to method described in Ref 
20
.  Referring to Fig. 3.4, the maximum occurs 
at a mole fraction of 0.5, implying a 1:1 complex.  Given a 1:1 stoichiometry, a 
Benesi-Hildebrand plot can be created to determine the binding constant of the 
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complex.  It should be noted that Benesi-Hildebrand plots are only applicable to 1:1 
complexes.  The Benesi-Hildebrand equation for fluorescence spectroscopy is given 
by:
21
 1/(I-I0) = 1/(I1-I0) + 1/(Kf (I1-I0)) x 1/[Zn
2+
]  where I0 is the emission intensity of 
a free ligand, and PyMDI is the emission intensity of the complex at some Zn(II) 
concentration.  Additionally, it is noted that the Benesi-Hildebrand plot confirms the 
assumptions made from the Job plot with respect to the 1:1 stoichiometric 



















           y = B*X + A
           B = 8.087E-10
           A = 1.53E-06
           K
f
 = A / B = 1892 M
-1
 
Figure 3.5.  Benesi-Hildebrand plot for titration of PyMDI with Zn
2+
 in solution. 

























Figure 3.4.  Job plot of PyMDI with Zn
2+ 
showing 1:1 binding. 
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relationship.  The Benesi-Hildebrand plot in Fig. 3.5 (shown below) yields an R
2
 = 
0.997 and gives a binding constant for Zn(PyMDI) of 1892 M
-1
. 
Metal cation binding 
  The response to Zn (II) and Cd (II), and to a smaller extent Pb(II), is consistent 
with the Irving-Williams order
22
 (see Fig. 3.6). This order is derived from the Kf of 
the M
2+
 ions of the 3d transition metals that show an increase in log Kf  values across 
the periodic row regardless of the ligand.  The general case is that an increase in 
stability correlates with ionic radius, suggesting an electrostatic effect.
23
   




 metals, have no mechanism for facile spin-
orbit coupling.  In contrast, both Fe(III) and Cu(II), as high-spin metals, readily 
facilitate rapid internal conversion, while the other metals have relatively little effect.  
Unfortunately, the salts of Cu(I), which is isoelectronic to Cd(II) and Zn(II), had very 
poor solubility in water and aqueous methanol, thus no reliable data could be obtained 
for cuprous salt solutions. 
  From its structure, PyMDI is readily classified as a fluorescent ligand.  Such 
compounds are marked by an aromatic or heterocyclic ring with functional groups 
that can act as metal-chelating sites.  These sites can function as both the binding and 
signaling site within the sensor.  Numerous examples of this class of ligands exist and  
Figure 3.6.  Fluorescence response of PyMDI in 15 mM methanol/water (1/1 vol) 














































































include bipyridyls, hydroxyquinolines, and Schiff bases, with many of these acting as 
bidentate ligands.  In a review by Rurack,
24
 it is noted that ligands within this 




 depending upon a number of 
factors, especially the binding site and functional groups present.  The selectivity 
toward Zn
2+
 for a number of ligands within this class is also attributed to the Irving-
Williams order.  The marked decrease in fluorescence intensity of Cd(II) and Pb(II) 
compared to Zn(II) can be rationalized by the heavy-atom effect.
25
  It is important to 
note that similar fluorescent responses were noted by Fahrni et al. with respect to 
Zn(II) and Cd(II), which provided a fluorescence turn-on of benzimidazole 
derivatives for use as ratiometric probes.
26
  The dissociation constant of Zn-PyMDI 
complex (Kd  = 1/Kf) is more than two orders of magnitude smaller that in Zn(II) 
complexes with bipyridyl and phenanthroline derivatives.
27
   
Crystallography of complex 
  By combining a stoichiometric amounts of PyMDI and Zn(NO3)2
.
(H2O)6 in 
methanol, it was possible to isolated a crystalline product whose X-ray structure is 
represented in Fig. 3.7. Curiously, this slightly deformed hexacoordinated bidentate 
complex involves two PyMDI molecules coordinated with zinc virtually orthogonally 
with a nitrate ion chelating zinc via its two oxygen atoms. There is no solvent (or 
water) present in the coordination sphere of zinc. Instead, a single molecule of 
methanol and two nitarte ions for charge compensation are found in the unit cell, 
composed of two Zn-PyMDI complex molecules which are placed outside the 
coordination sphere of zinc ions.  We attribute the double coordination to the higher 
concentrations of ligand obtained under crystallizing conditions. 
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pH studies   
  Both metallo- and prototropic responces of PyMDI were studied.  Upon pH 
decrease from 6 to 1, the bathochromic shifts of both absorption and emission 
maxima were observed resulting in the formation of a monocation with 
absorption/emission maxima at 370/497 nm.  Most probably the pyridine moiety of 
PyMDI is protonated first since the observed pKa is very close to that of some 2-
vinylpyridines.
28
  Lowering the pH of solutions of PyMDI did not yield an increase in 
the fluorescence intensity, which would be expected if the hydrogen bridged the two 
nitrogens and hindered cis/trans isomerizations, as noted for Zn(II) and Cd(II), or the 
mechanism of fluorescence quenching would be based on the photoinduced electron 
transfer.  Titration curves derived from the absorption and the emission spectra were 
identical within experimental errors and resulted in a pKa of 3.3.
16
  Such similiarity 
demonstrates an absence of an enhanced adiabatic photobasicity for PyMDI. We also 
have checked the dependence of PyMDI fluorescence on water concentration in 
methanol/water mixtures.  In all cases only the emission from the neutral species was 
observed.
16
  Its intensity decreased as the water concentration increased, due to an 
unestablished quenching mechanism.  The chemical structure of PyMDI assumes no 
acid-base transitions at pH > 6.  Nevertheless, upon pH increase from 6 to 10, a 
Figure 3.7.  Molecular structure of PyMDI zinc complex. ORTEP image with 35 % 
probability ellipsoids. 
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hypsochromic shift of the absorption maximum as well as strong fluorescence 
quenching was observed.
16
  These spectral evolutions were irreversible and are 
attributed to hydrolysis of the imidazolidinone ring.  
  It is also worthy to note an amazing similarity between the pKa and pKd 
values!  Such a relationship between the basicity of ligands and stability of chelates is 
a known phenomenon and was observed for several Zn complexes with bidentate 
ligands.
27 
We have checked the stability of the Zn-PyMDI complex at different pH.  
Upon a pH decrease the fluorescence was quenched, and the absorbance peak 
transformed from that of Zn-PyMDI into the monocation H-PyMDI.
16
 This 
observation demonstrates rather weak pH-stability of the complex.   
 
Conclusions 
  The observations noted within this work show the importance of inhibition of 
conformational freedom toward the EQY of AMI chromophore derivatives.  While a 
two-order of magnitude enhancement was achieved it is noted that additional 
photophysical mechanisms as well as a twisted complex do not allow for complete 
restoration of the EQY.  The sensitivity of PyMDI to Zn in methanol/water is 
remarkable, given that no attempt was made to optimize the association constant.  The 
use of additional complexing ligands, or, alternatively, unnatural amino acids such as 
azaphenylalanine to create zinc-sensitive derivatives of the green fluorescent protein, 
promises great potential in the optimization of sensors bases upon inhibition of the 
cis/trans (or Z/E) isomerizations of such chromophores. A similar, but indirect 
approach, has been developed recently by Mizuno et al.
29
  The GFP-based protein 
was demonstrated to fold into the trimeric coil (rigid -barrel) structure only in the 
presence of different metal ions.  As a result, the embedded fluorophore lost its 
flexibility and regained fluorescence.  Similarly, Fierke developed a Zn sensor with 
pM sensitivity based upon the known affinity of carbonic anhydrase for Zn.
30
  A wide 
 46 
variety of Zn-sensing proteins
31
 may serve as a molecular background for the ligand 
structure optimization.  Whether increased Zn sensitivity can be produced within such 
optimization is the subject of current research. 
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PHOTOCHEMISTRY OF GREEN FLUORESCENT-LIKE PROTEIN 
CHROMOPHORES IN THE SOLID STATE 
(Copyright by The American Chemical Society
1
) 
This work was carried out in collaboration with the laboratory of Dr. Pance Naumov at 
the Department of Material and Life Science, Graduate School of Engineering at Osaka 
University in Japan.  All compounds were synthesized, characterized, and optical 
characterized within the Tolbert lab while all the crystallographic data and experiments 
were done in the Naumov laboratory.  Data analysis and manuscript composition was 
equally shared. 
Introduction 
Fluorescence from the green fluorescent chromophore (GFP) and its derivatives is 
characterized by a complex ensemble of photophysical phenomena which allow the 
fluorescence to occur with high quantum yield only within the confines of the protective 
-barrel, which inhibits otherwise facile decay pathways. In other environments, 
including other proteins, fluorescence is in competition with a host of decay pathways, 
which have been explored by independent synthesis of the chromophores and 











and in the solid state.
7 
 Of these environments, 
the environment most analogous to the -barrel is arguably the solid state. A consistent 
theme to these studies has been the intervention of twisting modes, both involving the 
formal double bond and leading to double-bond isomerization and/or the single bond 
between that bond and the aryl group. Notwithstanding the strong role of the -barrel in 
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providing a strong restoring force, preventing both facile internal conversion via twisting 
and double-bond [trans (E) → cis (Z)] isomerization, proteins which undergo such 
isomerization (―photoswitching proteins‖)
8
 are now increasingly evident. Concerns about 
such restraining forces have led to widespread acceptance of the volume-conserving 
―hula twist‖,
9 
which incorporates simultaneous twisting about dihedral angles τ and φ in 
the excited-state. This ―least-motion‖ scenario, in order to maintain both aromatic rings in 
plane, would produce an initial conformer with any ortho or meta substituents in a syn 
relationship,
10 
as opposed to the anti relationship in the ―one-bond flip‖ process (see 
Scheme 1). Thus we have undertaken a study of such isomerization in the solid state, 
using derivatives which perturb crystal packing in rationalizable ways. As a result of 
these investigations, we now report a variety of direct photochemical consequences from 
the crystal packing, including a remarkable photomechanical effect of the 
benzylidenedimethylimidazolinone (BDI) chromophores, and additional insight into the 
possible intervention of the hula twist. 
We began these studies with derivatives of the parent chromophore, p-
hydroxybenzylidenedimethylimidazolinone (4-HOBDI).
7 
 We found that fluorescence 
―turn-on‖ occurred in the solid-state for O-alkyl derivatives which were almost 
completely non-fluorescent in solutions. Steady-state and time-resolved emission 
spectroscopy, as well as X-ray diffraction analysis, revealed the nature of complex 
emission in the crystals, including the fluorescence of monomers and aggregates. The 
size of O-alkyl substituents played a dramatic role in color tuning of crystalline 
luminescence. With the increase of alkyl group from methyl to hexyl to dodecyl, the 
interaction between the aromatic molecules in the lattice became weaker, resulting in a 
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hypsochromic shift in the apparent emission from the crystals. No emission was observed 
from the unsubstituted hydroxyl derivative, which, unlike the others, was characterized 
by hydrogen bonding between phenolic OH and the imidazolone carbonyl group. 
However, none of these molecules exhibited any permanent photochemistry in the solid 
state, nor could para substituents distinguish between the one-bond flip and hula twist 
processes. In order to further characterize their photophysics, therefore, we undertook a 
study of molecules for which substituents at the ortho and meta positions would provide 
additional stereochemical tags, allowing us to establish whether aryl rotation, at least, 
was a component of the solid-state chemistry and thus provide direct insight into the hula 
twist mechanism. 
Experimental Section 
Photolysis and product analysis  
A sample of 3-HOBDI (ca. 80 mg) was spread thin between glass plates and 
exposed to irradiation from a Hanovia Hg lamp for 1.5 h followed by flipping the plate 
and continuing irradiation for another 1.5 h. The powder was collected and acetone was 
used to remove the remaining starting material (4 times). The remaining white solid was 
allowed to dry on the frit funnel and used for spectroscopy. The yield was ~ 50% (no 
attempts were made to maximizing the yield of the product).  
Spectroscopy 
Ultraviolet-visible absorption spectra were recorded on a Perkin Elmer Lambda19 
spectrophotometer. Measurements of solid-state photoluminescence were carried out 
using the front face emission scan mode on a Jobin-Yvon FluoroLog-3 
spectrofluorimeter. The entrance/exit slits of the monochromators were adjusted to the 
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proper fluorescence intensity of each sample. Crystalline powder samples were placed 
between the quartz plates. Fluorescence lifetimes were measured using an Edinburgh 
Instruments time-correlated single photon counting (TCSPC) system. In this 
measurement, two picosecond excitation pulses diode lasers (LDH-P-C-375 and LDH-P-
C470) with different wavelengths (372 nm and 478 nm) were used as excitation light 
sources. The detection system consisted of a high speed MicroChannel Plate 
PhotoMultiplier Tube (MCP-PMT, Hamamatsu R3809U-50) and TCSPC electronics.  
Atomic force microscopy 
In order to more fully characterize the nature of the phototransformation of the 3-
HOBDI crystals, we examined the AFM images of the crystals before and after 
irradiation. The AFM imaging was completed on a single crystal of 3-HOBDI-A. For 
imaging, the crystal was mounted flat on its largest surface using carbon tape on silicon 
wafer in such a way that part of the crystal was immobilized on the tape while the 
remaining part was not attached, which allowed for unrestricted movement (a schematic 
of this assembly is shown in Figure 4.1). The crystal mounting process was done with 
limited ambient light; however ambient light was not entirely eliminated. From this, 
preexisting conditions cannot be rigorously excluded. The crystal was irradiated using a 
Pyrex-filtered Hanovia medium pressure 450 W Hg lamp for 15 minutes and subjected to 
AFM analysis. Both segments of the crystal (attached and non-attached) were analyzed. 
Atomic force microscopy imaging was performed with a model 5500 AFM from Agilent 
Technologies (Chandler, AZ). The 5500 AFM operates in a "top-down" configuration 
with the AFM probe mounted on the piezo-scanner for imaging of the sample surface. 
The AFM was placed in a vibration isolation chamber (Agilent Technologies, Chandler, 
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AZ), and additionally in a Faraday cage in order to reduce environmental vibration and 
electromagnetic noise. AFM images were post-processed with the PicoScan 5.3.3 
software (Agilent Technologies, Chandler, AZ) for tilt correction or flattening of the 
image background. For the imaging, Dynamic mode AFM technique was employed. In 
this technique, the cantilever is oscillated at a certain resonant frequency and amplitude 
damping as a result of repulsive tip-sample interaction is monitored. This reduces 
frictional forces at the sample surface due to the intermittent contact of the tip. 
 
Figure 4.1. Schematic of the setup for AFM analysis of 3-HOBDI-A (left) and optical 
image of the scanning (right). 
 
 
Polymorph screening and X-ray diffraction 
Extensive screening of the BDIs from fifteen common organic solvents was 
undertaken to check the existence of polymorphs and solvates. The identity of the crystals 
from different batches was checked by comparison of the cell parameters obtained from 
limited number of reflections. The samples for X-ray diffraction analysis were prepared 
by slow evaporation from hexane or ethanol solutions, which always afforded samples of 
best crystallinity. Except for 3-HOBDI-A, which always crystallized as very slender long 
crystals, all BDIs appear as large prismatic or blocky crystals. If exposed to room light 
for a week, some of the crystals (most notably, 3-HOBDI-A and 2-FBDI) tend to deform 
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and turn opaque. Therefore, all recrystallized samples were manipulated and stored in the 
dark (see below), under faint light or red safelight ( > 660 nm), including the X-ray 
measurements. 
The X-ray diffraction data were collected in ω-scan mode at room temperature 
with APEX2 diffractometer (Bruker AXS),
39
 using MoK X-rays obtained from a 
rotating anode source, a confocal multilayer X-ray mirror as monochromator and CCD 
area detector. The integrated and scaled
39
 data were empirically corrected for absorption 
effects with SADABS.
40
 The structures were solved by using direct methods
41
 and 
refined on Fobs with SHELXL.
42
 All non-hydrogen atoms were assigned anisotropic 
displacement parameters. The aromatic protons were set as riding bodies, and the methyl 
hydrogen atoms were placed at calculated positions, with their rotational angles refined 
from the electron density. The protons in the hydroxyl groups were kept at calculated 
distances, but their rotation angles were refined. The crystals of 3-HOBDI-A are 
extremely slender (the one used for X-ray diffraction was thick only 10 m) and tend to 
curve slightly during the crystallization process (see Figure 4.4), even when it is 
conducted in dark and at lowered temperature, which is why the structure could be 
refined only to R1 = 7.14%. Although not optimal, this accuracy was considered sufficient 
for the purpose of analysis of the molecular structure and intermolecular interactions 
topology. The photoreaction of 3-HOBDI-A is a homogeneous solid-state process,
43
 and 
proceeds simultaneously with the bending throughout any part of the crystals that had 
been exposed to UV light. Therefore, although that the resulting crystal still diffracted as 
one component, its diffraction pattern was inevitably distorted, which ultimately 
prevented us from structure determination of the product. The gradual distortion of the 
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diffraction picture was an expected consequence of the continuous progression of the 
reaction throughout the crystal, although the crystal integrity was preserved. The crystals 
of 2-FBDI were refined from a twinned crystal; the twinning was explicitly accounted for 
in the refinement. Both methyl groups at the imidazole ring of 3-MOBDI are rotationally 
disordered, and thus they were included in the model with two positions of equal 
occupancy. The structure of the partially reacted 3-HOBDI-C was refined by using 
several limitations, including constraints (± 0.2 Å) on the C8′―N12′ (1.400 Å), 
N10′―C9′ (1.340 Å) and C9′―O16′ (1.250 Å) bonds. Soft restraint was applied to keep 
the imidazolone ring atoms of the product flat, and two pairs of atoms were restrained to 
have similar displacement parameters. The effect on the changes in the crystal color 
observed by UV irradiation depended on the sample (2,5-DMBDI and 4-HOBDI turn 
yellow, while 2-FBDI turns opaque). The attempts to resolve the structure of the 
photoinduced dimer created in single crystals of the BDIs were not successful, because 
the crystallinity specimens decreased upon exposure to UV light, as it became evident 
from the diffraction pattern of 2,5-DMBDI.      
 
Results 
Synthesis, characterization and crystallization 
Over fifteen BDI chromophores were synthesized according to our previously published 
protocols.
2d,4b,7
  The crystal structures of six representative compounds were determined 
by single crystal X-ray diffraction
 
(Figure 4.3). One of these, 3-HOBDI, produced four 
polymorphs, three of which were completely structurally characterized and are labeled A, 
B, and C.
11 
 Form A (3-HOBDI-A) has the most distinctive crystal structure, with crystal 
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packing characterized by linear chains of molecules connected by strong hydrogen bonds 
between the phenolic OH and adjacent imidazolone carbonyls. Photoisomerization of 
such a supramolecular structure, if done in a single-crystal-to-single-crystal fashion, 
should favor the intervention of a hula twist in order to maintain the hydrogen-bonding 
network. We were gratified and surprised to see, not just a photochemical transformation, 
but a dramatic photomechanical effect, with rod-like crystals bending upon exposure at 
angles up to more than 90
o
 without breaking.  
 
Figure 4.2. Micrographs of crystals of the three polymorphs of 3-HOBDI recorded in 
transmission and in reflection mode. 
 
Of the remaining crystals, four (the other two polymorphs of 3-HOBDI, 2-FBDI and 2,5-
DMBDI, see Chart 1) underwent photoreactions with complete conversion to stable 
products within minutes, in yields sufficient for NMR characterization. Notably, such 
photoreactions were accompanied by readily observable photobleaching of the yellow 







R1            R2       Label                  #(CCDC)
3-OH          H       3-HOBDI -A
a
 
  CCDC #761072
3-OCH3      H      3-MOBDI       CCDC #761075
2-F             H       2-FBDI   
 
       CCDC #761068
2-CH3         H       2-MeBDI        CCDC #761069
2-CH3      5-CH3   2,5-DMBDI    CCDC #761071






Polymorphs: CCDC #761073 (form B), CCDC #761074 (form C)         
Figure 4.3.  Chemical structures and Cambridge Structure Database reference numbers 
of the respective crystallographic data of the six model GFP fluorophores. 
 
Photomechanical effects in 3-HOBDI-A crystals 
A 0.70 × 0.04 × 0.01 mm single crystal of 3-HOBDI-A was mounted at one end on a 
glass rod with epoxy adhesive (Araldite) and exposed to very weak (< 1 mW·cm
2
), 
unfocused, heat-filtered UV light (max = 365 nm, with minor contribution from the 313 
nm line) from a 250 W medium-pressure Hg lamp (SP-7, Ushio). On flashing by UV 
light (0.1 s), the slender, long crystals of 3-HOBDI-A underwent a dramatic deformation: 
the crystals bent along their longest axis to > 90
o
 without breaking (see Figure 4.4 and 
Movie S1 in the SI). As shown in panels bd of Figure 4.4, because the crystal curved 
only during excitation, the angle at the curvature could be controlled by varying the 
exposure time. At weak excitation power density, the crystal bending ceased in absence 
of excitation. After more than a minute of continuous or discontinuous irradiation, the 
crystal had curved more than 90
o
, before it started to twist due to bending along the 
second largest axis, until a fracture appeared at the kink and normal to the longest axis 
(see panels fg in Figure 4.4). If flashed or continuously irradiated with stronger UV light 
(> 5 mW·cm
2
), non-fixed crystals showed a readily observable photosalient effect: they 
jumped a few millimeters as a result of acute lattice distortion. This photomechanical 
effect was observed during a few seconds even after the excitation had been terminated, 
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probably due to latent release of the accumulated structural stress in the crystal lattice. 
The deformation was plastic, so that the original shape of the crystals was not restored, 
even after they had been aged in the dark. None of the crystals of the other compounds 
exhibited similar photomechanical behavior, but thicker crystals of 3-HOBDI-B, 3-
HOBDI-C, 2-FBDI and 2,5-DMBDI, as well as of the 4-hydroxy derivative, 4-HOBDI 
(analogous to the real GFP emitter), tended to crack perpendicular to the longest axis 
after long-term exposure to UV light. 
 
Figure 4.4. (ah) Photomechanical effects of the single crystal of 3-HOBDI exposed to 
unfocused weak UV light (left) and (i) schematic of the suggested mechanism. The 
panels bh show the deformation caused by consecutive exposure (each of bd 
corresponds to consecutive 0.1-s flash). Comparison of the panels f and g shows the 
twisting of the crystal that appears as a result of bending along the smaller axis, after the 
maximal bending has been reached along the longest axis (the fracture is arrowed in 
panel h). The perpendicular hydrogen-bonded tapes in the structure are represented 
schematically in panel i by red and blue ribbons.  
 
 UV irradiation (< 300 nm, Pyrex-filtered medium pressure 450 W Hg lamp) led to 
complete quenching of the weak emission of 3-HOBDI-A at em = 440 nm. Upon several 
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30 s-exposures to weak polychromatic UV light (250 W Hg lamp), the IR spectra of 
powders of 3-HOBDI (all three structurally characterized polymorphs), 2-FBDI, 2,5-
DMBDI and 4-HOBDI dispersed in KBr showed drastic changes due to gradual and 
complete conversion to photostable products (Figure 4.5), while the other three 
compounds remained nonreactive. Most characteristic were the blueshifts of the (CO) 
and of (OH) modes (in the case of 3-HOBDI and 4-HOBDI): typically, for 3-HOBDI-
A the respective values were ~  = 17 and 125 cm
1
. The reaction of 2-FBDI  
 60 
 
Figure 4.5. Effects of UV excitation on the IR spectrum of the six compounds tested. 
The irradiation time increases going down the spectrum with (a) representing t = 0 s. 
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and 2,5-DMBDI was more rapid relative to 3-HOBDI and was completed within a 
minute. The photoreactivity was confirmed by 
1
H NMR spectra recorded in solid state 
and in solution, and could be also visually observed as bleaching of excited powdered 
samples. The reaction product from 3-HOBDI was purified by removing the soluble 
starting material with multiple acetone washes. The NMR spectra clearly showed 
differences between the starting material and the product. Most pronounced was the loss 
of the vinyl double bond, along with appearance of a new two-proton singlet at 4.4 ppm. 
The signals due to the imidazolone ring were present and slightly shifted from their 
positions in the starting material. There was no change in the total number of protons in 
the product compared to the starting material. The 
13
C NMR spectrum indicated a total 
disappearance of the vinyl carbon atoms, and showed the presence of the imidazolone 
carbon atoms in addition to the appearance of two new signals, at approximately 53 ppm 
and 73 ppm. The total number of distinct carbon atoms remained the same as in the 
starting material. The mass spectrum of the pure product showed a molecular ion signal 
at 432 (M
+
) and a fragmentation peak at 216 (M
+
/2), which strongly suggested a dimer 
fragmenting in half across two C―C bonds. Symmetrical [2+2] photodimers of 
unsaturated compounds have been well characterized as containing either mirror 
symmetry (Cs) or two-fold symmetry (C2).  In retrospect, we now recognize that several 
of these derivatives showed the presence of ―impurities‖ in purified samples, a 
phenomenon we can now attribute to the photodimerization and which serves as a caution 
when handling such compounds in the solid state.  On the basis of the NMR spectrum, we 
believe that the homodimer of 3-HOBDI was the two-fold symmetric trans,trans species 
(see Scheme 3), although we must concede that we cannot exclude other symmetric 
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dimers. The remaining photoactive derivatives yielded analogous products, in all cases, 




































Crystal Structures of the BDIs 
Polymorph/solvate screening of the six BDIs in Chart 1 afforded four polymorphs 
of the m-hydroxy compound (3-HOBDI-A, -B, –C and -D), three of which were 
characterized, and a single form of each of the other compounds. None of the eight 
crystal structures characterized by X-ray diffraction analysis included solvent, as 
expected from the flatness of the BDI molecules and their close packing provided by the 
molecular stacking (Figure 4.7). The molecular shape varied from flat (the angle between 
the two rings is 1.52(11)
o
 in 2,4-DMBDI and 1.74(2)
o
 in 2-FBDI) to slightly bent (in the 
case of 3-HOBDI-B, 8.49(27) and 8.90(24)
o
, and 2,5-DMBDI, 7.86(10)
o
), so that some 
of the molecules appeared bow-shaped. The substituents at the phenyl ring did not appear 
to have significant effect on the intramolecular distances, so that the bridging double 
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bond (1.340(7) – 1.350(8) Å) and single bond (1.450(2) – 1.462(7) Å) remained 
essentially constant over all electron-donor and acceptor substituents. Although the free 
rotation of the phenyl ring around its axis indicates that both syn and anti isomers can 
exist for each of the non-symmetrically substituted compounds, in all cases where the 
phenyl ring is substituted with a group which is devoid of acidic proton (2-MeBDI, 2-
FBDI, 3-MOBDI, 2,5-DMBDI, 2,4-DMBDI), the proximate (ortho or meta) phenyl 
substituent in the crystals is juxtaposed anti in respect to the ortho-nitrogen of the 
imidazole ring. The preferred anti orientation is determined by the fact that it leaves the 
substituents to point outwards, turning them accessible for other intermolecular 
interactions.  
To our knowledge, 3-HOBDI is the only BDI-type molecule that has been 
crystallized as more than one polymorph (Figure 4.2). At ambient conditions, the 
majority of sample crystallized as form 3-HOBDI-A, presumably the thermodynamically 
Figure 4.7.  Packing in the crystals of the BDIs showing the relevant center-to-center 
distances (in Ångströms, rounded to ± 0.01 Å for clarity) and the relative molecular 
orientation. From the hydrogen bonds, only the strong O―H···O bonds in the three 
forms of the 3-hydroxyl derivative (3-HOBDI) are shown. 
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most stable structure. Occasionally, a small amount of 3-HOBDI-B was obtained 
concomitantly with 3-HOBDI-A. In a few trials, pure batches of the third form, 3-
HOBDI-C, were obtained. At a molecular level, most apparent factors for the existence 
of stable polymorphs of 3-HOBDI at room temperature and their absence in the case of 
other compounds, despite similar molecular shapes, is the combination of a very 
asymmetric structure of its nearly planar molecule with hydrogen bond donors (OH) and 
acceptors (CO and N) in both rings, and the rotational freedom around the C―Ph bond. 
The overall structure resembles that of the decamorphic compound ROY.
14
 3-HOBDI-A 
is also the only crystal which contains one of the two structurally different molecules 
having its phenyl substituent (the hydroxyl group) syn-orientated with respect to the 
imidazolone ring. In contrast to form A, in 3-HOBDI-B both crystallographic types of 
molecules are in the anti conformation, whereas in 3-HOBDI-C there is only one anti 
molecule (Figure 4.2). In the three polymorphs, these two conformations exist as three 
different hydrogen bonding patterns: infinite polymeric head-to-tail hydrogen bonded 
chains of either anti or syn molecules similar to 4-HOBDI in 3-HOBDI-A,
7
 and head-to-
tail hydrogen bonded dimers in 3-HOBDI-B and 3-HOBDI-C. The all-syn and all-anti 
chains in the crystal of 3-HOBDI-A are arranged into alternating sheets, each containing 
only molecules of identical stereochemistry, and the all-syn and all-anti chains from 
adjacent sheets are perpendicular to each other. Similar to 4-HOBDI,
6
 the double bonds 
in the crystals of 3-HOBDI, 2-FBDI and 2,5-DMBDI are separated at distances < 4 Å, 
but only in form C of 3-HOBDI, 2,5-DMBI and in the non-stacked 3-MOBDI, are they 
entirely parallel to each other (Figure 4.7 and Table 4.1). 
Steady-state and time-resolved spectroscopy of BDIs  
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To examine whether the emission properties of the solid-state BDI chromophores 
were stacking-mode specific, which might have implications for the GFP photochemistry, 
we used our previous approach,
7
 where we correlated the spectral features of 4-HOBDI 
and its ethers in the solid-state with their crystal packing properties leading to fine tuning 
of monomer-excimer emission. The two-dimensional excitation-emission spectra 
recorded from solid sample are shown in Figure 4.8. The variety of offset stacking 
geometries that we observe here for different substituents (Figure 4.8) provides grounds 
for more quantitative consideration of the relative importance of aggregation- and 
stacking-induced modulation of the emission energy.  
In polar basic solvent (DMSO)
13
 all six compounds demonstrated amazingly 
similar absorption and emission spectra (Table 4.1), showing very weak spectral 
dependence on the nature of the phenyl ring substituents. Minor bathochromic shifts of 3-
HOBDI emission maxima and broadening of the spectrum can be explained by the 
known solvatochromic behavior of phenols in basic solvents.
14 
 The fluorescence decays 
of 2-MOBDI, 2,4-DMBDI and 2,5-DMBDI were faster than 10 ps, the time resolution 
of our TCSPC instrument. However, the fluorescence lifetimes of 3-MOBDI, 2-FBDI 
and 3-HOBDI were considerably longer (as reported earlier for the latter compound),
15
 
and therefore they could be measured using TCSPC. Spectral and kinetic data of all 
compounds are summarized in Table 1. 
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Figure 4.8. Excitation-emission contour profiles of the solid GFP model chromophores. 
The intensity increased from blue to red regions. 
 
 
X-ray photodiffraction analysis of 3-HOBDI-C  
During handling of the BDI crystals, we noticed that some of the crystals which 
have not been protected from the fluorescent room light, gradually turned opaque during 
period of several weeks, even without prior exposure to UV light. Most of the samples 
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developed visible cracks perpendicular to their longest axis, and some also became 
curved (for micrographs of the curved crystals of 2-FBDI, see Figure 4.10). Intrigued by 
the reason for the apparent sensitivity of the BDI samples to visible light, we approached 
X-ray diffraction analysis of the opaque crystals which had been stored in air at room 
light for several weeks, performing all further experimental procedures (including the 
diffraction data collection) under red safelight ( > 660 nm). The reacted crystals from 
most of the samples were of insufficient diffraction quality, due to partial disintegration 
and/or deformation.  
Table 4.1. Selected structural and spectroscopic parameters of the 
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only in the case of 3-HOBDI-C, for which the crystal shape remained the least deformed, 
could we succeed in selecting several well-diffracting opaque specimens which remained 
compact for analysis with X-ray diffraction. 
The X-ray photodiffraction analysis of a reacted 3-HOBDI-C crystal, where the 
3-HOBDI molecule is in its Z configuration (Z-3-HOBDI), revealed that the crystal 
symmetry was preserved. However, the difference Fourier electron density map 
(FobsFcalc) clearly showed new peaks around the imidazolone ring from a secondary, 
product species with a population that refined to 12.9% (Figure 4.9).
18
 In the structure of 
the crystal refined as a two-component mixture,
19
 the carbonyl group of the product, 
which due to the symmetric methyl substitution represented a useful marker of the 
orientation of the imidazolone ring, was flipped to the opposite side of the ring relative to 
the double bond (Figure 4.9). The residual peaks corresponding to the methyl groups and 
the nitrogen atoms were also significantly and simultaneously shifted, so that the 
imidazolone ring of the product represented slightly offset mirror image of that of the 
reactant, which appeared as an increased angle at the bridging carbon atom. Except for 
somewhat increased thermal ellipsoids, no significant movements could be detected for 
the phenyl carbon atoms, so that the phenyl ring was retained at nearly identical position 
as in the reactant. It should be noted that the product molecule, with the -flipped 
imidazolone ring and E configuration (E-3-HOBDI), was the only detectable product; 
particularly, no evidence of a dimeric product (that is, peaks corresponding to 
cyclobutane atoms which were usually detected in [2 + 2] photodimerization reactions)
12
 
could be observed. This result clearly showed that the -one-bond-flipped isomer E-3-
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HOBDI was the main product of this slow photoreaction in the crystal exposed to visible 
light. 
The electron density increased from deep blue (negative) to white (positive) 
regions.  The parent (Z-3-HOBDI) and product conformations (E-3-HOBDI) are 
represented as black and red sticks, respectively. Note that the structure of E-3-HOBDI is 
drawn through the projections of the observed maximum peaks onto the ring plane of Z-
3-HOBDI, which appears as offset of the difference peak maxima from the atomic 
positions of E-3-HOBDI. A ORTEP-style plot of the disordered molecule of 3-HOBDI 
in the crystals of form C exposed to visible light is shown in figure 4.10 where the major 
(Z-3-HOBDI, 87.1%) and minor (E-3-HOBDI, 12.9%) components are represented as 
full and empty ellipsoids/bonds, respectively. Changes in the hydrogen bonding pattern 
occurring upon single τ one bond flip in the dimers of 3-HOBDI-C and respective O···O 
or O···N distances are noted in figure 4.10 item C. All but the hydroxyl hydrogen atoms 
Figure 4.9. (a) Slice of the residual electron density (FobsFcalc) through the 
imidazolinone. (b) ORTEP-style plot of 3-HOBDI. (c) Changes in hydrogen bonding 
following a one-bond flip.   
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are omitted for clarity. The hydrogen-bonded dimers in the unreacted crystal (left) and in 
the reacted crystal (one molecule in Z-3-HOBDI conformation and the other in E-3-
HOBDI  conformation, right) are shown. 
Discussion 
General Overview of Results 
Spatial and temporal in vivo monitoring of the GFP-tagged proteins, for example, 
by the double-labeling FRET method,
16 
requires excitation of the chromophore. In the 
low-energy region, the wild-type GFP absorbs at 397 nm (A band) and 475 nm (B band), 
corresponding to the neutral molecule and the conjugate base of the emitter, respectively, 
and excitation of both bands results in the green emission of the ion at 508 nm. Low-
energy excitation with light of moderate powers induces reversible changes and 
isomerization of the protein structure via a Förster cycle.
17
  However, at higher energies 
and increased light density, complex reactions leading to irreversible changes of the 
protein structures may occur, typically, decarboxylation of the proximate glutamate 
residue.
18 
 Such denaturation processes can be important for analytical methods which 
require high input powers due to low signal for detection, such as single-molecule 
spectroscopy
19 
or fluorescence correlation spectroscopy.
20
  The primary processes 
triggering irreversible chemical reactions of the protein are believed to start at the 
chromophore itself, and thus complete understanding of the photochemistry from the 
higher-order transitions and the faith of low-energy excitations which do not contribute to 
the main reaction pathways is essential to the improvement of the analytical feasibility of 
the GFP-like proteins. Such irreversible processes in model GFP systems and 
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particularly, the allosteric-like response from the chromophore environment, however, 
have not been investigated yet. 
By having access to a large variety of chromophores of similar electronic 
structure but varied crystal packing, we have a unique opportunity to examine how 
crystal packing influences their varied behavior, from photophysics to photodimerization 
to photoisomerization. On the one hand, the presence of a double bond in close proximity 
to another leads to efficient cycloaddition, a phenomenon that has been extensively 
studied in the cinnamate literature.
21 
 When such proximity is accompanied by an 
extensive hydrogen-bonded network, the bond contraction produced by dimerization can 
lead to a surprising photomechanical effect. On the other hand, when such proximity is 
absent, dimerization is extinguished and isomerization can take place. We now consider 
each of these phenomena in turn. 
Effect of crystal packing on the emission spectra of BDIs 
We find that the crystal packing of the BDIs strongly affects their fluorescence 
properties in the solid state, and it is reproduced well in the two-dimensional excitation-
emission spectra (Figure 4.10). In the crystal of 2-MeBDI, where the molecules are offset 
and isolated from each other (the distance between the double bonds is 6.892 Å), and 
they interact only by weak C―H···O hydrogen bonds (d(C···O) = 3.425 Å), the 
excitation energy remains localized within individual molecules. The emission from the 
singlet excited state, with max
ex
 = 395 nm, appears as a single strong peak with max
em
 = 
440 nm, along with the existence of a single major emitting species. As reported 
previously,
7
 this band is slightly red-shifted by the environment effects relative to the 
emission in solution (431 nm). The decay times are weakly dependent on the wavelength 
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and range from 0.99 ns (445 nm) to 1.37 ns (490 nm). Contrary to the isolated emission 
observed from 2-MeBDI, in the structure of 3-HOBDI-A, where the molecules exist as 
hydrogen bonded chains (d(O―H···O)syn-syn = 2.754 Å, d(O―H···O)anti-anti = 2.682 Å), 
the cooperative effects from the intermolecular interactions are expected to affect 
significantly the emission intensity and the time-decay profile from the individual 
molecules. Accordingly, only a weak emission with one major emission peak with max
ex
 
= 390 nm and max
em
 = 440 nm is observed. At all wavelengths, the decays of the 
emission are non-monoexponential and ultrafast, the major amplitude with a contribution 
of > 98% weight corresponding to a species that decays within 10 ps, which remains 
below the detection limit. Similar efficient fluorescence quenching in the solid state was 
observed previously for 4-HOBDI.
7 
 Although each of 2-FBDI and 3-MOBDI contains a single structural type of the 
respective molecule, they exhibit at least two emission centers, which are separated better 
in the case of 2-FBDI. For 2-FBDI, the stronger emitter is excited at max
ex
 = 390 nm and 
emits at two wavelengths, max,1
em
 = 450 nm and max,1
em
 = 570 nm. The second emitter, 
excited at max
ex
 = 450 nm, exhibits wider energy distribution and emits at max,1
em
 = 500 
nm. At 595 nm, the lifetime of the second component is 2.7 ns. The two emissions of 3-
MOBDI are strongly overlapped. The species emitting at max,1
em
 = 450 nm decays at 130 
ps, while the one max,1
em
 = 500 nm, with rise time of 240 ps, follows a biexponential 
decay law, with component lifetimes of 1.5 and 10.6 ns and an amplitude ratio of 12:1. 
Unlike 2-MeBDI and 3-HOBDI, the molecules of 2-FBDI and 3-MOBDI are not 
completely isolated and they are not included in extensive hydrogen bonding. Instead, in 
both cases two molecules are stacked with each other with at least one half of their 
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skeleton (Figure 4.10). 2-FBDI forms antiparallel dimers, where both the phenyl and the 
imidazolone rings of one molecule are stacked with the imidazolone and phenyl ring 
from its molecular counterpart. In the structure of 3-MOBDI, the molecules are displaced 
relative to each other, so that only one half of the molecule forms stack with the neighbor 
molecule (that is, the phenyl ring is stacked with an imidazolone ring). The emission of 
the individual molecules in such case will be affected by the proximity of the molecules 
by activation of excimer transitions, which could explain the complicated pattern 
observed in the kinetics of their emission spectra. 
Photomechanical effects in crystalline BDIs 
Mechanical effects in photomechanically active materials
22
 and thermosalient 
crystals
23
 (the latter occasionally also referred to as “jumping crystals”), such as the one 
described here for 3-HOBDI, are extremely rare solid-state phenomena and are 
considered important for the design of actuators, as well as for conversion of the light or 
kinetic energy into mechanical work. In particular, photomechanical effects in the solid 
state present an opportunity for photoactuators in several photoactive systems. A large 
number of these have relied upon cis/trans isomerization of azobenzene as the structural 
perturbation, with a clever recent example.
22c
 More commonly, such effects have been 
developed for azobenzene-containing polymers,
24





 cycloadditions have been also reported. 3-HOBDI-A presents a startling 
example for which a unique polymorph presents a special deactivation pathway. 
The very low excitation power, uniform excitation of the crystal, high melting 
point, short exposure time and absence of photomechanical effects in the other 
compounds (even when the crystal shape is similar to that of 3-HOBDI-A, such as is the 
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case with 2-FBDI) all indicate that the photoinduced effects observed for 3-HOBDI-A 
are not due to heating or partial (surface) melting, but to the photochemical reaction 
which was evidenced by IR (Figures 4.5) and NMR spectroscopy for bulk samples. The 
two-dimensional excitation-emission profiles (Figure 5) show that contrary to the other 
compounds, the fluorescence of 3-HOBDI is quenched in the solid state. This 
observation may indicate deexcitation through non-radiative pathways due to strong 
intermolecular interactions (hydrogen bonding) or by means of photochemical reaction 
from the excited state.  
 
Figure 4.10. (a) Sheets of hydrogen bonded chains of syn (green) and anti (blue) 3-
HOBDI molecules in the crystal of 3-HOBDI-A. (b) and (d): AFM images of the crystal 
surface before and after UV irradiation, showing the UV-induced changes of the crystal 
surface morphology. (c) and (e): packing of the crisscrossed layers of syn-3-HOBDI 
(green) and anti-3-HOBDI (blue) in the unreacted crystal (c) and in a model structure in 
which the closer pairs are dimerized, considering the usual geometry of the central 
cyclobutane ring. 
 
The main reason behind the different photochemical properties and the 
appearance of dramatic photomechanical effects of 3-HOBDI-A, which are not observed 
for the other forms of 3-HOBDI and the other compounds in this group, are the strongly 
anisotropic packing interactions. As explained above, the structure of 3-HOBDI-A is 
composed of alternating and perpendicular to each other layered two-dimensional sheets 
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of all-syn hydrogen-bonded strings parallel to the c-axis and all-anti zigzag strings 

























































Figure 4.11. Polymeric (A, B) and dimeric (C) hydrogen bonding patterns observed in 
the three characterized polymorphs of 3-HOBDI 
 
Larger bunches of the coaxial molecular strings in 3-HOBDI-A are observed by AFM 
spectroscopy as ridges in the surface of non-irradiated crystal (Figure 4.11b). The surface 
of the crystal is relatively smooth with a roughness of 2.6–6.4 nm. From these 
dimensions, the surface of the crystal appeared fluted, reminiscent of a grating, with large 
ridges approximately 1 μm apart. Individual structures consist of smaller, parallel string 
substructures, with some layering close to the top of the features also being apparent. 
This arrangement is reminiscent of cylinders placed side-by-side. The molecules within 
the chains are held together by strong intermolecular O―H···O hydrogen bonds, whereas 
the stacked sheets are crisscrossed and interact with each other through weak ― 
interactions. Unlike forms B and C, for which the strong interactions in the crystal are 
confined within the doubly hydrogen bonded head-to-tail anti dimers (Chart 2), the 
infinite chains of strong hydrogen bonds in 3-HOBDI-A provide notable strength and 
flexibility within the sheets, and could act as basis for one-dimensional transfer of 
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cooperative effects within the crystal. Being glued by much weaker interactions, the 
shear-free, individual sheets have larger freedom to slide on the top of each other, which 
is related to the unusual elasticity of the crystals of form A during the bending.  
 Pairs of any two symmetrically non-equivalent molecules from the adjacent 
perpendicular strings (colored green and blue in Figure 4.10a), which are stacked in 
antiparallel displaced fashion, define two types of alternating C---C separations, with 
nearly identical inter-bond dihedrals: molecular pair 1 (3.648 and 3.555 Å, angle: 56.9
o
) 
and molecular pair 2 (4.005 and 4.176 Å, angle 57.3
o
). According to the topochemical 
criteria,
13
 it is expected that all bonds of the first, closer pair, are photoreactive. Although 
there might be competition for dimerization between the two pairs, the notable difference 
in the double bond separations at virtually identical relative orientations of the double 
bonds indicates that the dimerization of the double bonds within the pair of closer bonds 
(bond pair 1) is preferred and largely prevents subsequent reaction between the bonds of 
the more distant bonds (bond pair 2). Coincidentally, such dimerization leads to a 
trans,trans symmetric dimer which is the most stable according to semiempirical 
calculations.  Therefore, most of the molecules from one sheet selectively form dimers 
with their counterpart molecules from the other sheet rather than from different sheets, 
that is, the dimers are almost exclusively formed between molecular pairs 1 but not 
between molecular pairs 2, as shown in Figures 4.10. Due to the bending of the individual 
reacting molecules and the inclination of the phenyl rings upon the cyclobutane ring 
formation, the molecules of the dimerized sheets become devoid of the ― interactions 
with molecules from the adjacent dimerized (or still monomeric) sheets, thus resulting in 
“pairing” of the originally equidistant sheets and subsequent separation of the resulting 
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sheet pairs. The disappearance of the ― interactions, which served as weak “glue” 
between the paired sheets, increases their mobility in respect to each other, so that small 
perturbations such as local heating or defects are expected to cause significant and 
cooperative sliding of the sheets of dimers relative to each other. This photomechanical 
effect, which is macroscopically observed as bending of 3-HOBDI-A crystals, is induced 
by dimerization, and it is shear-driven at a molecular level. Moreover, because the 
original strings are composed of different types of molecules (syn and anti along the c 
and b axes, respectively), the preference for sliding along the two directions are different, 
which corresponds well with the subsequent bending along the second longest axis that 
ultimately results in twisting motion. Apparently, after maximum strain has been 
achieved by sliding of the paired layers in one direction, the sliding in the second 
direction becomes dominant to the point where the mechanical strain overweighs the 
cooperative forces and a macroscopic crack appears on the crystal perpendicular to its 
longest axis Figure 4.10. This mechanism is consistent with the absence of observable 
photomechanical effect in forms 3-HOBDI-B and 3-HOBDI-C, where the anti 
molecules form head-to-tail bonded dimers, despite the fact that both forms are 
photochemically active (IR spectroscopy). Although the dimerization in forms B and C 
occurs, the crystals do not bend, but instead they tend to crack normal to the longest axis. 
Similar disintegration is observed for the other photoreactive compounds (2-FBDI and 
2,5-DMBDI).  
 As exemplified with the syn chains in the mechanism shown in Figure 4.11, the 
formation of dimers inevitably results in disruption of the intermolecular hydrogen bonds 
by separation of the hydroxyl (donor) and keto (acceptor) groups from each other, which 
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is confirmed by the large blue shift (125 cm
1
) of the (OH) mode observed in the IR 
spectra of completely photoreacted sample. The disruption of the hydrogen bonds along 
the strings and the notable shrinkage of the strings due to the bending of the component 
molecules (Figure 4.11) is expected to result in accumulation of mechanical stress along 
the strings. On a microscopic scale, this perturbation of large numbers of molecules along 
the initially straight strings has to be released, which would affect the macroscopic 
appearance of the crystal surface. Indeed, AFM images of UV-irradiated crystal (Figure 
4.10) show that the crystal surface is visibly more disturbed, and the roughness has 
increased to 10–14 nm. The initially smooth parallel ―waves‖ appear ―chopped‖ and out-
of-plane, giving the crystal surface a fish scale appearance—a consequence of crystal 
bending and mass redistribution. The image of the crystal which remained unattached to 
the basis is similar but the roughness, depending on area, is as low as 7 nm but as high as 
43 nm.  
Packing effects on the photoisomerization by one-bond-flip  
In contrast to 3-HOBDI-A, 3-HOBDI-C allows us to test the influence of crystal 
packing on cis/trans isomerization. The hula twist has been accepted as a compelling 







 evidence exists that such a double motion 
pays considerable energetic penalties within the fluorescent protein barrel. Unfortunately, 
neither tyrosine nor phenylalanine, which form the aromatic rings of the largest group of 
protein chromophores, has a meta or ortho substituent to isolate the double twist. Either 
the tryptophan or histidine derivative (“cyan fluorescent protein”) could plausibly test 
such motions.  
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Although the relevance of our observations to the protein itself can be argued, we 
note that when the aromatic ring is constrained by hydrogen bonding as in 3-HOBDI-C, 
facile isomerization via one-bond rotation about the double bond occurs even within the 
solid state (Figure 4.9). From the X-ray diffraction analysis of partially photoreacted 
crystal, it is concluded that while dimers of the BDIs are obtained by high-energy 
excitation (365 nm; see the NMR, IR and MS results described above), in single crystals 
of 3-HOBDI-C, prolonged exposure to low excitation energies in the visible region 
(ambient light) cause Z―E isomerization with  one bond flip of the imidazolone ring. 
Similar dependence on the dimerization versus isomerization on the excitation energy 
was reported previously for solutions of 5-aryl- and 5-pyridylmethylenehydantoins.
29
 Our 
result represents the first direct evidence of such processes occurring in crystals of pure 
BDI chromophore. Based on this observation, we conclude that conservation of volume is 
not a sufficient impediment to isomerization via a bond twist.  
Closer analysis of the supramolecular structure in the 3-HOBDI-C crystal reveals 
an important effect of the photoreaction, induced from the excited state, to the 
intermolecular interactions. Assuming a statistical distribution of the product molecules, 
the small conversion (12.9%) implies that, after imidazolone ring flipping, almost every 
reactive molecule rebinds to its non-reacted counterpart (Figure 4.9). Therefore, because 
the position of the phenyl half of the molecule is essentially preserved in the product, a 
weaker hydrogen bond O―H···N (3.312 Å) is substituted for a stronger hydrogen bond 
O―H···O (2.655 Å). This clearly thermodynamically disfavored process is only possible 
from excited state. Once created, however, the flipped product is stabilized by the newly 
formed hydrogen bond, which is why the product molecule accumulates to detectable 
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amount. This result may have implications for the one-bond flip mechanism suggested 
for the GFP chromophore.  
The dimers in 3-HOBDI-B and 3-HOBDI-C are confined to a space of similar 
shape, and the two molecules within each dimer interact with hydrogen bonds of similar 
strength. Yet, only in the latter can flipping occur to a significant extent without 
interfering with the long-range crystalline order. This observation can be rationalized by 
inspection of the Hirshfeld surfaces
30
 plotted around the respective monomers (Figure 
4.12).  
 





 provide a convenient way to depict the molecular shape and to 
visualize the intermolecular interactions. They represent plots, which are obtained by 
partitioning the space in the crystal into regions where the contribution from the electron 
distribution of a sum of spherical atoms for the molecule exceeds the contribution from 
the corresponding sum over the crystal. From the red regions on the imidazolone ring in 
3-HOBDI-B it becomes apparent that it is sandwiched more tightly and interacts more 
strongly by the surrounding neighbor molecules. The imidazolone ring in 3-HOBDI-C, 





The spectroscopic and chemical properties of AMI chromophores within the solid 
state show great differences than those compared in solution.  It has been common 
practice to consider the reactivity of molecules independent of their extended 
environment. With the advent of ―supramolecular photochemistry‖, we now recognize 
that reactivity can be promoted or constrained by rigid environments. The systems 
studied here illustrate that when the ―solvent‖ is the molecule itself, the disposition of 
such molecules within the solid state can have a profound influence, and different 
polymorphs can have totally different reactivities. The way in which structure determines 
crystal packing and thus reactivity in the solid state continues to be an elusive and 
important goal.   
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ENCAPSULATION OF GFP CHROMOPHORE ANALOGS IN 
SUPRAMOLECULAR HOSTS:  OCTA ACIDS AND CHOLATE 
SALT AGGREGATES 




Introduction to octa acid cavitands 
 The chromophore

 in the green fluorescent protein (GFP) exhibits a remarkable 
difference in emission quantum yield as a function of sequestration within the -barrel.  
Upon denaturation, the fluorescence diminishes by four orders of magnitude, the result, 
presumably, of disruption of the restraining -barrel.
4
  The effect of sequestration has 
mostly been interpreted as inhibition of double bond twisting to a diradical state, although 
rotation about the formal single aromatic bond has been proposed.
5
  The former effect is 
somewhat belied by both the fluorescence of some chromophores which also undergo 
cis/trans isomerization and by the relatively modest viscosity effect.  Alternatively, a 
combination of the two twisting modes (“hula twist”) has been speculated to account for 
a volume conserving process within the -barrel (see Scheme 1).
6
  We were therefore 
intrigued with the possibility of encapsulation of the chromophore within a deep cavity 
cavitand, the so-called “octa acid” (OA), which forms a hydrophobic capsule-like 
container, of dimensions 14 x 7 Å upon dimerization
7
 and mimics the -barrel.   
Following the initial results from the encapsulation studies using various alkyl-substituted 
AMI’s the motivation arose to separate the influence of electronic and steric effects on 
the encapsulation phenomenon, which differ both in their steric volumes and the 
electronic effects, on the fluorescence turn-on. 
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 The BMI chromophores were synthesized using previously described methods.
8
 
(see R1 and R2 in Table 1) and were exposed to buffered solutions of OA in D2O.  In all 
cases, complexation of the chromophores
9
 was validated by the upfield NMR chemical 
shifts of the guests compared to CD3CN solvent, corresponding to placement of protons 
within the shielding region of the aromatic cavity.  As seen in our earlier studies,Error! 
Bookmark not defined.
,10
 the alkyl derivatives experienced strong shielding of both aryl 
ring and N-alkyl groups within the cavity.  Notably, CH3CH2- as an ortho substituent did 
not lead to a stable complex. 
Experimental for octa acid studies 
Stoichiometric titration 
Titration of OA solution (1 mM solution of OA made in 10 mM borate buffer in 
D2O) with GFP chromophore (in DMSO-d6) was studied by 
1
H NMR spectroscopy by 
gradual addition of guest (GFP chromophore) to the host solution. Titration showed that 
all of them form 1:2 capsular assemblies (G : H) with OA along with the up field shift of 
the guest’s proton signal. The guest resonances were assigned based upon systematically 





 M solution of GFP chromophore was prepared in benzene and in 4 10
-5
 M 
solution of OA (G : H = 1 : 4, 10 mM borate buffer solution).  Fluorescence spectra of 
these solutions were recorded (excitation 370 nm) and compared. For comparison of the 
fluorescence intensity the same excitation wavelength was used for each chromophore.  
Quantum yield  studies 
Quantum yields were determined the by relative method by using quinine sulfate 
standard (ex 349 nm, f = 0.54).  In each case the absorbance of the given samples (in 
H2O and in benzene) were matched to the standard (in 50 mM H2SO4) and maintained < 
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0.1.  Quantum yields were calculated using equation below, where F represents the 
emission area and is reflective index of the solvent. 




Photoirradiation of 10-5 M solution of GFP chromophore in OA (H : G = 2:1, 
2*10-5 M) and benzene was done a using 310 nm filter.  Fluorescence measurements 
were taken after given increments of time to note the intensity change of the 
chromophore.  
Photochemistry Studies 
A 0.5 mM solution of GFP chromophore was prepared in CD3CN and complex 
solution of these compounds were prepared in 1 mM octa acid solution (H:G = 2:1, 10 
mM borate buffer solution of D2O).  These solutions were irradiated using a 310 nm 
filter.  The relative time required to reach photo stationary state for conversion of cis 
isomer to trans isomer (TPSS) and the ratio of two isomer was monitored by 
1
H NMR.  
Thermal Isomerization Studies 
A solution of OA (1mM) and cis and trans-GFP were prepared in a 2:1 ratio.   A 
0.5 mM solution solution of the given GFP chromophore in CD3CN was prepared. These 
solutions were irradiated using a 310 nm filter and additionally were separately heated at 
60 
o
C in water bath.  The relative ratios of the given isomers was monitored by 
1
H NMR.   
 
Encapsulation studies of alkylated AMIs within octa acids 
General Overview of alkylated AMIs within octa acids 
Using previously described methods, we synthesized a number of benzylidene-3-
methylimidazolidinones (“BMIs”) with alkyl groups on both the phenyl ring and C-2 (see 
Table 1) and exposed them to buffered solutions of OA in D2O.
11
  Complexation of the 
chromophores is associated with upfield chemical shifts, corresponding to placement of 
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protons within the shielding region of the hydrophobic (aromatic) cavity (see 
supplementary information).  For reference spectra, acetonitrile-d3 is used.  As we 
anticipated from earlier studies, the p-methyl or p-ethyl derivatives exhibited strong 
shielding of the alkyl groups within the cavity, as did the N-alkyl groups > ethyl (see 
below).  In contrast, m- and o-alkyl groups were shielded less effectively, suggesting that 
the para groups anchor the aryl group effectively at one end of the capsule.   
Examination of the effect of encapsulation on fluorescence led to relative 
quantum yields, relative to benzene solution, which were at variance with our 
expectations based upon anchoring of the aryl groups.  Thus neither the para-alkyl group 
nor the meta- alkyl group was effective in ameliorating internal conversion.  In contrast, 
the ortho-alkyl groups had a dramatic effect, increasing the emission intensity by ca. one 
order of magnitude.  
GFP chromophores, as do certain GFP mutants, undergo relatively efficient 
cis/trans isomerization.
12
 Thus we were intrigued by the possible effect of encapsulation 
on the photochemistry as well.  Indeed, all of the chromophores, which were produced in 
their initial cis configuration, readily underwent isomerization in CH3CN to reach a 
      
# R1 R2 # R1 R2 
1 H Me 10 2-Me n-Bu 
2 2-Me Me 11 2-Me n-Pent 
3 3-Me Me 12 3-Me n-Pr 
4 4-Et Me 13 2-Et n-Pr 
5 2,5-Me Me 14 4-Me Et 
6 4-Me Me 15 4-Et n-Pr 
7 2-Et Et 16 4-Me n-Pr 
8 2-Me Et 17 2-Me i-Pr 







Table 5.1.  Substitution pattern of BMIs incorporated in octa acid cavitand.  
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photostationary state (PSS) with cis:trans ranging from ca. 40:60 to 60:40 (see Table 5.2).  
In contrast, irradiation in OA capsule produced, in most cases, PSS favoring the less 




NMR Studies of alkylated AMIs within octa acids 
The PSS favoring trans is rationalized by the more efficient sequestration of the 
two ends of the molecule in the more extended conformation.  The OA causes the 
chemical shifts of the N-alkyl substituents in the cis isomer to be greatly shifted upfield 
as a result of placement within the shielding region of the aromatic rings.  Upon 
conversion to the trans isomer, the N-alkyl protons are shifted downfield, while the C-2 
methyl substituent is shifted upfield, reflecting a better fit when the imidazolinone ring is 




Figure 5.1. Representative emission spectra showing the response of o–Me substituted 
GFP chromophore and benzyl GFP chromophore (parent compound) in OA (blue) (H:G 









































No. OA (cavitand) CD3CN  Emission 
 After irrad. 
(cis:trans) 
TPSS (min) After irrad. 
(cis:trans) 
TPSS (min) f 
(in OA) 
x10-3 
1 5 : 95 6 50:50 10 5.64 
2 22:78 8 43:57 10 0.95 
8 22:78 8 58:42 10 3.04 
9 6:94 2 39:61 10 4.42 
10 24:76 10 39:61 10 3.83 
11 2:98 10 39:61 10 1.17 
  








H NMR spectra. Irradiations were done by using a 310 nm cutoff filter. 
b








H NMR (500 MHz) spectra of selected OA-complex of cis- isomer of GFP 








Figure 5.4. 1H NMR spectra of selected OA-complex of cis and trans isomer of given 
GFP chromophores with OA (h:g = 2:1).  Trans signals are denoted with a (‘).  
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This is further supported by the increasing trans isomer in the case of the o-Me derivative 
on progressing from methyl through pentyl on the imidazolidinone ring, which packs the 
molecule more tightly.   
 
We note, parenthetically, that while the cis isomer is the most stable one in solution, 
encapsulation of the chromophore drives the photostationary state toward the trans 
isomer, reflecting the more favorable equilibrium for encapsulation of the trans.  
Similarly, the slow ground-state isomerization of the chromophore also drives formation 
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 o-F/N-Me in benzene 
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Figure 5.5.  Fluorescence emission spectra  of  photoirradiation of GFP-chromophore in  






H NMR (500 MHz, 10 mM sodium tetraborate in D2O) spectra for the 
capsular assemblies of (i) cis-o-Me/N-Pr@OA2 (9) and (ii) trans-o-Me/N-Pr@OA2 (9). 
(Host resonances are represented as ‘a-g’; ‘●’ represents the ~5% of cis- isomer and ‘*’ 
represents the residual water resonances). 
 
Curiously, the propensity for cis/trans isomerization does not correlate readily 
with internal conversion efficiency.  Isomerization of stilbene-like molecules, for 
instance, is generally associated with formation of a twisted-diradical state which 
quenches fluorescence.
13
  In our case, the presence of an ortho substituent inhibits 
internal conversion without necessarily inhibiting isomerization.  We are forced to 
conclude that, within the OA capsule, the ortho substituent prevents ready twisting 
around the single bond (motion ).  Thus when single-bond rotation is prevented, less 
efficient internal conversion allows either fluorescence or double-bond isomerization to 
take place.  In solution, however, the combination of one-bond flip with efficient single-
bond twisting allows both ready isomerization and efficient internal conversion.  As we 
have observed, in the protein a low frequency motion is largely responsible for the loss of 
fine structure and contributes heavily to internal conversion.
14
 
Finally, we note that, in cases where the cis form fluoresces, the PSS also 
fluoresces, although with an efficiency that requires a much lower quantum yield from 
the trans form.  We note, parenthetically, that so-called switchable fluorescent proteins 
exhibit similar behavior,
6b,15
 with fluorescence almost invariably occurring 
predominantly from the cis form. 
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Steric and electronic studies of encapsulated AMIs within octa acids 
General Overview of steric/electronic studies of AMIs within octa acids 
Following the success of encapsulation of alkylated AMIs, the necessity arose to 
determine the steric and electronic parameters relative to the substitution patterns.  This 
motivation arose from the observation that ortho substitution gave the greatest emission 
quantum yield within the alkylated AMIs.  To explore this motivation, the electronic and 
steric effects on excited-state decay by appealing to the fluorescence quantum yields Φf
X
 















) is the rate constant for total 
decay and knr
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).  Making the somewhat less than rigorous assumption that the 











.  Strictly speaking, we are interested in non-




, but for relatively low Φf
X
 we can assume that total decay 
is dominated by internal conversion.  Spectroscopic data used for these equations is 
provided in Table 5.3. 
Substituent effects are classically a function of electronic and steric effects, 
represented by a Linear Free Energy (LFE) relationship (see Equation 1).  Here σ is the 
Hammett substituent constant and ρ is the reaction constant, while χ is a steric constant 
and α is the related proportionality constant.  Steric constants have been represented in a 




  However, these 
generally do not capture the total volume of a substituent, but rather only its steric 
hindrance, which may be inappropriate for the effect within a confined space.  For 
instance, a methoxy group has a larger volume but a smaller A-value than a methyl group 
because the nearest neighbor atom is smaller.  Instead we deem it more appropriate to 
represent χ by the change in molecular volume, determined via DFT calculations, upon 
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Table 5.3. The quantum yield of chromophores in OA (G : H = 1 : 4) and in benzene. 
 
# Chromophore 
Quantum  yield  








f  (in OA) / f  (in 
Benzene) 
1 H/N-Me 3.3 1.4 2.4 
2 o-F/N-Me 69.0 4.4 15.7 
3 m-F/N-Me 125.5 8.8 14.2 
4 p-F/N-Me 2.3 1.2 1.9 
5 o-Cl/N-Me 78.0 5.6 13.9 
6 m-Cl/N-Me 18.8 6.8 2.8 
7 o-Br/N-Me 137.7 5.3 26.0 
8 m-Br/N-Me 13.50 6.5 2.1 
9 p-Br/N-Me 15.4 3.3 4.7 
10 o-Me/N-Me 1.4 1.0 1.4 
11 m-Me/N-Me 1.2 1.3 0.9 
12 p-Me/N-Me 1.7 0.8 2.1 
13 o-OMe/N-Me 2.3 1.1 2.0 
14 o-OMe/N-Me 2.3 1.1 2.0 
15 p-OMe/N-Me 1.0 0.6 1.7 
16 o-CF3/N-Me 435.6 38.8 11.2 
17 m-CF3/N-Me 75.5 13.1 5.8 
18 H/N-Pr 14.7 1.4 11.3 
19 o-Me/N-Et 3.2 1.3 2.5 
20 o-Me/N-Pr 10.0 1.5 6.7 
21 o-Me/N-Butyl 4.9 1.1 4.5 
22 o-Me/N-Pentyl 2.2 1.2 1.8 
23 m-Me/N-Pr 2.0 1.4 1.4 
24 p-Me/N-Pr 2.3 0.9 2.6 
25 m-F/N-Pr 215.6 8.8 24.5 
26 p-F/N-Pr 7.3 1.8 4.1 
27 o-Cl/N-Pr 163.4 5.6 29.1 
28 m-Cl/N-Pr 20.0 5.8 3.4 
29 o-Br/N-Pr 183.4 5.2 35.7 
30 m-Br/N-Pr 7.6 7.1 1.1 
31 p-Br/N-Pr 28.6 2.9 9.9 
32 o-OMe/N-Pr 9.0 1.0 9.0 
33 m-OMe/N-Pr 10.7 2.2 4.9 
34 p-OMe/N-Pr 1.3 0.6 2.2 
35 o-CF3/N-Pr 146.0 41.3 3.5 




replacing hydrogen with the substituent on benzene in the case of R1 and 














) = σ∙ρ + α∙χ1 + β∙χ2     2 
 
Use of the Hammett equation for excited-state processes has a somewhat 
checkered history, and there have been a number of substituent constants proposed for 
photochemical processes.
18
  To determine the relationship between electronic (Hammet 
parameters) against emission of GFP encapsulated within octa acid cavitands, quantum 
yields of the GFP- chromophore analogs with a methyl substitution on the N-terminus of 
the imidazolinone with varying phenyl substitutions were measured in benzene and OA.  
The data for these experiments is presented in the below tables and tabulated within the 
chart that follows.  The logarithmic value of the ratio of emission intensity of these 
chromophore with parent compound, unsubstituted benzyl derivative, was plotted with 

































































































Figure 5.7.  Representative emission response showing the spectra of –CF3 substituted 





























Table 5.4. Fluorescence quantum yield vs.   in benzene (Hammatt’s plot). 
 
Chromophore 




  [in X axis] 
log (QY/1.4) [in Y 
axis] 
H/N-Me 1.4 0 0 
H/N-Pr 1.4 0 -0.0165 
m-Me/N-Me 1.3 -0.069 -0.0203 
m-Me/N-Pr 1.4 -0.069 -0.00972 
p-Me/N-Me 0.8 -0.17 -0.2521 
p-Me/N-Pr 0.9 -0.17 -0.20165 
p-OMe/Me 0.6 -0.268 -0.3530 
p-OMe/Pr 0.6 -0.268 -0.3607 
m-OMe/Me 2.2 0.115 0.2049 
m-OMe/Pr 2.2 0.115 0.1983 
m-F/N-Me 8.8 0.337 0.7963 
m-F/N-Pr 8.8 0.337 0.7974 
p-F/N-Me 1.2 0.062 -0.0551 
p-F/N-Pr 1.8 0.062 0.1203 
m-Cl-Me 6.8 0.373 0.6864 
m-Cl/N-Pr 5.8 0.373 0.6188 
m-Br/Me 6.5 0.393 0.666391 
m-Br/Pr 7.1 0.393 0.703942 
p-Br/Me 3.3 0.232 0.3760 
p-Br/Pr 2.9 0.232 0.3193 
m-CF3/N-Me 13.1 0.43 0.9711 
m-CF3/N-Pr 13.1 0.43 0.9734 




Figure 5.9.  Hammett’s plot of emission intensity vs. electronic effect () in Benzene. 
Figure 5.8. Hammett’s plot of emission intensity vs. electronic effect () in OA. 
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Table 5.5. Fluorescence quantum yield vs.   in OA (Hammatt’s plot). 
 
Chromophore 
Quantum yield in OA 
(QY) 
  [in X axis] 
log (QY/3.3) 
[in Y axis] 
H/N-Me 3.3 0 0 
Bz/N-Pr 14.7 0 -0.38492 
m-Me/N-Me 1.2 -0.069 -0.4457 
m-Me/N-Pr 2.0 -0.069 -0.21826 
p-Me/N-Me 1.7 -0.17 -0.2939 
p-Me/N-Pr 2.3 -0.17 -0.15623 
m-OMe/Me 3.8 0.115 0.06751 
m-OMe/Pr 10.7 0.115 0.5156 
p-OMe/Me 15.4 -0.268 -0.4825 
p-OMe/Pr 28.6 -0.268 -0.3939 
m-F/N-Me 125.5 0.337 1.58 
m-F/N-Pr 215.6 0.337 1.81 
p-F/N-Me 2.3 0.062 -0.149 
p-F/N-Pr 7.3 0.062 0.3487 
m-Cl-Me 18.8 0.373 0.7135 
m-Cl/N-Pr 20.0 0.373 0.6721 
m-Br/N-Me 7.6 0.393 0.36658 
m-Br/N-Pr 13.5 0.393 0.616965 
p-Br/Me 15.4 0.232 0.6729 
p-Br/Pr 28.6 0.232 0.9424 
m-CF3/N-Me 75.5 0.43 1.3636 
m-CF3/N-Pr 171.2 0.43 1.719 
 
 
The data clearly show that an excellent correlation exists for the chromophores within 
benzene but this relationship is somewhat muddled when the chromophores are  
encapsulated within octa acid.  As is generally the case in LFEs, we appeal to the success 
of the method at reproducing data. Moreover, while LFEs are well developed for meta  
and para substituents, the use of σ-values for ortho substituents is fraught with problems, 
almost all of these have to do with dissecting electronic vs. steric effects.
19
  Thus we 
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adopt the ortho σ-values developed by Tribble and Traynham, which are based upon the 
apparently sterically-independent chemical shifts of phenols.
20
   
Using benzene solvent as a proxy for the aromatic OA interior,
21
 we perform a 
linear regression on Equation 2 for each of the ortho, meta, and para substituents, 
obtaining the correlation (open circles) shown in Figure 5.10.  We now consider the 



























Figure 5.10.  Fit of Equation 2 to experimental data. 
 
 Host ρ α (R1) β (R2) 
Ortho  C6H6 1.17 0.011 -0.001 
Weight  84.1% 15.1% 0.8% 
Meta  C6H6 1.92 0.002 0.000 
Weight  99.7% 0.3% 0.0% 
Para  C6H6 1.17 -0.001 -0.001 
Weight  98.5% 0.4% 1.1% 
Ortho  OA 1.88 0.014 0.010 
Weight  82.7% 9.1% 8.3% 
Meta  OA 3.09 -0.009 0.005 
Weight  90.4% 8.1% 1.6% 
Para OA 2.11 0.003 0.003 
Weight  96.6% 1.7% 1.7% 
 
Table 5.6. Relative contribution of electronic and volumetric factors. 
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each factor (see Table 2).  First, we consider the substituent effects in benzene.  We note 
that the electronic effect of the substituent σ dominates the decay, and the effect of the 
ortho substituent is similar to that of the para, consistent with the usual ortho/para 
formalism.  Second, the effect of the substituents is almost entirely electronic. 
The one exception, of course, is the ortho substituent, where 15.1 % of the 
variance is due to the steric effect.  Again, this is not surprising given the difficulty in 
dissecting steric from electronic effects in ortho substituents.  Third, the N-alkyl 
substituent (R2) has almost no effect, in agreement with little steric perturbation of the 
transition state.  Finally, the ρ-value is positive and >1, indicating substantial negative 
charge transfer to the aryl ring in the transition state for decay.  Since the excited-state 
can be represented by a diradical and is known to have significant negative charge 
transfer to the imidazolidinone ring, it is not surprising that internal conversion would 
reflect that reverse charge transfer.  We now consider the effect of encapsulation.  Unlike 
the results in benzene, the remote N-alkyl substituent has a significant effect (see Table 
2), approaching that of the ortho substituent and decreasing in the order 
ortho>meta>para, as suggested by our previous results.Error! Bookmark not defined.  
Curiously, as we increase the volume in the series R2 = Me, Et, Pr, Bu, and Pn (pentyl), 
keeping R1 = Me, we see a linear increase, then a decrease, in the fluorescence 
enhancement (see Figure 5.11), reflecting, presumably, the effect of locking, and then 
overcrowding, the capsule.  Parenthetically, we note that the Charton and A-values for 
propyl, butyl, pentyl are nearly identical,
16
 validating our use of molecular volume.  For 
this reason, we restrict our consideration to Me and Pr as N-alkyl groups but maintain the 
linearity with volume as the contribution to the LFE.  
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Comparing the steric effects for ortho, meta, and para, we see a decreasing steric 
effect for the phenyl substituent and a more dramatic decrease for the N-alkyl substituent.  
The “locking” effect we suggested earlierError! Bookmark not defined. is seen more clearly, 
with the ortho and meta substituents having a major steric effect while the para 
substituent, which cannot prevent aryl rotation, having less impact.  
Finally, we consider the nature of the Hammett -value in the capsule.  With 
some variation for the ortho, meta, and para substituents, which presumably result from 
different sets of -values in each case, in all cases, we note that >PhH.  Thus 
internal conversion within the octa acid must require more charge transfer back to the 
ground state, resulting in the observed higher values for within the octa acid than in 
benzene solution.  This may reflect a larger amount of twist within the capsule than in 
benzene.  Thus the role of the host molecule in rigidifying the chromophore is clearly 
demonstrated. 
In other guest molecules, including biomolecules, we have observed analogous 
rigidification of FP chromophores which are dependent upon structure in analogous 
ways.  We believe that such topological control of fluorescence represents a diverse 
















Figure 5.11.  Effect of N-alkyl substituent. 
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Introduction to cholate salt aggregates 
 Bile salts, including sodium cholate (NaCh), are amphiphilic molecules with a 
concave hydrophilic side and a convex hydrophobic side.
22
 By forming aggregates in 
aqueous solution, these natural surfactants serve vital biological roles for the 
solubilization of cholesterol, lipids, and fat-soluble vitamins, and thus are involved in the 
transport and absorption of important biological molecules.
23
  The aggregation of bile 
salts has been the focus of literature review.
24
  A widely adopted model argues that at low 
concentrations, bile salt monomers aggregate to form single primary binding sites while 
at high concentrations further aggregation results in the formation of secondary binding 
sites (See Figure 5.12).
25
  Additional models argue the formation of hydrogen bonds 
between monomer units
26
 while a third model argues the interactions are not defined in 
that multiple interactions may interplay to the overall system.
27
  A general classification 
of the binding sites is marked by their encapsulation of both hydrophobic molecules 
(hydrophobic site) and hydrophilic molecules (hydrophilic site).
28
  Following our success 
with encapsulation of fluorescent protein chromophore (FP) analogs by synthetic 
hydrophobic and hydrophilic hosts, based upon substitution patterns,
29
 we now report the 
Hydrophobic Site 
Hydrophilic Site 
Figure 5.12.  Idealized bile salt aggregate showing hydrophobic (yellow) and 
hydrophilic (orange) binding sites. 
 107 
binding and turn-on of other analogs by bile salt aggregates, observations which may lead 
to new tools for studying trafficking in these important systems. 
Experimental for cholate salt aggregate studies 
Titration Experiments 
A series of cholate solutions were prepared by dissolving given aliquots of a 
NaCh stock solution (400nM) in 0.2M NaCl aqueous solution.  The solutions prepared 
contained a final NaCh concentration of:  (0, 10, 20, 30, 40, 60, 75, 100, 125, 150, 175, 
200) mM.  To each of these solutions, 0.02mL of chromophore stock solution (5mM) was 
added and allowed to stir capped for 24hrs under ambient conditions.  Absorbance and 
emission spectra of each solution was taken to determine the optimal NaCh concentration 
for other experimental conditions.  These tests were repeated 3 times to ensure 
reproducibility.   
Emission Quantum Yield Studies 
Quantum yields were determined the by integrative method by using quinine 
sulfate standard (ex 349 nm, f = 0.54).  In each case the absorbance of the given 
samples (in 0.2M NaCl solution) were matched to the standard and maintained < 0.1.  
Quantum yields were calculated using the equation below, where I represents the 
emission area and is reflective index of the solvent. 
Φsample  = Φreference ( Isample / Ireference) ( sample / reference)
2
 
Emission “turn-on” Ratio Experiments 
For each chromophore, a 0.02mL aliquot of chromophore stock solution in MeOH 
(5mM) was added to 2.0 mL of a 75mM NaCh / 0.2M NaCl aqueous solution.  Baseline 
fluorescence of studied chromophores was determined using a 0.02mL aliquot of 
chromophore stock solution in 0.2M NaCl aqueous solution.  Both solutions were 
allowed to stir capped under ambient conditions for 24 hrs before measurement.  Relative 
turn-on ratios were determined by dividing the corrected absolute peak intensity with and 
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without NaCh present.  The reported values in Table 1 within the manuscript represent 
the average of 3 trials. 
Isomerization Study 
A 0.02mL aliquot of chromophore stock solution (5mM) was added to 2.0mL of a 
75mM NaCh / 0.2M NaCl aqueous solution.  The sample was irradiated at 310nm for the 
given time intervals followed immediately by collection of an emission spectrum.   
For the NMR study, a chromophore solution was prepared in CD3CN and added to a 
75mM NaCh / 0.2M NaCl deuterated solution (prepared in D2O).  This solution was 
irradiated for 24 hrs and following at 310nm which was directly followed by collection of 
NMR spectrum. 
 
Results of inclusion studies within cholate salt aggregates 
AMIs were synthesized using previously described methods (see Table 5.6).
30
  
Substituents for the FP analogs were chosen based upon the hydrophobic/hydrophilic 
nature and their steric bulk.  For all studies, 0.2 M NaCl aqueous solutions were used and 
were allowed to stir 24 hrs prior to measurement to allow equilibrium. Encapsulation of 
the chromophores into the binding sites was marked by a shift in the absorbance 
maximum compared to that of free chromophore in solution.   The hydrophilic 
chromophores are included in the hydrophilic sites whose interaction with the 
chromophores is starkly different, thus allowing for significantly more non-radiative 
processes and lower quantum yields.  Additionally, a wide variation in turn-on ratios is 
noted, with the hydrophobic chromophores most sensitive due to structural changes in the 
bile salt aggregation site structure upon inclusion.  This phenomenon has been noted for 
bile salts.
4,31









Table 5.7.  FP Analogs and Spectroscopic Characteristics in bile salt aggregates.  
a
Intensity(AMI+NaCh)/Intensity(AMI) at em.  AMI [10
-5
 M] and  NaCh [75 mM] was 
used. 
b











1 H Me 19 347/352 1.25 
2 4-Br Me 96 353/360 2.06 
3 2-CF3 Me 157 340/354 2.10 
4 3-CF3 Me 75 346/357 2.12 
5 4-CF3 Me 122 348/359 2.15 
6 4-OH Me 2 372/383 0.77 
7 2-Br Me 57 348/359 2.01 
8 2-Cl Me 93 348/359 1.88 
9 3-OH Me 5 354/358 0.75 
10 H n-Pr 44 340/355 2.13 
11 2-CF3 n-Pr 212 340/355 2.98 
12 4-OH n-Pr 5 371/379 1.65 
13 2-Cl n-Pr 167 350/361 2.76 
 
Titration of AMIs with NaCh shows an emission enhancement with increasing 
concentration, owing to the continuing formation of hydrophobic binding sites.
33
   
Figure 5.13.  Titration of 11 with NaCh in 0.2 M NaCl 
 
Figure 5.13 shows the fluorescence response with 11 where peak enhancement is 
















a standard, F/Fo ratios were calculated using 75 mM NaCh for all experiments.  Support 
for the inclusion of hydrophobic chromophores into the hydrophobic sites is also shown 
through spectroscopic shifts in cyclohexane vs. water.  Table 5.7 and Figure 5.14 show a 
distinct red shift in absorbance upon inclusion due to the change in polarity.   
 
An additional bathochromic shift of 7nm is observed compared to cyclohexane, perhaps 
due to planarization of the chromophore.  This result is also rationalized through the 
higher F/Fo ratios achieved by the hydrophobic chromophores in 75 mM NaCh solution.  
The data in Figure 5.13 were fit to a two-site cooperative binding model
34
 with two 
dissociation constants (Kd) of 74 mM and 2.0 mM and a saturation ratio of 73.   
























 4-OH in 0.2 M NaCl






 in 0.2 M NaCl
 2-CF
3
 in 75 mM NaC
Figure 5.14.  Absorbance spectra comparing 11 in NaCh and 11 in cyclohexane.  Note 
that similar shifts are observed when encapsulated within NaCh and dissolved in 
cyclohexane owing to inclusion into primary aggregates. 
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In solution, rapid deactivation (<1 ps) of FP chromophores is attributed to 
twisting in the excited state, leading to isomerization and taking the chromophores from 
the fluorescent cis (Z) isomer to the non-fluorescent (E) isomer.
35
  Irradiation of 11 
within cholate aggregates shows a quenching of fluorescence, consistent with the 
conversion of the initially planar cis isomer--the initial conformation of all AMIs--to the 
non-planar trans isomer.   
 
This observation is further confirmed by NMR studies which show significant amounts of 
the trans product produced following irradiation with NaCh present.  Additionally, this 
reinforces the significance of rotation about the formal single aromatic bond toward the 
overall photophysics of AMI’s, since from Figure 5.15 we conclude that inclusion 
inhibits internal conversion (via blocking rotation about the formal single aromatic bond) 
but not isomerization, an observation reminiscent of previous work within our group 
documented in the literature
5
.   






















 0     Min
 5     Mins
 10   Mins
 20   Mins
 30   Mins
 40   Mins
 50   Mins
 70   Mins
 100 Mins
Figure 5.15.   Irradiation of 11 in 75 mM NaCh. 
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Hydrophobicity is generally indicated by octanol/water partition coefficients (log 
P values, Table 1) that can be estimated using computational means.  While the 
hydrophobic/hydrophilic substituent of the chromophores dictates their general inclusion 
into hydrophobic and hydrophilic aggregation sites respectively, a plot of F/Fo vs. log P 
values (not shown) provides a good correlation of the emission response to the 
hydrophobic nature of each chromophore.  It should be noted that for AMIs 3, 4, and 5, 
with similar substitutions, the log P is ~2.10, but yields significantly different F/Fo values.  
This is consistent with the results of Amundson, et al., who showed that packing of NaCh 
monomers around hydrophobic aromatic guests depends upon the shape and dimensions 
of guests to provide optimal encapsulation efficiency.  We surmise that, for 3 and 11, the 
o-CF3 group provides optimal characteristics, most likely obtaining an optimal packing of 
the monomer units
36
 forming the adaptable aggregate cavity, while the n-Pr substituent 
provides additional hydrophobicity, yielding an even greater interaction and inhibiting 
deactivating torsional motions. We note parenthetically that a similar “ortho” effect holds 
7.207.407.607.808.008.208.408.608.809.00
7.207.407.607.808.008.208.408.608.809.00
Figure 5.16.  NMR spectra of 11 in 75mM NaCh (10% CD3CN/90% D2O) with no 
irradiation and 18 hrs of irradiation at 310 nm.  Black arrows indicate cis isomers 
while red arrows represent trans isomers. 
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true in bile salts and in “octa acid” cavities,
29
 again reinforcing the role of twisting about 
the single bond.  
It is tempting to conclude that the two-site binding model obtained from the fit of 
Figure 5.13 represents the affinity for the two binding sites in the cholate aggregates.  
However, the equilibria for such complexes is extraordinarily complicated, and our data, 
because of the scatter in these slowly equilibrating systems, do not allow a definitive 
conclusion.  Nevertheless, the use of such turn-on small fluorophores certainly provides 
an additional tool to study such complexation.   
In summary, following encapsulation of FP chromophores, bile salts inhibit non-
radiative decay processes and thus restore some of the EQY by mimicking -barrel 
conditions.  Encapsulation of hydrophobic chromophores is markedly different due to the 
guest interactions, which recently were shown to dictate the guest-aggregate system
37
, 
with the bile salt aggregate resulting in planarization of the chromophore and a distinct 
EQY enhancement.  The biological role of bile salts within the body allows them to act as 













log P (Partition Coefficient)
Figure 5.17.  Log P values vs. F / Fo enhancement ratios of all compounds studied 
noting the  correlation observed between emission enhancement and electronic 
parameters.   
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relationships of these compounds with macromolecular transporters can provide 
significant information allowing for the optimal design of compounds for both probes and 
medicinal purposes.  Additionally, various biological processes and interactions 
involving bile salts remain mysterious.  AMIs within this study allow us to develop 
fluorescent probes for bile salt aggregates to examine these interactions.  Of specific note 
are the interactions of bile salts with nuclear receptors and other proteins, for which our 
group has developed fluorescent probes different from those highlighted in this 
manuscript.
38
  It is instructive to note that in vivo, bile salts are mixed with lipids and 
behave differently than bile salts in solution.
39
  With this, the interaction of the 
chromophores will be different; however the presence of restrictive aggregate sites 
should encapsulate the chromophores, yielding a fluorescence response and making these 
useful probes within these systems.  This work shows that FP chromophores provide a 
convenient tool for studying the macromolecular environment of bile salts.  These results 
demonstrate that the subtle interplay between the bile salt host and its guests is significant 
to the details of the encapsulation complex.   
Conclusions 
As noted from the octa acid and cholate salt aggregate studies, the inclusion of 
GFP chromophore analogs into supramolecular spaces results in a emission quantum 
yield enhancement.  Irradiation studies show that this enhancement is a function of 
hindering the free rotation about the aryl-single bond.   
 
Figure 5.18.  Depiction of photophysical processes within GFP chromophore analogs 
upon inclusion within supramolecular hosts. 
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In both studies cis/trans isomerization was noted in both cases leading to a quenching of 
fluorescence due to the conversion of the fluorescent cis isomer to the non-fluorescent 
trans isomer.  Studies within the octa acid showed that this was even further accelerated 
due to the stabilizing of the trans isomer within the cavitand.  Regardless of the 
consequence of irradiation, the results within this chapter show that inclusion within a 
host system provides a means to restore a portion of the emission quantum yield 
rendering these chromophores useful for application as fluorescent probes.  Additionally, 
these results show the importance of the free rotation about the single aryl bond as a 
method of deactivation possibly contributing to the rapid internal conversion experienced 
by these chromophores outside of the protective -barrel.  The consequences of this 
chapter will be the foundation of multiple chapters within this dissertation that follow this 
one on the motivation that inclusion of these chromophores coverts these essentially non-
fluorescent molecules into fluorescent ones providing the framework for molecular 
probes.     
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FLUORESCENCE RESPONSE PROFILING OF THE GREEN 
FLUORESCENT PROTEIN CHROMOPHORE AND ITS 
DERIVATIVES. 
 
(Copyright 2011 by the American Chemical Society1) 
This work was carried out in collaboration with the laboratory of Dr. Young-Tae 
Chang at the National University of Singapore.  All compounds were synthesized within 
the Tolbert lab and emission data gathered at the Chang lab.  Data analysis and 
manuscript composition were equally shared.  For the purposes of maintaining the same 
terminology as found within publication, “BDI” is used throughout this chapter but refers 
to the same compounds as is found throughout this manuscript as “AMI”. 
Introduction 
The green fluorescent protein (GFP) has attracted great attention as a fluorescent 
probe to study diverse problems in molecular biology.2 Taking advantage of the 
autocatalytic cyclization and oxidation of three amino acid residues to form a natural 
chromophore (p-hydroxybenzylideneimidazolone, p-HBDI),3 GFP generates a very 
effective and intense fluorescence signal. Nevertheless, investigation of the chromophore 
reveals distinct differences in fluorescent properties between wild type GFP (wt GFP) 
and the synthetic chromophore. The fluorescent quantum yield of the synthetic 
chromophore is much less and shows solvent and temperature dependence.4 Studies 
suggest that the GFP -barrel structure plays a critical role in protecting the chromophore 
and reducing conformational flexibility and thus diminishing the rate of radiationless 
decay. Within the rigid -barrel structure, p-HBDI undergoes excited-state proton 
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transfer (ESPT)5 from the chromophore to the adjacent residue, E222,6 resulting in very 
efficient emission from the anionic form. To exploit the GFP chromophore as a sensor, 
this environment-sensitive fluorescence turn-on phenomenon is utilized in several bi-
molecular fluorescence protein sensors.7 However, the chromophore itself is rarely 
scrutinized to detect analyte molecules directly.  
We envisioned that synthetic GFP chromophore derivatives have superior 
potential as small molecule fluorescent sensors, due to their desirable characteristics such 
as extremely low background in aqueous solution and high environmental sensitivity. 
Low background sensors are favorable in many applications due to their high signal-to-
noise ratio.8 Recently, the Burgess group has demonstrated that, by incorporating an 
ortho-aryl BF2 group which complexes with the imidazolone nitrogen, the conformation 
of the chromophore can be frozen and the emission turned on.9 Similarly, Chou has 
demonstrated that incorporation of an ortho hydroxyl group can turn on the emission 
through intramolecular hydrogen bonding, leading in the latter case to excited-state 
proton transfer.10 We concluded that such fluorescent turn-on detection for target 
molecules could be attained by specific interactions between GFP chromophores and 
analyte molecules, which instead of freezing the conformation intrinsically through the 
structure of the chromophore, instead freezes the conformation after complexation with 
the analyte.  Indeed, recently we observed that proper construction of a hydrophobic 
chromophore could increase the fluorescence response by a factor of 15.11 Accordingly, it 
would be of interest to investigate the chromophore modes of interaction with 
endogenous biomolecules, despite most previous studies, which focused on the nature of 
chromophore within the -barrel in wt GFP. In this paper, we report a systematic analysis 
of the fluorescence change of the GFP chromophore and its derivatives when applied for 
sensing of biologically relevant analytes. 
In order to develop an effective fluorescent sensor, an important criterion that 
must be met is high selectivity for a target molecule. The selectivity of probes can be 
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evaluated by parallel comparison against a similar class of analytes. For example, 
Chang’s group validated selectivity of their metal probes by carefully comparing various 
kinds of metal ions together with the target metal ions.12 Many examples of diversity-
oriented fluorescence sensors were discovered by in vitro fluorescence response 
assessments prior to their application in a biological system.13
,14 It is noteworthy that the 
fluorescence response profile against diverse analytes could provide ultimate selectivity 
information. While similar profiling approaches have been widely used in drug 
discovery,15 their application to develop fluorescent sensors is still at an early stage.  
The challenge of large-scale, quantitative investigation of fluorescence sensor 
development requires a practical high-throughput screening platform. For this, a 
microplate assay platform is chosen due to its unique advantages, such as simple adoption 
for any kind of analytes, flexible throughput control, and the homogeneous interaction 
between a sensor molecule and an analyte. To broaden the scope of fluorescent sensor 
discovery, we collected 10 classes of bio-analytes (total 94 individual analytes) for high-
throughput in vitro screening and performed an assay in 384-well microplates.  From the 
resulting profile, we identified fluorescent small molecule sensors for pH, human serum 
albumin (HSA), and total ribonucleic acid (RNA).  
Experimental 
General Experimental 
All reagents were purchased from commercial sources and used without further 
purification. The solvents used for the spectroscopy experiments were of 
spectrophotometric grade. Spectroscopic properties of compounds and in vitro high-
throughput screenings were performed on SpectraMax M2 plate reader (Molecular 
Devices Inc.).   NMR spectra for the synthetic component were recorded using a Varian 
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Mercury spectrometer (300MHz) and processed using MestRe-C 2.3a.  Mass 
spectroscopy data was completed by the Georgia Tech Mass Spectroscopy Center.   
Materials and Methods  
All the materials were obtained from commercial suppliers (Aldrich) and used 
without further purification. The solvents used for the spectroscopy experiments were of 
spectrophotometric grade. Spectroscopic properties of compounds and in vitro high-
throughput screenings were performed on SpectraMax M2 plate reader (Molecular 
Devices Inc.).  
Quantum Yield Measurements  
Quantum yields were calculated by measuring the integrated emission area of the 
fluorescent spectra and comparing that value to the area measured for FITC in EtOH 
when excited at 489 nm (FITC =  0.93). Quantum yields for the BDI compounds were 
then calculated using equation (1), where F represents the area of fluorescent emission, n 
is reflective index of the solvent, and Abs is absorbance at excitation wavelength selected 
for standards and samples. 
 
Determination of the dissociation constant   
The fluorescent emission spectra with various concentrations of BDI compounds 
were measured on a SpectraMax M2 plate reader. The fluorescent titration curve was 
fitted to the standard equation using Graphpad Prism v5 software. The bound fraction (X) 





where Fc and Fo are the fluorescence intensities of a given concentration of BDI 
compounds with and without target analyte, respectively. Fsat is the fluorescence intensity 
at the same concentration of BDI compounds when fully bound with target analyte. Fsat 
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was determined by fluorescence titration at each concentration with a series concentration 
of analyte. The results were plotted according to a non-linear fitting curve equation (3) 
F  Fo  (Fsat  Fo)([BDI]) / (KD  [BDI])  
where KD is dissociation constant, [BDI] is concentration of BDI compound. 
 
In vitro Fluorescence Screening  
BDI compounds (100 µM) were screened in 20 mM HEPES, pH 7.4.  
Fluorescence intensities were measured using a SpectraMax M2 plate reader in 384-well 
format. Excitation was provided at each compound’s excitation range, and emission was 
obtained starting from at least 30 nm longer wavelengths from the excitation. All the 
analytes were tested at four serial concentrations depending on the endogenous 
concentration of the analyte (Table 6.1). Every analyte was prepared same day prior to 
the fluorescence experiment to minimize sample contamination. For detailed protocols 
refer to the supporting information. 
Solubility test 
A 1mg sample of the chromophore was added to 10 mM DMSO in a 1.5 ml 
microcentrifuge tube (note that if the molecule is not fully dissolved it is reported as 
“Solubility Problem in DMSO”).  For the molecules fully soluble in 10 mM DMSO 
solution, 1l of 1 mM DMSO solution was placed into a 0.5 ml microcentrifuge tube, and 
99 l of HEPES (20 mM, pH 7.4) was added to give 100 uM final concentration solution. 
In the event precipitation occurred upon adding the solution to the buffer a note of 
(“Solubility Problem in HEPES”) was recorded, otherwise the compound was tested for 
emission response reproducibility. 
Fluorescence spectrum reproducibility test.  
 Using the stock solutions prepared in the previous section, 1 l of stock was 
placed into one well of transparent 96-well plate, and 99 l of HEPES (20 mM, pH 7.4) 
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added to provide 100 M final concentration solution.  Successive dilutions of this stock 
solution were done to produce testing concentrations of 1 and 10 M final concentration.  
These solutions and finished 96-well plates were placed into the plate reader for analysis. 
 
In vitro fluorescence response screening. 
 All analyte samples were prepared daily.  The analyte solutions were placed into 4 
separate deep-well pates according to the analyte map depends on the concentration 
(Figure 6.1).  The initial Plate A was prepared followed by dilution from Plate A to give 
Plate B, C, D respectively (Plate A: the highest concentration, Plate B: 2
nd
 highest 
concentration, Plate C: 3
rd
 highest concentration, Plate D: the lowest concentration set).  
For testing 200 l of 10 mM dye stock solution was titrated into a reservoir, and 3.8 ml of 
HEPES buffer added.  The dye concentration for all experiments was 500 M.  
Approximately 10 l of 500 uM dye solution was transferred into each well of the plate.  
For combinatorial analysis, 40 l of analyte solutions were transferred to designated 
positions of 384-plate using Precision
TM
 Microplate Pipeting System (Biotek Inc.).  The 
plates were incubated for 10 min at room temperature and the emission spectra measured. 
Table 6.1. In vitro screening analyte molecules and their classes. 
 
Analyte class Individual analyte molecules                               [concentrations] 
Control Distilled water, HEPES (10 mM, pH 7.4) 
Viscosity Glycerol                       [volume %: 25 %, 18.75 %, 12.5 %, 6.25 %] 
pH pH 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 
Nucleotides and 
nucleosides 
Adenosin, AMP, ADP, ATP,         
Cytidine, CMP, CDP, CTP, 
Guanosine, GMP, GDP, GTP, 
Uridine, UMP, UDP, UTP, 
Sodium phosphate, sodium pyrophosphate, 
Sodium triphosphate,  
cyclic AMP, cyclic GMP              
                                                       [100 uM, 50 uM, 25 uM, 12.5 uM] 
Genetic 
macromolecules 
single strand DNA (ssDNA)  
double strand DNA (dsDNA) 
transfer RNA (t-RNA) 
total RNA                       




Table 6.2. Continued 
Peptides HA tag (YPYDVPDYA) 
HA12CA5 tag  (CYPYDVPDYA) 
His tag (HHHHHH) 
HisG tag (HHHHHG) 
VSV-G tag (YTDIEMNRLGK) 
V5 tag (CGKPIPNPLLGLDST) 
IQ tag (IQSPHFF) 
AP tag (KKKGPGGLNDIFEAQKIEWH) 
FLAG tag (DYKDDDK) 
cMyc tag (EQKLISEEDL) 
                                       [100 g/ml, 50 g/ml, 25 g/ml, 12.5 g/ml] 
Protein Human Immunoglobulin G (human IgG) 
Bovine Immunoglobulin G (bovine IgG) 
Human serum albumin (HSA) 









Cytochrome C              
                                       [1mg/ml, 0.5mg/ml, 0.25mg/ml, 0.12mg/ml] 
Metal ions NaCl, KCl,                                         [5 mM, 1 mM, 200 M, 40 M] 
MgCl2, ZnCl2, FeCl2, CaCl2                       [100 M, 20 M, 4 M, 0.8 M] 
Oxido-reduction 
related molecules 
Ascorbic acid                       
DL-dithiothreitol (DTT) 
L-Glutathione reduced form (GSH) 
L-Glutathione oxidized form (GSSG) 
Nicotinamide adenine dinucleotide (NAD) 
Sodium hypochlorite (NaOCl) 
Potasium dioxide (KO2) 
Hydrogen peroxide (H2O2) 
Iron (II) with hydrogen peroxide (Fe2++H2O2) 
2,2-azobis(2-methylpropionamidine) dihydrochloride (AAPH) 








Phosalone                                          [10 M, 5 M, 2.5 M, 1.2 M] 
Miscellaneous 
molecules 
Heparin                              [1 mg/ml, 200 g/ml, 40 g/ml, 8 g/ml] 
 
Caffeine 
gamma-aminobutyric acid (GABA) 
Monosodium glutamate (MSG) 
Histamine, Dopamine          [5 mg/ml, 1 mg/ml, 0.2 mg/ml, 40 g/ml] 
 
Glucose, Glucose phosphate 
Fructose, Fructose phosphate          [10 mM, 2 mM, 400 M, 80 M] 
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The screening was done using a 96-well plate that was arranged using the analyte 
concentrations from Table 6.1 as shown in arrangement in Figure 6.1. 
 
 
Figure 6.1.  Plate map of analyte stock solutions. NADH was excluded in this BDI study 
because fluorescence emission of NADH was overlapped with most of BDI compounds. 
 
Results and Discussion 
Design of BDI Compounds 
The endogenous GFP chromophore contains two aromatic moieties, a para-
hydroxy benzene and an imidazolinone ring linked by a methine group. Based on these 
building block structures, 41 benzylideneimidazolinone (BDI) derivatives were 
synthesized with substitution patterns highlighted in Table 6.2. Since a lot of 
benzaldehyde building blocks are commercially available, we could easily maximize 
structural diversity of R1 moiety. Each BDI compound shares a common core moiety, 
however each analog has distinct structures that may provide unique fluorescent turn-on 
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phenomena by interacting with target molecules.  Synthesis of the BDIs was carried out 
by a 2 + 3 cycloaddition of the corresponding aromatic Schiff base with the imidate as 
highlighted in Chapter 2 of this thesis.16 
Photophysical Properties in Solution 
The spectroscopic properties of BDI compounds were examined and are 
summarized in Table 6.2. As previously reported, most BDI compounds show very low 
extinction coefficients and fluorescence quantum yields in ethanol. Each of these 
compounds absorbs in the visible range, with max (abs) between 341 nm and 440 nm and 
has fluorescence emission ranging from 464 nm to 599 nm.  
BDI compounds that consist of either 4-diethylamino (BDI 24) or 4-
dimethylamino (BDI 25, 33, 35) exhibit significantly longer absorption max wavelength 
than other derivatives (abs = 71.7 nm between the mean absorbance wavelength of BDI 
24, 25, 33, and 35 compared to other compounds). The notable red shift of the 
absorbance indicates the elongated “push-pull” electronic conjugation from the 
aminobenzyl group.  
 
Table 6.2. Substiution patterns and spectroscopic properties of BDI compounds.  
a
All 
data were measured in ethanol with the presence of 1% DMSO as co-solvent. The 
fluorescence quantum yield was determined using FITC as a standard (fl = 0.93 in 0.1 
M NaOH). 
 







1 4-OH Me 368 473 2,596 0.0060 
2 4-OMe Me 367 490 12,961 0.0018 
3 4-OAc Me 350 472 5,106 0.0045 
4 4-CO2H Me 356 474 5,913 0.0085 











Me 373 471 8,888 0.0021 
7 3-OH Me 365 469 1,857 0.0247 
8 2-(N)/4-OH Me 359 481 3,805 0.0485 
9 4-Me Me 348 471 7,105 0.0044 
10 3-Me Me 348 468 5,499 0.0050 
11 2-Me Me 349 472 5,630 0.0034 
12 2,4-Me Me 352 472 5,630 0.0036 
13 2,5-Me Me 357 478 4,360 0.0041 
14 4-Et Me 353 478 6,733 0.0032 
15 2-CF3 Me 341 490 3,826 0.0455 
16 3-OMe Me 355 510 9,501 0.0041 
17 2,3-OMe Me 352 579 6,251 0.0471 
18 2,4,5-OMe Me 413 527 5,894 0.0111 
19 2,5-OMe Me 396 548 3,799 0.3062 
20 4-NO2 Me 376 599 4,869 0.2008 
21 4-Cl Me 352 472 6,598 0.0060 
22 2-F Me 351 475 6,299 0.0096 
23 4-CN Me 361 475 5,498 0.2490 
24 4-N(Et)2 Me 438 527 12,817 0.0065 
25 4-N(Me)2 Me 430 527 13,529 0.0029 
26 1-naphthyl Me 374 476 2,247 0.2080 
27 2-naphthyl Me 369 483 9,026 0.0048 
28 2-quinoline Me 372 476 3,784 0.0971 
29 1-naphthyl Et 378 464 5,214 0.0039 
30 4-OH n-Pr 369 476 10,783 0.0018 
31 4-Me n-Pr 351 470 8,334 0.0034 
32 4-i-Pr n-Pr 353 509 6,434 0.0039 
33 4-N(Me)2 n-Pr 433 504 8,604 0.0739 
34 4-OH n-Bu 371 476 10,739 0.0018 
35 4-N(Me)2 n-Bu 440 505 10,063 0.0650 
36 4-OH n-Pentyl 371 503 9,031 0.0019 
37 4-OH C3H6N(Me)2 372 471 4,867 0.0029 
38 4-OH C3H6N(Me)3 369 472 4,091 0.0035 
39 4-OH n-C11H22OH 369 554 8,007 0.0020 
40 4-OH n-C16 371 504 6,723 0.0020 
41 3-OH n-C16 353 474 3,328 0.0112 
 
High throughput in vitro fluorescence response profiling  
Prior to experimentation, the solubility of all compounds was validated in 100 M 
concentration of HEPES buffer (20 mM HEPES with 1% of the DMSO stock solution at 
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pH 7.4). Under these conditions, all 41 BDI compounds avoided precipitation, and the 
absorbance/fluorescence spectra exhibited reproducible peak shape in spite of their 
extremely weak extinction coefficients and low quantum yields. 
To systematically investigate the fluorescence response profile of BDI 
compounds, 10 classes of analytes related to various biological processes were screened. 
The analyte classes were (i) pH standard solutions, (ii) viscous buffer solution, (iii) 
nucleotides and nucleosides, (iv) nucleic acids, (v) peptides, (vi) proteins, (vii) metal 
cations, (vii) oxidation-reduction related molecules, (viii) pesticides, and (ix) 
miscellaneous analytes, totaling 94 individual analyte molecules (Table 6.1). Each 
analyte was tested at four serial concentrations together with a given concentration of 
BDI compounds to determine the dose response dependence on their endogenous 
concentration or effective concentration, and these fluorescent emission intensities were 
compared with the value of chromophore itself in the buffer solution.  Additionally, the 
entire concentration-response pattern was used for investigation of the selectivity among 
the different sets of analytes.   
Fluorescence spectra were obtained using a monochromator-based fluorescence 
microplate reader not only to investigate emission spectra change, but also to increase 
throughput.17  Excitation wavelengths of individual BDI molecules were determined 
based on their maximum wavelength of absorbance in 20 mM HEPES. It should be noted 
that maximum wavelength of excitation and emission used in vitro screening are different 
from the values in Table 6.1 due to the solvent effect. Fluorescence emission spectra were 
measured for all BDI compounds and 94 analytes at 4 concentrations. In order to 
facilitate the broad use of this data, a fluorescence response profile database was 
configured. Primary screening results of total spectra were stored in the database, and 
changes to the emission spectrum were visualized by a heat map method. A heat map is a 
graphical representation of fluorescence fold change using two color codes to simplify 
complexity of data. Green represents an increase of emission intensity, while red 
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represents a decrease in emission intensity. In this two-color profile, the fluorescence 
response pattern against 94 analytes could be easily evaluated. For instance, Figure 6.2 
shows the in vitro fluorescence response profile of BDI 8, which showed strong pH 
dependence with a fluorescence increase in acidic media as well as showing a 
fluorescence increase in the presence of one metal cation and two miscellaneous analytes 
in a dose dependent manner. The concentration dependent response pattern is useful to 
evaluate the quality of an assay, and allows for the determination of dynamic ranges and 
sensitivity of probes.18  For those analytes that showed remarked response, further 
experiments were pursued to determine the sensitivity for selective sensor application.  
The given profiles were analyzed for structure fluorescence response relationships. 
 
Figure 6.2. (a) Structure of BDI 8, and (B) in vitro fluorescence response profile of BDI 
8. The number inside the parenthesis indicates the number of individual analytes. Green 
color represents fluorescence intensity increase, and red color represents fluorescence 
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decrease as denoted in the scale bar. Four serial concentrations were stacked in the same 
column in a dose dependent manner. Fluorescence intensity fold change was obtained at 
520 nm (ex = 370 nm). For detail decoding table, refer Figure 6.1. 
 
Fluorescence response profile and structural relationship 
 The present profile allows for evaluation of the fluorescence intensity change of a 
given BDI compound with its structural building blocks. In pH profiles, all amino benzyl 
containing BDI compounds (BDI 24 and 25) revealed strong fluorescence quenching in 





 = 0.021). Compounds containing different functional groups in the 
ortho position showed a distinct pH dependent pattern. Four functional moieties were 
compared within a given series of equivalent R2 substitutions including compounds of:  
methyl (BDI 11, 12, 13), trifluoromethyl (BDI 15), fluoro- (BDI 22), and methoxy- (BDI 
17, 18, 19), with fluorescence quenching in acidic solution observed for only ortho-
methoxy compounds (Figure 6.5). Single atom substitution in the aromatic ring also 
induced dramatic changes in the fluorescence response patterns.  The wt-GFP 
chromophore, BDI 1, showed slight emission enhancement in basic media, however, its 
pyridine derivative, BDI 8, exhibited a strong emission enhancement in acidic solution 
(Figure 6.2, pH=2
 BDI 8
 = 0.786, pH=7
 BDI 8
 =0.008). Likewise, we observed an emission 
decrease from the quinoline derivative (BDI 28), whereas the naphthalene derivative 
(BDI 29) showed minimal pH response (Figure 6.3).  
Similar structural analysis could also be performed based on the structure of 
analytes. Within the miscellaneous analyte class, primary amines caused fluorescence 
enhancement at high concentration for most BDI compounds (Figure 6.3). Since the pH 
changes induced by two primary amines, dopamine and histamine, were already included 
in the pH profile, it is believed that BDI compounds share common interaction modes 
with those primary amines. Another notable response is the hydrophobic interaction with 
macromolecules. Many fluorescent small molecules, including 8-
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aminonaphthalenesulfonamide or rosamine compounds, show non-specific fluorescence 
increase to hydrophobic proteins such as albumin.14  Conversely, most BDI compounds 
exhibited fluorescence quenching towards albumins. Considering the fluorescence 
enhancement in wt-GFP stimulated by rigidifying the chromophore structure, this profile 




Figure 6.3. Heat map profile of miscellaneous analyte class.  Most BDI compounds 
exhibit fluorescence intensity increase trend to molecules that contain primary amine 
moiety (dopamine: 2
nd
 column, and histamine: 9
th
 column). Figure 6.4. Heat map profile of genetic macromolecule class.   
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 The results of these analyses demonstrate that the profiles generated are useful to 
analyze the relationship between fluorescence responses and structural characteristics in 
both analytes and probes. With this general response pattern information, we further 
sought to discover selective fluorescence turn-on sensors. 
 
 
Figure 6.5.  Heat map profiles of pH response from BDI compounds containing (a) para-
amino benzyl, (b) ortho-methoxy moieties, and (c) other functional group in the ortho 
position. Fluorescence profile comparison between homocyclic and heterocyclic rings; 
(d) p-hydroxyl benzyl and p-hydroxyl pyridine derivatives, (e) naphthalene and quinoline 
derivatives. 
 
Fluorescence sensor discovery from the profile 
 To be maximally useful, the fluorescence response profile should allow for the 
discovery of novel sensor molecules. Since we initially classified analytes in terms of the 
nature of the individual analyte, it was straightforward to compare fluorescence response 
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within the same class of analytes. In this study, we found two sensor molecules from 
separate analyte classes that warranted further investigation. 
 
Figure 6.6. Heat map profile of protein class analytes.  Most BDI compounds exhibit 




Although fluorescence small molecule sensors for nucleic acid macromolecules 
have been extensively used for cell imaging and sequencing, the continued development 
of improved sensors that can distinguish different kinds of nucleic acids is currently of 
great interest.19 Accordingly, 4 kinds of nucleic acids were collected as a primary 
screening analyte class to discover sensors that could discriminate double strand DNA 
(dsDNA), single strand DNA (ssDNA), RNA, and t-RNA. First of all, we found BDI 37 
and BDI 38 exhibited an increase in fluorescence emission for all four kinds of nucleic 
acids from the primary screening (Figure 6.4). BDI 38 contain a positively charged linker 
in the BDI derivatives, and it has strong Coulomb interaction with all negatively charged 
nucleic acids. 
Primary hit compounds that enhanced emission in the presence of RNA compared 
to DNA were further tested to confirm primary profiles, and 3 BDI compounds revealed 
selectivity towards total RNA. Interestingly, all selected RNA sensors, BDI 2, BDI 3, and 
BDI 5, contain alkyloxy/aryloxy groups (-OR) at the para position in the R1 moiety. 
These findings suggest that the para-alkyloxy group plays a role in distinguishing RNAs 
over DNAs in BDI scaffolds. We also note that the para-alkoxy groups played a 
significant role in enhancing the fluorescence in the solid state.
18 
Among the three 
primary hits, the para-methoxy group brought not only the highest fold change in 
fluorescence to total RNA, but also exceptionally low cross reactivity to other nucleic 
acids (Figure 6.7). When we tested these hit compounds toward different 16-mer RNA 
oligomers, they generally exhibited higher fluorescence increment towards “AU” rich 
oligomers (Figure 6.7). Although we observed a response trend against “AU” rich 
oligomers, it is still not clear which specific RNA sequences were necessary for selective 
recognition of each compound or how these compounds were interacting with total RNA 
mixture in solution. However, this example clearly shows that large-scale profiling could 
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identify novel modes of interaction between sensor molecule and analyte.  Such studies 
are currently in progress. 
 
Figure 6.7. Fluorescence intensity fold changes of (a) BDI 2 at em 512 nm, (b) BDI 3 
and (c) BDI 5 at em 532 nm against 4 nucleic acids at 1 mg/ml final concentrations in 20 
mM HEPES (pH 7.4). 
 
Human Serum Albumin Sensors 
As mentioned earlier, most BDI compounds showed fluorescence quenching 
towards many proteins (Figure 6.6). Noticeable primary hit compounds were BDI 24 and 
BDI 25. These two compounds, which contain a dialkylamino motif, showed clear 
emission enhancement to human serum albumin (HSA) in a dose dependent manner. 
HSA is the most abundant protein in human blood plasma (60 % of total plasma 
protein) and is known to bind to diverse exogenous drug molecules by hydrophobic 
interactions.20 Since BDI 24 exhibited a greater fold increase, we further examined the 
bindings between HSA and BDI 24. In the presence of HSA, the maximum wavelength 
of fluorescence emission was blue-shifted from 530 nm to 515 nm, while the intensity 
increased by 10.4 fold (Figure 6.8). This hypsochromic shift can be caused by 
solvatochromism, the reduction of non-radiative decay, or the perturbation of electronic 
conjugation system through the binding with HSA. To further investigate the binding 
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properties of HSA and BDI 24 quantitatively, various concentrations of BDI 24 were 
titrated with HSA and a fractional saturation curve revealed a dissociation constant (Kd) 
of 3.57 M (Figure 6.8).  Results from this screening will provide the motivation to 
Chapter 8 in this dissertation. 
Conclusions 
Although the sensitivities displayed here do not compare to others for the same 
proteins, they are based upon a limited initial set of chromophores.  Nevertheless, this 
study represents the first example of small molecule fluorescence sensor discovery 
utilizing the green fluorescent protein chromophores by large-scale fluorescence 
profiling. We believe this profiling approach could accelerate the fluorescence sensor 
discovery process for other fluorescent scaffolds, since the diversity of the fluorophores 
introduced here represents a very small fraction of the potential structural space. In the 
current report, we have demonstrated the use of the fluorescence response pattern based 
sensor discovery utilizing the green fluorescent protein chromophore and its derivatives. 
41 structurally related BDI compounds were synthesized and exploited for the generation 
of fluorescence response profiles towards 10 classes of analytes or a total of 94 individual 
biologically relevant analytes. From the large-scale fluorescence profile, the structural 
Figure 6.8.  Fluorescence titration analysis for the binding of BDI 24 with HSA. (a) 
Fluorescence spectral change of BDI 24 (100 uM) upon addition of the HSA in 20 mM 
HEPES buffer (pH 7.4). (b) Fractional saturation curve of BDI 24 with HSA. 
Dissociation constant was measured. using 7.5 M concentration HSA. Experimental 
Kd = 3.57 M. 
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moieties that induce specific pH response were identified as well as those showing a 
unique response pattern to specific analytes. Further experiments exhibited a selective 
fluorescence emission enhancement upon interaction between BDI 24 with HSA (Kd = 
3.57 M) and BDI 2 with total RNA, which showed a marked selectivity with a 5-fold 
emission increase. The use of more carefully focused recognition elements should 
increase the sensitivity and approach the on/off ratio of GFP itself.  For instance, we now 
have increased the sensitivity to the hydrophobic “octa acid” by another factor of 10.21 
Further studies are currently in progress. 
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ACTING AS A FLUORESCENT PROBE AND A LIGAND:  THE 
INTERACTION OF AMI CHROMOPHORES AND NUCLEAR 
RECEPTORS 
(Copyright 2011 by the American Chemical Society
1
) 
The research highlighted within in this chapter represents  collaboration between 
the Tolbert lab and the Doyle/Azizi lab.  Throughout the entire collaboration, the 
synthesis and design of the chromophores was completed within the Tolbert lab and the 
work with nuclear receptors was completed within the Doyle/Azizi lab.  Data analysis 
and manuscript preparation was equally shared between the two collaborating labs. 
Introduction to the Estrogen Receptor 
 Nuclear receptors (NR) are a superfamily of ligand-activated transcription factors 
that play crucial roles in a number of important biological and physiological processes.
2,3
 
Their role in the regulation of gene expression via small molecule ligands makes their 
function critical to many developmental processes. Structurally, they share a common 
organization that consists of a highly conserved DNA binding domain (DBD) and a 
ligand–binding domain (LBD), connected by a flexible hinge region. The C- terminal 
helix (helix 12) of the LBD plays a critical role in its function, serving as a main region 
for interaction with coactivator proteins in the activation mechanism.
4,5
 Following 
binding, ligand activating receptors position the helix 12 in an active conformation, 
providing an interaction surface for co-activator proteins and eventually recruiting 




Figure7.1. Depiction of mechanism of nuclear receptor actions upon binding of agonist 
in ligand binding domain. 
 
The estrogen receptor α (ERα) is a member of the NR superfamily and represents 
one of the first NRs to be discovered. Endogenous estrogens, i.e., 17β-estradiol and its 
derivatives, are natural ligands of ERα.
6
  The wide distribution of ERα in various human 
tissues, including bone, uterus, breast and brain, along with their significant role in gene 
expression, implicates this receptor in a number of diseases, including breast cancer, 
osteoporosis and cardiovascular diseases.
7
 Tamoxifen, the most widely used drug to treat 
breast cancer, is, in fact, an ERα antagonist.
8
 A keen interest lies in developing novel 
ligands for ERα as well as other NRs that could serve as potential drugs for a number of 
NR-related diseases.  Furthermore, some highly successful drugs, like tamoxifen, which 
are used in the treatment of the ER- positive breast cancer, face the issue of cells 
developing  resistance as  noted in 40% of  patients.
9
 Thus identification of a novel class 
of small molecules as potential agonists or antagonists is a key step in developing drugs 
that will enhance therapy for ER related diseases. 
In recent years, the discovery of fluorescent probes has helped visualize NRs 
inside cells, enhancing and increasing knowledge about the localization and trafficking of 




Aequorea victoria fused to specific nuclear receptors has provided a powerful method for 
detecting both function and mobility of NRs in vivo.
10
  
A disadvantage to using fusion proteins is the potential interference with the 
natural function of receptors, since nuclear receptors undergo a conformational change 
upon ligand binding, the presence of a bulky protein such as GFP could affect the normal 
conformational change of these proteins. The use of potentially fluorescent small 
molecule ligands would provide additional diagnostic capabilities, while allowing the 
receptor to act in its natural state, thus providing additional insight into various NR 
mechanisms.  
Recent studies have described various ERα ligand/fluorescent dye conjugates for 
the detection and expression of ERα. In most cases the fluorescent conjugates are 




Figure 7.2.  Selected structures of fluorescent ligands for ERα. 
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However, the bulky conjugates of these ligands decrease their affinity for the receptor.
12
 
This manuscript focuses on the development of new ER ligands with unique visualization 
properties, derivatives of fluorescent protein chromophores containing the 
arylmethyleneimidazolidinone (AMI) fluorophore, which mimic non-steroidal ERα 
ligands.  Based on the AMI core structure, a variety of chromophore analogs were 
designed that could activate the estrogen receptor without the exhibition of fluorescence 
or bind the receptor thus mimicking the restrictive -barrel of GFP providing 
chromophore emission upon binding to the receptor’s ligand binding domain (LBD). It 
should be noted that unlike GFP, these molecules are virtually devoid of fluorescence in 
solution. 
Experimental Protocols for Nuclear Receptors with AMI Chromophores 
Synthesis of Ligands  
Synthesis of the ligands was carried out as highlighted in Chapter 2.  For compounds 1-3 
and 5 the Schiff base was obtained by reacting the aromatic aldehyde (1eq), the primary 
amine (1eq) and sodium hydroxide (1.1eq) in 40.0 mL of MeOH at reflux for 4hr, 
followed by removal of solvent under reduced pressure to yield product.  For 4 and 6-9 
the aldehyde (1eq) and primary amine (1eq) were allowed to stir 12 h, yielding pure 
product.  The imidate was prepared as previously described.
13
 Imidazolindinones ligands 
were synthesized by combining the corresponding Schiff base with the imidate and 
~0.5mL of MeOH with stirring for 12 h which resulted in precipitate formation for 4 and 
6-9.  Solvent removal from compounds 1-3 and 5 under reduced pressure provided solid 
products as nearly pure materials.  All products were further washed with cold Et2O to 
yield the desired products as light yellow crystalline materials.  Characterization of these 
compounds is found in Appendix A. 
In Silico Docking Studies  
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Modeling of ligand–protein complexes was carried out with  AutoDock Vina®
14
  using 
the estradiol–ERα ligand binding domain (pdb: 1ERE) crystal structure under standard 
parameters. The estrogen receptor was prepared for docking via UCSF CHIMERA, an 
interactive molecular graphics program, by removing the ligand and water molecules, 
adding polar hydrogens, and assigning Kollman united atom charges.
15
 Ligands were 
created using ChemBioDraw Ultra 11.0 / ChemBio3D Ultra 11.0 (Cambridge Soft, USA) 
and were minimized using MMFF94 force field.  Ligands were modified with the 
AutoDockTools by adding Gasteiger charges to set the partial charge of each atom.
16
 The 
best docked ligand/receptor complexes were subjected to further studies.  
Liquid Quantification Assay in Yeast  
Variants were tested in liquid quantification assays in 96-well plates with media lacking 
histidine, leucine, and tryptophan (SC-HLW), 0.1 mM 3AT, and with or without 
chromophores or 17β-estradiol at varying concentrations.  Media and cells were added in 
a 4:1 ratio into 96-well plates.  Plates were incubated at 30°C, with shaking at 170 rpm.  
Optical density (OD) readings at 630 nm were recorded at 0, 24, and 48 hours to measure 
growth density. 
Cell culture 
HEK293T cells (ATCC, USA) were transfected with the plasmid pCMXwthERαLBD.  
This plasmid contains the Gal4DBD (GBD) fused to the wild-type ERα ligand binding 
domain LBD (GBD:LBD fusion under the control of a cytomegalovirus (CMV) 
promoter).  The reporter plasmid, p17*4TATAluc, contained the Renilla luciferase gene 
under the control of four Gal4 response elements located upstream from a minimal 
thymidine kinase promoter. The pCMXβgal, a plasmid containing the β-galactosidase 
gene under the control of the mammalian CMV promoter, was also used as an internal 
standard. Lipofectamine 2000 (Invitrogen, USA) was used as the cationic lipid and 
transfection experimental details are described in Taylor et al.
17
  Ligands were added to 
the wells at various concentrations.  Cells were harvested and analyzed for luciferase and 
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β-galactosidase activity.  All data points represent the average of triplicate experiments 
normalized against β-galactosidase activity.   
Fluorescence Microscopy  
Transfection of NIH3T3 cells was performed in a single plate with PolyFect (Qiagen, 
USA) transfection reagent according to the manufacturer’s protocol. Plasmids 





were co-transfected into NIH3T3 cells.  After 8 hours of transfection at 37˚C in 
humidified air with 5% CO2, the media in the wells was removed and ligand (10mM) was 
added with the media to the wells. Cells were then subjected to microscopy after 30 hours 
of incubation. Samples were washed with 1X PBS and confocal imaging was performed 
using a Zeiss LSM 510 NLO w/META MPE confocal microscope (Carl Zeiss 
MicroImaging GmbH, Germany). 
Results of ER with AMI Chromophores 
Fluorescent protein chromophore design.   
The ERα selective FP chromophores were rationally designed using the 
arylmethyleneimidazolidinone (AMI) core, to resemble the ABCD ring system of 
steroids (Figure 7.3).  
Figure 7.3.  Rational design of AMI based on ABCD steroid ring system (common 
ligands for ER ). 
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Substituents were not incorporated at the B ring, by analogy to known estrogen receptor 
agonists incorporating only the A-CD ring system.
18
 In analyzing the AMI core, a 
phenolic aryl group was retained to play a role analogous to the functionalized ring A of 
the steroid molecule. The imidazolindinone group in the AMI structure was designed to 
mimic the C ring of a steroid molecule, and alkyl substituents around the heterocycle 
(R4) were employed to compensate for the absent steroidal D ring. A series of such 
derivatives was designed based on the core structure, with the addition of substituents to 
create potential ligands for ERα. 
The ability of the designed chromophores to mimic the overall interaction of the 
heterocyclic core of various ERα ligands was determined via molecular modeling.  AMI 
4 was docked into the crystal structure of the ERα ligand binding domain (1ERE) using 
AutoDock Vina
14
  and showed binding to ERα with favorable superimposition with 
estradiol. In addition, modeling showed the phenolic group superimposed on the A ring 
of estradiol (E2), created a potential hydrogen bond with glutamate E353 and arginine 
R394 (Figure 7.3A), analogous to estradiol. However, the same calculations failed to 
overlay the imidazolindinone ring of the AMI compound with the C ring of 
estradiol. This is probably due to the free rotation between the phenyl and the 
imidazolindinone ring, which is crucial for the fluorescence of these AMIs, as 
A B 
Figure 7.4.  Docking resulting of structures of the AMIs ligands docked into the crystal 
of ERα (pdb:1ERE) using the software Autodock Vina with compound 4 (A) and 






Based on the docking results and examination of known structures with ERα agonists, 
additional compounds were designed with potential hydrogen bonding between the ligand 
and H524. Histidine H524 is known to form a hydrogen bond with the 17-β hydroxyl 
group on the D-ring of E2 (Figure 7.3B).
20
 From this, adding a polar group such as the 
hydroxyl group as in compound 3 or with the addition of the carboxyl group in 
compound 1, could provide the additional hydrogen bond, based on the in silico modeling 
results providing increased probability of ligand binding and activation.  
Despite the advantages of molecular modeling as a tool for visualizing protein-
ligand interactions, such calculations are limited in providing information about the 
importance of specific substituents. Therefore, additional AMI molecules with various 
substituents were designed, synthesized, and tested. The various activation profiles could 
help in determining a correlation between the structures of moieties and ligand binding 
with ERα (Table 7.1). 












1 H OH H H C3H6CO2H 
2 H OH H H C5H10CO2H 
3 H OH H H C3H6OH 
4 H OH H H C3H7 
5 H H H H C3H6CO2H 
6 H CH3 H H CH3 
7 H H H H CH3 
8 CH3 OH CH3 H CH3 
9 H N(Me)2 H H CH3 
10 H N(Me)2 H OH C5H11 
 150 
Chemical Complementation: evaluating fluorescence ER chromophore interaction 
with the receptor in yeast.  
Chemical complementation is a semi high-throughput selection, where the 
survival of the yeast (Saccharomyces cerevisiae) strain, PJ69-4A, is linked to the ability 
of a small molecule ligand to activate a nuclear receptor.
21
  PJ69-4A contains Gal4 
response elements (Gal4RE) controlling expression of the genetic selection genes, HIS3 
and ADE2, involved in the histidine and adenine biosynthetic pathway, respectively. Two 
fusion proteins consisting of the Gal4 DNA binding domain (GBD) fused to the ERα 
LBD (GBD: ERα LBD) is transformed into yeast along with the fusion protein of the NR 
coactivator fused to Gal4 activation domain (GAD). Upon ligand binding to the ERα 
LBD, the GBD: ERα LBD fusion binds to Gal4RE, recruiting the coactivator, the GAD 
fusion protein. Thus the GAD serves to recruit the yeast transcriptional machinery 
required to initiate transcription of the selection gene (ADE2 or HIS3).
21b
 Activation of 
the selection gene, such as the HIS3 gene, enables the yeast strain to grow on media 
















Thus, the survival of the yeast depends on the presence of the small ligand molecules. 
Chemical complementation has successfully been used as a versatile quick and efficient 
system for detecting new ligands capable of activating various nuclear receptors.
21a
  
Ten synthetic AMI ligands were tested in chemical complementation. The growth 
of the yeast strain PJ69-4A expressing fusion proteins GBD: ERαLBD and SRC-1: GAD 
was observed in histidine selective media at (SC-HLW with 0.1 mM 3AT), containing 
concentrations of chromophores ranging from 0.01 μM -10 μM. To reduce leakiness of 
the HIS3 gene, 3-amino-1,2,4-triazole (3AT) was added.
22
  Chromophores 1 and 2 
showed slight activation (two-fold) and low sensitivity (EC50 >10µM) with ERα, as 
shown in Figure 7.7. However, most of the tested ligands did not induce growth in yeast, 
indicating that the ligand was unable to bind and activate the receptor, allowing the yeast 
to survive. 
Figure 7.6.  Results of chemical complementation in histidine   selective media (-HLW) 
with 1mM 3-AT. The ligand concentration of 10 μM was used. Gal4 is a ligand 
independent transcription factor and is used as a positive control. ERα with estradiol 




Estrogen Receptor Activation by Fluorescent ER Chromophores in mammalian 
cells.  
To determine whether a similar trend in activation seen in yeast is observed in 
mammalian cells, the chromophores were analyzed for activation and fluorescence in 
human embryonic kidney 293T cells (HEK293T). The Gal4 DNA binding domain fused 
to the ERα ligand binding domain (GBD: ERαLBD) was cloned into a mammalian 
expression vector (pCMX) containing a cytomegalovirus (CMV) promoter. Using a 
luciferase reporter gene assay, HEK293T cells were co-transfected with a reporter 
plasmid containing the Renilla luciferase gene under the control of Gal4 response 
elements. Cells were transfected with the two plasmids and various chromophores were 
added and tested for activation at concentration of 10 μM.    
The ten synthetic AMI chromophores were tested with ERα at a concentration of 
10μM or absence of ligand. The highest activation was observed with chromophores 1-4, 
8 and 9 displaying an approximately 10–14 fold activation as shown in Figure 7.7, in 
comparison to the 21- fold activation observed with estradiol.  
Figure 7.7.  Activation profile of chromophores in mammalian cells (HEK293T), A) 
Relative inductions of ERα in the presence of 10μM of each ligand B) Dose response 
curves for the activation of ERα (Gal4DBD: ERαLBD)  in response to various 
concentrations of 1, 3, 4, 8, 9. Activity is measured in relative light units (RLU) 
derived from the measurement of luciferase activity and normalization against a β-




To determine the EC50 values of these compounds, a dose response curve was generated 
for each compound. As seen in Figure 7.7, compounds 4, 8 and 9 showed the highest 
sensitivity with an EC50 of 3 µM whereas compounds 2, 3 and 4 displayed EC50 > 3 µM.  
Compounds 5, 6 and 7 showed no activation.  Despite the fact that these compounds have 
a higher EC50 value and lower activation in comparison to ERα and estradiol (873 pM), 
compounds 4, 8 and 9 show promise as starting points for a potentially a new class of 
ERα agonists.  
Visualization of ERα in mammalian cells using Fluorescent ER Chromophores  
As mentioned previously, a goal of developing AMIs as novel ligands was to 
determine if fluorescence would be observed upon binding to the NRs. The 
chromophores were tested for fluorescence in the presence of ERα in NIH3T3 
mammalian cells. Confocal microscopy was used to monitor cellular uptake and 
localization of the chromophores in the cell. The cells were transfected with the 
mammalian expression vector pCMXGhERLBD expressing Gal4DBD:ERαLBD fusion 
protein and incubated in media in each of the ten chromophores. To determine the 
amount of background fluorescence observed with cells and the compounds, a series of 
negative controls were employed. First, the NIH3T3 cells transfected with ERα were 
exposed either to no ligands or to estradiol alone, addressing the basal fluorescence 
observed due to the cells and in the presence of ERα. Cells lacking the ERα were also 
exposed to the AMI compounds, addressing the potential fluorescence due to non specific 
binding of the fluorophore to endogenous proteins.  
As shown in Figure 7.8, slight basal fluorescence was observed in the case of one 
of the controls, cells lacking ERα and incubated with compound 10. In the presence of 
ERα, 6 out of the 10 of the chromophores that showed activation yet displayed no 
fluorescence. However in case of compound 10, fluorescence was observed in the 
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cytoplasm of the NIH3T3 cells. This finding was surprising, since compound 10 did not 
activate the ERα,  
but also suggests that activation and fluorescence can be independent of each other. In 
other words, these chromophores could serve as agonists that bind, activate and display 
fluorescence. Conversely, in other instances these compounds can bind and fluoresce but 
not activate, similar to a traditional antagonist. The localization of the observed 
fluorescence in the cytoplasm of the cell was also unexpected due to the fact that 
previous research and findings have shown ERα localizes to the nucleus in the presence 
of agonist or an antagonist.
23
  However, Rickert et al have recently shown that OHT- 




ERα + 4 ERα + 10 no ERα + 10 
Figure 7.8.  Imaging of NIH 3T3 cells with the fluorescent chromophores. Mammalian 
cells expressing ERα (Gal4DBD: ERαLBD)  were incubated with 4 and 10. As a 
negative control cells lacking ERα were incubated with 10. 
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Discussion of ER with AMI Chromophores 
The wide interest in nuclear receptor ligands as potential drug targets and 
therapeutics for diseases, including cancer, makes these receptors compelling 
pharmaceutical objectives, particularly in the case of ER. Novel agonists and antagonists 
for ERα, as well as selective estrogen receptor modulators (SERMs) and selective 
estrogen receptor down-regulators (SERDs) have expanded the possibilities of ERα 
related drugs, serving as drugs for several NR based diseases.
24
 Due to the build-up of 
resistance with current ER ligands, developing a new class of ligands as potential drugs 
will enhance therapy for these diseases. Furthermore, in addition to drug development, 
designing ligands with visualization features would prove extremely useful in the 
determination of expression and trafficking of nuclear receptors, such as ERα in specific 
tissues.
11
  In recent years, ER ligands with fluorescent conjugates have been developed 
for applications in ER mobility, but have been limited in their binding affinity to these 
receptors.
10,11
 An additional approach, using a fusion of GFP to the estrogen receptor, has 
been useful but interference from the bulky GFP is hypothesized since nuclear receptors 
undergo severe structural changes as a consequence of their function. This fusion may 
limit the full scope of the NR binding and activation. 
A novel class of arylmethylene-imidazolidinone (AMI) chromophores, based on 
the steroid ring system of estradiol to mimic A-CD rings were designed and in silico 
studies of these novel ligands indicated that AMI derivatives would bind to binding 
pocket similar to that observed with ERα and estradiol (Figure 7.4). These were tested 
with ERα.  Of the ten compounds tested via chemical complementation in yeast, 
compounds 1 and 2 displayed slight activation (Figure 7.7) in comparison to estradiol. 
However, when tested in HEK293T mammalian cells, the activation profile for these 
compounds with ERα differed from that in yeast. Most of these compounds displayed 
similar activation with the highest sensitivity (1μM) and the highest activation observed 
with 4, 8 and 9.  
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These results confirm our initial hypothesis, based on molecular modeling, that a 
key moiety for binding of ERα LBD is the hydroxyl group of the phenyl ring of AMI, 
which could potentially form a hydrogen bond with E353 and R394. Compounds 5, 6 and 
7 lack a hydroxyl group at that position and as expected, these compounds did not display 
activation of the estrogen receptor. The importance of creating polar contacts with H524 
has also been taken into account. Thus, the key moiety of chromophores is thought to be 
the substituent R5 on the imidazolindinone ring. Hydrogen-bonding moieties on the alkyl 
group can potentially lead to an interaction with H524. However, such polar groups do 
not seem essential for activation. This is evident with 8, lacking this group, which 
displays the same sensitivity as 1 containing a carboxyl group at this position.  This 
substitution activity is noted for 3 with a hydroxyl group and 1 and 2 with carboxyl 
groups, which show the same degree of activation. A main feature of chromophore 
design is that the length of the alkyl group has little influence on sensitivity. 
Chromophore 1, which lacks two carbons in the alkyl chain compared to 2, has only 
slightly higher activation than 2. Another factor that might contribute to increased 
sensitivity to ERα is the presence of substituents in positions R3 and R5. On the other 
hand, 9, with methyl groups in these positions, shows higher sensitivity, similar to that of 
1. These groups can possibly play a role in hydrophobic interactions with non-polar 
residues in the binding pocket. In addition, substitutions at these positions may reduce the 
flexibility between the phenyl and imidazolindinone rings that can lead to a more planar 
conformation of the chromophore, similar to the enforced conformation of estradiol and 
similar to the conditions found within the restrictive -barrel of GFP.  
The absence of fluorescence in ligands which activate ERα presents a conundrum. 
As observed with compound 10, no activation is observed with ERα, but fluorescence is 
seen in the presence of the receptor and ligand. This suggests that the chromophore is 
able to bind ERα and fluoresce without activation. This lack of activation may be due to 
the presence of a dimethylamine group rather than the hydroxyl at R2. The hydroxyl 
 157 
group in this position, creating a hydrogen bond with Glu353 and Arg394, may be 
essential for activation. Further work involving the design of AMIs that will both 
fluoresce and activate ERα, serving as an agonist by improving the affinity to the 
receptor.  Such binding may produce an agonistic effect, depending upon the 
conformation produced.  Similarly, fluorescence will depend upon the geometry of the 
chromophore upon bonding.  Thus the production of fluorescence and/or activation upon 
binding creates a new tool for investigating the stereochemistry of ligand/receptor 
interactions.  
Finally, the fluorescence of compound 10 was located in the cytoplasm. Our 
findings indicate that uptake of this ligand appears to be mediated by ERα, and the 
mechanism of compound uptake and apparent exclusion from the nucleus is not clear. 
Further studies of this localization are in progress. 
 
Introduction to the Pregnane X Receptor 
The pregnane X receptor (PXR; NR1I2) is a member of the nuclear receptor 
superfamily, expressed in liver and intestine.
25
 PXR regulates a number of enzymes 
involved in xenobiotic metabolism, including cytochrome P450, UDP-
glucuronosyltransferases, sulfotransferases and drug transporters that metabolize and 
excrete endogenous and exogenous potentially toxic chemicals.
26
  By its nature, PXR is 
activated by structurally diverse ligands such as androstanes, bile acids, hormones, 
dietary vitamins and a broad range of prescription and herbal drugs such as rifampicin, 
tamoxifen, paclitaxel and St John’s Wort.
27
 The diversity of ligands able to bind and 
activate this receptor, make PXR a promiscuous receptor, which is evident through the 
structure.  
               The identification of new PXR ligands, both agonists and antagonists, could 
lead to the discovery of potential drugs, since this receptor has been shown to play a role 
in lipid homeostasis and inflammation.
28
  Although exact diseases have yet to be 
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identified, the discovery a new class of ligands will aid in the further understand of the 
mechanism of this receptor in vivo. However, further studies are necessary for finding 
interaction in which PXR is involved in the cell. Thus cellular localization of PXR in 
cells will be important. Currently, there is no consensus about localization of PXR.
29
 
Some groups have indicated that PXR is only localized in the nucleus; however others 
have determined that PXR is traslocated from cytoplasm to nucleus upon ligand 
binding.
30
  From this, the motivation to study the localization and trafficking of PXR, 
fusion of nuclear receptor with green fluorescent protein (GFP) from Aequorea victoria is 
currently used. While this has provided valuable information toward the understanding of 
the overall actions of this nuclear receptor, this system is not ideal for studying 
trafficking and function due to the bulky protein GFP that can affect the conformational 
change and recruitment other protein by nuclear receptor.  Noting this, the Tolbert group 
has proposed novel ligands capable of visualization properties, designed based on the 
arylmethyleneimidazolidinone (AMI) chromophore of GFP. 
               Based on the findings of the ER a library of AMI chromophores were 
identified and designed as novel PXR agonists based on novel AMI core. These novel 
ligands are specific PXR agonists and do not activate ERα. This new class of PXR 
ligands does not only introduce novel agonists but also enhanced fluorescence upon 
ligand binding. These novel small molecules could be potential novel therapeutic drugs to 
treat PXR related diseases. 
Results and Discussion of Pregnane X Receptor with AMI Chromophores 
Based on the known promiscuity of PXR and the knowledge that some ER 
ligands are activated by PXR, the entire library of AMIs highlighted in Chapter 2 was 
checked for agonistic activity with PXR. Human embryonic kidney 293T cells 
(HEK293T) were transfected with a mammalian expression vector expressing the Gal4 
DNA binding domain fused to the PXR ligand binding domain (GBD:PXRLBD). 
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Transfected cells were incubated with various fluophores at concentration of 10 μM and 
tested for activation. The activity of PXR was determined using a luciferase report gene 
under the control of Gal4 response elements. Analysis of activation have shown that 
AMIs that activated ERα, do not activate PXR. However, ligand 13 displayed 
fluorescence upon binding, but do not show agonistic activity with ERα, activates the 
PXR as shown in Figure 7.9. These results suggested that ligands based on the AMIs core 
could be potential agonists for PXR.  













11 H N(Et)2 H OH CH3 
12 H N(Et)2 H OH C3H7 
13 H N(Et)2 H OH C5H11 
14 H N(Et)2 H OH C6H13 
15 H N(Et)2 H OH C7H15 
16 H N(Et)2 H OH C8H17 
17 H N(Et)2 H OH C10H21 
18 H N(Et)2 H OH C3H6CO2H 
19 H H H CH3 CH3 
  
 
Noting the structure of these compounds, it was hypothesized that the activation observed 
by 13 could be due to the presence of a diethylamino group at R2 position.  The 
importance of this substitution is evident when the RLU response of 13 is compared to 
19, which lacks this functional group at R2 position and does not display activation. 
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The importance of creating and maintaining key hydrophobic contacts in the 
binding pocket was taken into account for the rational design of new AMIs through the 
employment of different lengths of alkyl groups in the R5 position. Following this 
motivation, chromophores 11 – 17 with increasing alkyl chain length were synthesized. 
The highest fold activation was observed in case of compound 14 that exhibited a two-
fold higher activation than rifampicin, the known “industry standard” PXR activator 
shown in Figure 7.9. Slightly lower fold activation compared to 14 displays 15 and 16 
that differ by 1 and 2 carbons in the alkyl group, respectively. However, 12 displays less 
than half the fold activation noted by 14. These fold activation results suggest that the 
optimal length of alkyl chain for activation is six carbons, while more than eight carbons 
in this position result in a drastic decrease in the activation. Methyl group in this position 
in compound 11 as expected did not display activation. On the other hand, 18, which has 
carboxyl group on the same length of the alkyl group as 12 shows significant lower 
activation. These findings suggest that not only alkyl chain length is crucial for achieving 
the high activation but also the AMIs overall hydrophobicity measured by log P values.  
Figure 7.9.  Activation profile of AMI chromophores in mammalian cells. 
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These results confirm our initial hypothesis, that a key moiety for binding of PXR 
is not only dimethylamine but also alkyl group that can possibly play a role in 
hydrophobic interactions with non-polar residues in the binding pocket. Thus, the length 
of the alkylic chain is the crucial for getting optimal these interactions.  To determine the 
EC50 values of these compounds, a dose response curve was generated for each 
compound. As shown in Figure 7.10, all synthesized compounds showed the highest 
sensitivity with an EC50 of 1µM in comparison to the 10 µM of rifampicin. However new 
compounds showed significantly higher fold activation in comparison to known PXR 
activators such as rifampicin and T090. 
Conclusions 
From the data presented in this chapter it is shown that a series of fluorescent 
protein chromophores can be used as ligands, especially agonists, which can be used to 
activate the estrogen receptor α as well as the pregnane X receptor. These novel 
fluorescent ligands provide for a new class of ligands toward the development of new 
fluorescent probes for ERα that do not involve fluorescent conjugates attached to a 
known ERα ligand core.  This provides great advantages as a non-invasive approach to 
monitor nuclear receptor mechanisms through the fluorescence generated by these small 
molecules compared to bulky fluorescent proteins that are commonly employed.  This 




chapter highlights work completed to the date of this dissertation but it should be noted 
and is highlighted in the future work section that additional ligands that interact with 
other nuclear receptors are currently underway.  Additionally through the employment of 
rational design, a variety of different AMI chromophores are proposed to both increase 
the sensitivity and emission quantum yield enhancement upon binding to nuclear 
receptors.   
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RECAPTURE OF FLUORESCENCE IN A PROTEIN HOST:  PROBE 
DEVELOPMENT USING GFP CHROMOPHORES 
(Copyright 2011 by the American Chemical Society 1) 
Introduction 
 The green fluorescent protein (GFP) and its derivatives have revolutionized 
molecular biology by providing a fluorescent tag which can be attached to other proteins 
using gene expression techniques.  The marker itself, a 238-amino acid protein which 
maintains the chromophore within a restrictive barrel,2 serves primarily as a probe 
without providing direct functional information.  Moreover, the size of this 29kD protein 
limits a number of applications, which has driven us to examine the use not of the 
protein, but only of its chromophore, derivatives of which, however, are invariably 
weakly fluorescent, an observation we have been able to attribute to the intervention of 
additional vibrational modes in the unbound state.3 
Mimicking the effects of the barrel and restoring the fluorescence by 
rigidifying the otherwise conformationally flexible chromophore has been the subject of 
several studies.  For instance, we showed that encapsulation within an octa acid cavitand 
results in a 15-fold fluorescence enhancement.4  Could we obtain similar results using a 
protein host?  If so, such a chromophore could act as a high-sensitivity “turn on” probe 
for proteins.  Unlike other probes, e.g., aminonaphthalenesulfonate (ANS), which 
respond to hydrophobic vs. hydrophilic sites, such a probe would be a topological one, 
responding to the conformational rigidity of a host site. 
Using an unbiased high-throughput screening process, a variety of GFP 
chromophore analogs were tested against selected protein analytes, and those with 4-
N(Et)2 substituents showed selective emission quantum yield (EQY) enhancement for 
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human serum albumin (HSA).5  Using this lead, we now report an HSA probe with 
dramatically improved sensitivity and proof of concept that proteins can act to turn on 
fluorescence in benzylideneimidazolidinones (BDIs) when the guest is rigidified in a 
binding site.  
HSA, the major protein component of blood plasma, is marked by an exceptional 
affinity that allows binding a myriad of ligands.
6
  In fact, its twelve binding sites are 
probably a reason that albumin would be selected in a broad spectrum assay.   
Although HSA is not a primary target for disease screening, microalbuminuria 
(MA), referring to a urinary albumin content of 30-300mg/24hr, has become an important 
diagnostic and is linked to various diseases.7  Thus a sensitive and selective determination 
of albumin concentration over this range is of medical significance.  Moreover, such a 
protein serves as a test case for the use of BDIs in protein binding.   
Currently, Albumin 580 (AB580) is commercially used as a fluorescent probe, 
given its selectivity for albumin over other proteins, its low susceptibility to 
environmental factors, and its favorable spectroscopic characteristics (abs = 580 nm, em 
= 610 nm).8  Other assays used for HSA detection include immunoassays9, 
electrochemical assays10, and spectrophotometric assays.11  
Experimental 
General Experimental Section  
All reagents were purchased from commercial sources and used without further 
purification.  NMR spectra were recorded using a Varian Mercury spectrometer 
(300MHz) and processed using MestRe-C 2.3a.  Absorbance spectroscopy was 
completed using a Perkin-Elmer Lambda 19 Spectrometer and fluorescence spectroscopy 
was completed using a Horiba Jobin Yvon Flurolog Spectrophotometer.  Mass 
spectroscopy data was completed by the Georgia Tech Mass Spectroscopy Center.   
Synthesis 
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Synthesis of the 13 compounds was carried out by a 2+3 cycloaddition of the 
corresponding aromatic Schiff base with the imine ester highlighted in Chapter 2.  Schiff 
bases (imines) were prepared by the reaction of 4-diethylaminobenzaldehyde or 2-
hydroxy-4-diethylaminobenzaldehyde with the corresponding primary alkyl amine in 
quantitative yields.  The imine ester was prepared as highlighted in Chapter 2 by the 
reaction of glycine methyl ester and ethyl acetimidate with potassium carbonate in a 
water/diethyl ether solution.  
Emission On/Off Ratio Studies 
For each chromophore, 10 mL of a ~5x10
-5
 M of each chromophore was prepared 
with absorbance and fluorescence spectra taken of each, which would act as the baseline 
for each.  The absorbance for all solutions was approximately 0.5.  Following this, 5.0 mg 
of HSA was added to give an albumin concentration of 0.5 mg/L in each case.  
Absorbance and fluorescence spectra were immediately taken of each.  Using these 
maximum values, the F/Fo value was calculated by taking the ratio of the maximum 





 M solution of chromophore was prepared and titrated with a HSA 
solution in increments of 10 mg/L albumin.  Following each addition, spectroscopy was 
immediately completed.  Titration continued until no change (increase) in fluorescence 
intensity was noted.  
Competition Studies 
Ibuprofen and Warfarin titrations:  5.0 mL of 3.00x10
-5
 M solution of 
chromophore was prepared and to this was added 1eq of HSA.  Following, an Ibuprofen 
(0.1071 M) and separately a Warfarin (5.64 x10
-2
 M) solution was titrated using pre-
determined equivalents (1, 5, 10, 30, 50, 75, 100, and 200) of each.  After each addition, 
absorbance and fluorescence spectra were immediately taken of each.  Following the 
 168 
separate titrations, a titration of warfarin to 100 eq. followed by ibuprofen to 100 eq. was 
done to determine if all chromophore could be competitively expelled. 
AB580:  AB580 was purchased from Sigma-Aldrich as a 0.1% 2-propanol 
solution.  For this, equimolar concentrations of AB580 and chromophore were prepared 
and titrated with HSA in increments of 10 mg/L.  Following each addition, an absorbance 
and fluorescence spectrum was immediately taken.  (Spectra provided in paper)  
Fluorescence Quantum Yield Studies 
Fluorescence quantum yields were determined using the integrated emission area 
for the known standard Rhodamine 6G when excited at 488 nm ( = 0.95).  Quantum 
yields were calculated using the below equation, where Q represents the quantum yield, n 
is reflective index of the solvent, I is integrated intensity, and OD is optical density.  In 
each case the subscript r represents the values of the standard. 








   
  
Interference Studies 
For each protein/macromolecule, 2.0 mL of 8.35x10
-5
 M ligand stock solution 
were combined with 2.0 mL of 1.0 mg/L solution of each protein/macromolecule and 
mixed to give a final concentration of 4.18x10
-5
 M ligand and 0.5 mg/L 
protein/macromolecule.  Absorbance and fluorescence spectra were immediately taken.  
For the F/Fo ratio, a 4.18x10
-5
 M ligand solution (giving an absorbance of approximately 
0.5) was prepared to act as the baseline. 
Fitting data to one-site and two-site binding models 
The relative fluorescence quantum yields F/Fo were fit to a one-site and a two-site 
binding model according to the equation:       
   
     
 for a one-site binding model and 
      
          
 
           
  for the two-site binding model.  The results are shown in Figure 
8.1, with the one-site model in green and the two-site model in red. The dissociation 
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constants were 3.33x10-6 in the first case and 4.26 x10-6 and 2.23 x10-6 in the second, with Fsat 
= 138 in the first case and 113 in the second.   
 
Results 
From an initial EQY screening showing enhancement for R2 = Me, n-Pr or pentyl, 
a number of 4-N(Et)2-FP analogs were combinatorially synthesized using techniques 
highlighted elsewhere12 to determine the maximum EQY achievable with a given 
substitution.  These results are summarized below in Table 8.1.   
Table 8.1. FP Analogs and EQY Enhancements of compounds 1-13 with HSA.  
[a]
 
Intensity(bound)/Intensity(unbound) at em for 7.5 M (0.5 mg/mL) HSA solutions. 
Increasing turn-on ratios with increasing alkyl chain length substitution are 
readily rationalized by the increasing hydrophobicity of the chromophores coupled with 
the known hydrophobicity of the binding pockets,13 which reach a limit, respective of 
alkyl chain length, with the heptyl group. Additionally, we speculated that substitution of 
an ortho- hydroxyl would provide additional sensitivity due to a cluster of polar residues 
located in each site.14 
From the preliminary screening, 10 was chosen for more extensive studies to 
determine its application to albumin sensing in aqueous solution.  For all experiments, 
phosphate buffered saline (PBS) at pH = 7.4 was used.  Within PBS, 10 showed 




# R1 R2 F/Fo
[a]
 # R1 R2 F/Fo
[a]
 
1 H Me 3 8 OH Pentyl 36 
2 H n-Pr 11 9 OH Hexyl 67 
3 H Pentyl 24 10 OH Heptyl 72 
4 H Hexyl 20 11 OH Octyl 52 
5 H C3H6CO2H 6 12 OH Undecyl 7 
6 OH Me 30 13 OH C3H6CO2H 28 









differences compared to the Green Fluorescent Protein abs = 398nmem = 508nm).
15  A 
Langmuir calibration curve for 10 required a two-site cooperative binding model16 and 
showed a sensing range of 0.15 M to 15 M (10 mg/L to ~1000 mg/L) with two 
dissociation constants (Kd) of 0.24 M and 0.45 M, offering a higher sensitivity and 
greater sensing range than AB580 (Figure 8.1).   
 

















































































Given the relative fluorescence yield of 72, which we obtain at saturation with the 
heptyl analog 10, we also subjected the bound protein to competitive binding studies 
against 10 using warfarin and ibuprofen, which selectively bind Sudlow’s Sites I and II.17 
As noted from Figure 8.2, binding of 10 to HSA occurs at both binding pockets, each of 
which is displaced by one of the secondary binders.  We attribute the initial increase in 
fluorescence to allosteric effects, a conclusion consistent with the two-site binding model.  
These results, mentioned earlier, are not surprising since secondary binding of ligands to 
HSA sites is common and well established.18  Apparently, binding of one ligand, either 
Warfarin, ibuprofen, or HSA itself, leads to tighter binding of the secondary site and an 
increased fluorescence. 
Figure 8.3. Emission response of 10 with proteins and macromolecules 7.5 M (0.5 
mg/mL) in PBS buffer. 




















Figure 8.4.  Competitive binding study with ibuprofen and Warfarin. 
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HSA probes find application in the medical community as methods of 
quantification of albumin within biological samples.  For these purposes, probes must be 
both selective and sensitive to quantify HSA as well to operate within an aqueous 
environment.  To explore the selectivity of 10, buffered solutions of proteins 
representative of those found in biological fluids were prepared with equimolar amounts 
of the probe.  Additionally, the selectivity of 10 was explored by testing other albumins.  
The results of these interference studies are summarized in Figure 8.3.  
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Figure 8.5.  Emission spectra of compound 10 with various biological analytes. 
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The data from Figure 8.4 shows the selectivity of 10 to HSA compared to other 
analytes.  One remarkable quality is the selectivity over albumins from other species.  In 
PBS buffer, 10 showed a ~70-fold enhancement at 5 mol HSA (for general reference,  
= 0.25) compared to a 5-fold and a 13-fold enhancement for Bovine Serum Albumin 
(BSA) and Rat Serum Albumin (RSA), respectively.   
The similar responses of RSA and BSA were anticipated, due to the high degree 
of structural homology shared by HSA, BSA, and RSA.19  Other proteins did not show 
such enhancements, and in one case exhibited emission quenching, providing a very 
robust probe that experiences little interference. 
Conclusions and Outlook 
Mentioned earlier, AB580 has gained significant application as a fluorescent 
probe for the detection of albumin in biological samples.20  To test the competitiveness of 
10 against AB580, equimolar probe solutions were prepared and tested in PBS buffer. In 
Figure 8.1, 10 exhibits significantly higher fluorescence enhancement ratios compared to 
AB580 as well as a wider operation range for sensing providing for its use as a candidate 
for a small molecule probe for HSA.  AB580 is generally used to accurately detect 
albumin from 0.15 M to 3.0 M (10 mg/L to 200 mg/L).  In both cases, the probes 
exhibit weak unbound fluorescence followed by 10 to 100-foldstrong enhancements with 
binding to HSA.  Given the few synthetic iterations completed to attain an optimization 
on the initial hit, we anticipate that further enhancements using combinatorial synthesis 
will produce even better probes with relative ease.21  
The efficient fluorescence of the chromophore in GFP has been ascribed to the 
uniqueness of the -barrel.  We have shown that such chromophores can be activated by 
a non-barrel protein and can accommodate an aqueous environment.  This study 
represents one of the first cases utilizing a FP chromophore as a probe, with the exclusion 
of metal sensing,22 and provides motivation for this class of compounds to be considered 
for general sensing applications.  We note that other probes for HSA exist and are 
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documented in the literature23, however unlike probes which depend upon changes in 
environmental (solvent) polarity, this is a topological probe, depending instead upon 
conformational freezing for its efficacy and signalling mechanism.  
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AMI CHROMOPHORES AS LIQUID CRYSTALS 
 Work highlighted in this chapter was carried out in collaboration with the 
laboratory of Dr. Mohan Srinivasarao.  The synthesis of the compounds tested was 
completed within the Tolbert lab while the solid-state optical spectroscopy and testing of 
liquid crystal properties was completed within Dr. Srinivasarao’s laboratory.  Additional 
studies were completed at Argonne National Lab, APS MUCAT (Sector 6). 
 
Introduction 
 Liquid crystals have found wide application in optical displays and other devices.1  
Extensive literature exits on the physics of the organization and orientation of liquid 
crystals as well as how external effects including temperature, pressure and composition 
cause significant changes in the properties, both physical and optical of liquid crystals.2  
This chapter is by no means designed to provide an overview of this widely important 
class of molecules but rather provides motivation for use of AMI chromophores as 
possible candidates for liquid crystalline molecules.  Compounds termed as mesogens are 
commonly cited as having liquid crystalline properties.  These compounds are 
characterized as being both rod-like and disk-like in their appearance.3   In the case of 
rod-like mesogens, the compounds are characterized by a number of different properties 
but a specific class that is widely used contains an aliphatic/aromatic hydrocarbon moiety 
that provides rigidity, a flexible aliphatic chain and an electron-withdrawing group.4   
From their structure, arylmethyleneimidazolidinones (AMIs) possess a similar scaffold 
with a hydrophobic phenyl moiety that can readily be substituted with various 
functionalities to become increasingly hydrophobic, while the imidazolindinone ring 
provides the electron-withdrawing group.   
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A class of rod-like mesogens that have gained significant application are the 4-n-alkyl-4’-
cyanobiphenyls.5  Within devices, two of these mesogens include 4-n-octyl-4-
cyanobiphenyl (8CB) and 4-n-pentyl-4-cyanobiphenyl (5CB), whose wide application 
results from their large, complimenting operating ranges, with respect to temperature, as 
well as their general synthetic ease for manufacturing.6  Using these compounds as 
motivation, it was envisioned that replacement of the cyano group with the 
imidazolindinone ring should provide compounds with liquid crystal properties.  
Additional to this motivation are continuing studies on the solid state behavior of AMI 
chromophores where the fluorescent properties of these compounds upon solid-liquid 
transitions could provide insight into the interaction of AMI’s within the solid state as 
highlighted in Chapter 4. 
Experimental 
Synthesis 
Synthesis of the compounds was carried out as highlighted in Chapter 2 following 
the synthesis of the aldehyde.  Synthesis of the aldehyde is accomplished by adding 0.02 
mol of 4-alkyl-4’-cyanobiphenyl with 50 mL of 75% formic acid and 4g of Raney Ni that 
is refluxed for 2 hrs.  Following this, 3g of Raney Ni is added to the mixture and allowed 
to reflux an additional hrs.  The solution is cooled and diluted with 50 mL of H2O.  The 
organic layer is extracted with 40 mL of Et2O with the remaining reaction slurry filtered 
and washed with an additional 10 mL of Et2O.  The organic extracts were combined and 
solvent removed in vacuo to afford pure aldehyde product in good yield (~60%).7 
Figure 9.1.  Structures of 5CB (left) and 8CB (right) mesogens. 
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The Schiff base was obtained by stirring the biphenylbenzaldehyde (1eq) with the 
primary amine (1eq) in 5.0 mL of MeOH overnight, followed by removal of solvent 
under reduced pressure to yield product.  The aminoimidate was prepared as previously 
described.
8
 Imidazolindinones (liquid crystal candidates) were synthesized by combining 
the corresponding Schiff base (1eq) with the imidate (1.1 eq) and ~0.5mL of MeOH, 
which with stirring for 12 h resulted in the formation of bright yellow precipitate.  
Filtering of the precipitate followed by washing with cold Et2O yielded the desired 
products as bright yellow powdered materials.  Characterization of these compounds is 
found in Appendix A. 
Differential Scanning Calorimetry (DSC) 
DSC measurements on the imidazolinones were completed by preparing a 3.00 
mg of sample of each in a seal aluminum pan and completing a heat/cool/heat scan with 
the following sequence: 
1: Equilibrate at -20.00 °C  2: Ramp 20.00 °C/min to 100.00 °C  
3: Mark end of cycle    4: Isothermal for 2.00 min  
5: Ramp 5.00 °C/min to -30.00 °C 6: Isothermal for 2.00 min  
7: Mark end of cycle 0  8: Ramp 5.00 °C/min to 300.00 °C 
9: Isothermal for 2.00 min  10: Mark end of cycle 0 
 
Results 
Results of DSC measurements show similar phase transitions as the parent 
compounds.  The transitions for the 5-CB and 8-CB parent compounds are well 
documented.  For the 8CB mesogen the following transitions are noted. <20 C degree, 
crystalline; 20-34 C degree, Smectic-A;  34-41 C degree, Nematic;  >41 C degree, 
isotropic.9  As a control, the DSC of both the synthesized molecule and the commercially 
available 8CB are shown (Figure 9.2).  
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Figure 9.2.  DSC measurements of 8CB (top) and AMI C8 (bottom).   
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From these DSC results, the 3 major transitions noted for the 8CB can be compared to 
AMI C8 and are summaried in Table 9.1.  Additional studies on AMI C8 were completed 
using a much slower heating and cooling rate.  
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Additional XRD studies completed at Aragon National Lab, show the compounds reach 
an isotropic phase, which is a phase where the compound exhibits properties of a 
conventional liquid. XRD shows that the imidazolinone samples are crystalline below 
isotropic.  Further characterization of these molecules using a polarizing microscope 
Figure 9.3.  Polarized microscope images at transitions temperatures of AMI C8 
showing Semitic B phase characteristics.  
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reveals a Smectic B phase of the molecule upon heating and cooling as indicated by the 
mosaic appearance of the crystals. 
Following the completion of DSC measurements the emission spectra of the 
compounds reveals a high emission quantum yield in the solid state most likely attributed 
to the tight, ordered organization of the molecules hindering the conformational freedom 
that provides the main emission deactivation for these compounds.  Following heating to 
58
o
C, the first transition, a marked difference in the EQY is observed with a quenching of 
the fluorescence upon the transition from solid to liquid phase (Figure 9.3).  A similar 
EQY vs. temperature profile was noted upon cooling but did not result in full restoration 
of the EQY observed in the initial solid.  This observation could be attributed to the 
different reorganization of the solid upon cooling possibly resulting in a bending of these 






Discussion and Conclusions 
From the data, it is initially shown that substitution of the cyano group with the 
imidazolinone group provides a molecule with similar but significantly contrasting 
characteristics compared to the parent 4-alkyl-4-cyanobiphenyl compounds. XRD results 
show that only a crystalline structure is observed below the isotropic phase both for AMI 
C8.  Characterization using a polarized microscope reveals a Semitic B is observed with 
these compounds.  Following these initial studies it is also noted that upon heating and 
cooling a significant change in the EQY is noted for both temperature cycles.  The 
melting of the solid provides a quenching of the fluorescence while cooling restores a 
portion of the EQY but does not provide a restoration to the initial EQY level.  This study 
can be used to support the hypothesis that the solid state does provide an inhibition of the 
torsional motions of AMI chromophores as evident from the high initial EQY and the 
resulting restoration of EQY upon cooling and recrystallization.  Additional studies to 
continue the characterization of these compounds and explore their liquid crystalline 
Figure 9.4.  Emission spectra of AMI C8 with incremental heating (top) and cooling 
(bottom) coupled with respective EQY inserts.  
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properties are currently underway in collaboration with Dr. Mohan Srinivasarao.  Studies 
involving the doping of these compounds with the parent 4-alkyl-4-cyanobiphenyl 
compounds are also underway. 
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CONCLUSIONS AND FUTURE WORK 
 
Conclusions 
 Since its discovery in the 1960’s and subsequent isolation, the Green Fluorescent 
Protein has revolutionized molecular biology by providing a highly fluorescent marker in 
a myriad of environments.  Responsible for the remarkable fluorescence within this 11-
stranded -barrel protein is a chromophore protectively housed from the surrounding 
environment resulting from an autocatalytic cyclization and autoxidation of the Ser-65, 
Tyr-66, and Ser-67 residues.
1
  The resulting p-hydroxybenzylideneimidazolidinone 
chromophore along with multiple analogs have been successfully synthesized
2
 and 




Figure 10.1.  Encapsulated chromophore within the 11-stranded -barrel and torsional 
motions that result following removal from the restrictive -barrel. 
  
A number of these studies revolve around the observation that upon denaturation, the 
chromophore no longer exhibits the same photophysical characteristics as when 
encapsulated owing to excited state torsional motions that provide for rapid internal 
conversion resulting in a four order of magnitude emission quantum yield decrease.  It is 
believed that this observation is the result of cis/trans isomerization about the benzylidene 
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 a hula twist,
6
 or phenyl rotation.
7
  
 From the interesting photophysical properties noted in both the protein and the 
denatured chromophore, the necessity to develop synthetic protocols to study this 
interesting class of molecules is readily noted.  Prior to the work in this dissertation, 
synthesis of GFP chromophore analogs in the literature has commonly been carried out 
using Tonge’s modification
8
 of the Niwa synthesis,
9
 often referred to as the Erlenmeyer 
azalactone synthesis.  This synthesis involves somewhat harsh conditions and is not 
amiable to a number of functionalities.  Additionally, this synthesis requires multiple 
purification steps leading to poor and fair yields.  To overcome this obstacle and to fully 
study the properties of FP chromophores, a combinatorial synthesis utilizing a 2+3 
cycloaddition highlighted within Chapter 2 is proposed and shows great promise and 
results as a way to readily synthesize AMI chromophores in good to excellent yields with 
minimal purification and overall excellent synthetic tolerance.  Further research has 
shown that functionalization on all branches of the AMI chromophore is realized through 
synthetic modifications as well as post-synthetic modifications of the AMI 
chromophores.  As noted throughout this work, this cycloaddition has provided avenues 
to a myriad of products that in subsequent studies have significantly added to the 
understanding of these AMI chromophores as well as providing new uses for this class of 
compounds.  Chapters 3-9 highlight a number of completed research projects that were 
made possible through the efficient synthetic protocols developed within this dissertation.  
 Following the successful synthesis of a number of compounds, studies highlighted 
in Chapters 3 and 5 show the importance of conformational freedom within AMI 
chromophores whereby inhibition of certain torsional motions restore some of the 
emission quantum yield.  Chapter 5 adds a significant result in that the inhibition of free 
rotation about the formal single aryl bond leads to a portion of the internal conversion 
noted within the free AMI chromophores in solution.  This is verified in both the octa 
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acid cavitands and the cholate salt aggregates in that irradiation of the encapsulated 
chromophores still exhibit cis/trans isomerization as verified through complete emission 
quantum yield quenching as well as NMR experiments showing formation of the trans 
product.  This result has not been reported within the literature extensively prior to the 
works of this dissertation.  Most significant to note is the notion that inhibition of 
different paths and inclusion within a restrictive environment provide for an emission 
“turn-on” mechanism.  This finding was exploited within the works highlighted in 
Chapters 4 and 5-8. 
 Noting the discoveries concerning the photophysics of inclusion within 
supramolecular environments, it follows that these AMI chromophores can act as probes 
for various analytes.  To test this hypothesis, collaboration with Dr. Young-Tae Chang 
provided for an efficient screening mechanism to determine possible interactions between 
AMI chromophores synthesized using the 2+3 cycloaddition and various analytes 
including biologically relevant analytes.  These results highlighted in Chapter 6 show the 
emission quantum enhancement of AMI chromophores in the presence of a variety of 
chromophores.  Additionally, this screening method, by experimental design, allows for 
the development of AMI chromophores that can act as selective probes for a number of 
analytes.  These results coupled with the combinatorial synthesis allow for a rational 
design of probes.  This idea was realized in Chapter 8 where the development of a human 
serum albumin probe proved successful by selectively sensing HSA compared to other 
homologous albumins and competitive binding in the presence of known ligands.  In an 
additional collaboration, the use of AMI chromophores as ligands for nuclear receptors is 
also realized as highlighted in Chapter 7 working off the principles of rational synthetic 
design coupled with emission quantum yield enhancement upon inclusion.  Results show 
that AMI can act as ligands for both the ER( nuclear receptor as well as ligands for the 
pregnane X receptor.  In the case of the latter, binding of AMIs is shown to be greater 
than the leading ligands found within the literature. 
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 Work within this dissertation shows a building principle based upon the discovery 
of an efficient synthesis whose products can be used in a variety of studies.  Coupling the 
observation that inclusion within supramolecular environments leads to an emission 
quantum yield enhancement with the noted synthetic versatility, the application of these 
chromophores as small molecule probes that upon inclusion (the sensing mechanism) go 
from effectively non-fluorescent to fluorescent provides the basis and evidence for the 
use of AMI chromophores as a new class of probes.   
 
Future Work 
 While this dissertation highlights a wide body of work completed on the 
synthesis, photophysics, and application of AMI chromophores, a considerable amount of 
work remains.  Expansion of the combinatorial synthesis and building of the AMI 
compound library will provide additional substitution patterns that may provide 
applications to different environments than currently tested and may provide for the 
discovery of new photophysical data.  Expansion of the library could focus on the 
production of bathochromically shifted chromophores using the SeO2 oxidation or 
exploitation of specific functional groups as highlighted in Chapter 2.  These red-shifted 


























 AMI81 with -lactoglobulin
 AMI81 no -lactoglobulin
Figure 10.2.  Emission enhancement spectra of a tetramethyl-AMI derivative in the 
presecene of -lactoglobulin. 
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chromophores could provide favorable spectral characteristics that are advantageous to a 
number of different applications. 
 Following the expansion of the AMI compound library, additional screening 
studies expanding the analytes tested is motivated to expand this class of compounds as 
small molecule probes.  Interactions with different analytes may provide new discoveries 
into the photophysical nature of these chromophores while at the same time adding to the 
rational design protocols currently developed. 
 The notion of using specific AMI chromophores as small molecule probes has 
provided interesting results especially in the case of HSA as highlighted in this work.  
Preliminary work with -lactoglobulin, the main protein found in mammalian milk, 
shows that the rational design of an AMI chromophore provides an order of magnitude 
EQY enhancement (Figure 10.2).  Continuing studies using the combinatorial synthesis 
coupled with these initial results are motivated from these initial findings.   
 The findings of the interaction of AMI chromophores with nuclear receptors 
warrants the synthetic design of chromophores for other NR’s expanding beyond the 
initial two highlighted in Chapter 7.  At the time of publication, new collaborations are 
being developed to expand chromophore design to sense the androgen receptor, the 
retinoic X receptor, and the retinoic acid receptor.  Preliminary results (not provided) 
show promise but extended rational design and additional synthetic analogs are needed. 
 Finally, work toward the inhibition of cis/trans isomerization upon inclusion of 
AMI chromophores within supramolecular environments is motivated from the multiple 
studies highlighted within this dissertation.  While the enhancements in EQY are notable 
upon inclusion, isomerization still remains a main deactivation pathway for use of these 
chromophores.  Synthetic modifications to freeze the rotational path have allowed for 
some advancements on this front such as the bidentate ligands highlighted in Chapter 3, 
but additional work is warranted within this area. 
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in CDCl3:  2.35 (s, 
3H); 2.37 (s, 3H); 3.16 
(s, 3H); 7.08 (s, 1H); 
7.21 (d, JHH = 8.2 Hz, 
2H); 8.01 (d, JHH = 7.7 
Hz, 2H) 









2 3-OMe Me 
in CDCl3:  2.36 (s, 
3H); 3.16 (s, 3H); 3.84 
(s, 3H); 6.92 (dd, JHH 
= 8.2, 1.2 Hz, 1H); 
7.06 (s, 1H); 7.31 (t, 
JHH = 7.8 Hz, 1H); 
7.63 (d, JHH = 7.5 Hz, 
1H); 7.31 (t, JHH = 1.6 
Hz, 1H) 












3 3-OH Me 
in DMSO-d6:  2.33 (s, 
3H); 3.07 (s, 3H); 6.79 
(dd, JHH = 7.8, 2.0 Hz 
1H); 6.84 (s, 1H); 7.21 
(t, JHH = 7.6 Hz, 1H); 
7.50 (d, JHH = 7.8 Hz, 
1H); 7.72 (t, JHH = 2.1 
Hz, 1H); 9.58 (s, 1H) 









4 2,3-OMe Me 
in CDCl3:  2.37 (s, 
3H); 3.18 (s, 3H); 3.87 
(s, 3H); 3.88 (s, 3H) 
6.94 (dd, JHH = 7.8, 
1.8 Hz, 1H); 7.12 (t, 
JHH = 8.1 Hz 1H); 7.57 
(s, 1H); 8.31 (dd, JHH 
= 8.1, 1.3 Hz, 1H) 











5 4-NO2 Me in CDCl3:  2.41 (s, in CDCl3:  245.1 (100); 
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3H); 3.20 (s, 3H); 7.04 









6 2,5-OMe Me 
in CDCl3:  2.35 (s, 
3H); 3.17 (s, 3H); 3.82 
(s, 3H); 3.83 (s, 3H); 
6.82 (s, 1H); 6.88 (d, 
JHH = 3.3 Hz, 2H); 
7.62 (s, 1H); 8.41 (d, 
JHH = 2.7 Hz, 1H) 


















in CDCl3:  1.47 (s, 
18H); 2.35 (s, 3H); 
3.18 (s, 3H); 5.59 (m, 
2H); 7.08 (s, 1H); 8.06 
(s, 2H) 











8 4-CO2H Me 
in DMSO-d6:  2.36 (s, 
3H); 3.10 (s, 3H); 6.95 
(s, 1H); 7.88 (d, JHH = 
8.2 Hz, 2H); 8.10 (d, 
JHH = 8.2 Hz, 2H) 









9 4-N(Me)2 Me 
in CDCl3:  2.35 (s, 
3H); 3.04 (s, 6H); 3.17 
(s, 3H); 6.69 (d, JHH = 
9.3 Hz, 2H); 7.08 (s, 
1H); 8.04 (d, JHH = 9.0 
Hz, 2H) 












10 2-F Me 
in CDCl3:  2.37 (s, 
3H); 3.18 (s, 3H); 7.04 
(s, 1H); 7.08 (AA’ of 
a AA’XX’ spin 
system, 2H); 8.12 
(XX’ of a AA’XX’ 
spin system, 2H) 
in CDCl3:  
15.65, 26.56, 




(JCF = 8.0 Hz), 
138.24, 162.64, 








11 4-OBz Me in CDCl3:  2.35 (s, in CDCl3:  306.1 (84); 
 192 
3H); 3.17 (s, 3H); 5.11 
(s, 2H); 7.00 (d, JHH = 
8.7 Hz, 2H); 7.39 (m, 


















in CDCl3:  2.34 (s, 
3H); 3.17 (s, 3H); 3.87 
(s, 3H); 3.92 (s, 3H); 
3.93 (s, 3H); 6.46 (s, 
1H); 7.62 (s, 1H); 8.54 
(s, 1H) 



















in DMSO-d6:  2.33 (s, 
3H); 3.08 (s, 3H); 6.83 
(s, 1H); 7.03 (dd, JHH 
= 5.6, 0.6 Hz, 1H); 
8.05 (dd, JHH = 2.3, 
0.6 Hz, 1H); 8.61 (dd, 
JHH = 8.2, 0.6 Hz, 1H) 








14 4-OH Me 
in DMSO-d6:  2.31 (s, 
3H); 3.07 (s, 3H); 6.82 
(d, JHH = 8.8 Hz, 2H); 
6.88 (s, 1H); 8.07 (d, 
JHH = 8.8 Hz, 2H); 
10.11 (s, 1H) 










15 2-Me Me 
in CDCl3:  2.37 (s, 
3H); 2.48 (s, 3H); 3.19 
(s, 2H); 7.21 (m, 1H); 
7.25 (t, JHH = 2.1 Hz 
1H); 7.28 (s, 1H); 7.39 
(s, 1H); 8.59 (dd, JHH 
= 5.1, 3.0 Hz, 1H) 














16 4-CN Me 
in CDCl3:  2.39 (s, 
3H); 3.18 (s, 3H); 6.99 
(s, 1H); 7.65 (d, JHH = 
9.0 Hz, 1H); 8.19 (d, 
JHH = 8.1 Hz, 1H) 










17 4-N(Et)2 Me in CDCl3:  1.17 (t, JHH in CDCl3:  271.2 (87); 
 193 
= 7.2 Hz, 6H); 2.33 (s, 
3H); 3.15 (s, 3H); 3.39 
(q, JHH = 7.2 Hz, 4H); 
6.64 (d, JHH = 8.7 Hz, 
2H); 7.05 (s, 1H); 8.01 











18 4-OH n-Pr 
in CDCl3:  0.94 (t, JHH 
= 7.8 Hz, 3H); 1.65 
(m, 2H); 2.36 (s, 3H); 
3.56 (t, JHH = 7.2 Hz, 
2H); 6.82 (d, JHH = 8.1 
Hz, 2H); 7.09 (s, 1H); 
7.94 (d, JHH = 9.0 Hz, 
2H) 














19 4-OH n-Pn 
in CDCl3:  0.88 (t, JHH 
= 7.0 Hz, 3H); 1.32 
(m, 4H); 1.60 (m, 2H); 
2.36 (s, 3H); 3.58 (t, 
JHH = 7.0 Hz, 2H); 
6.83 (d, JHH = 8.7 Hz, 
2H) 7.08 (s, 1H); 7.94 
(d, JHH = 8.7 Hz, 2H) 
















20 4-OH n-Bu 
in CDCl3:  0.94 (t, JHH 
= 7.2 Hz, 3H); 1.36 
(m, 2H); 1.60 (m, 2H); 
2.38 (s, 3H); 3.60 (t, 
JHH = 7.2 Hz, 2H); 
6.82 (d, JHH = 8.7 Hz, 
2H); 7.09 (s, 1H); 7.95 
(d, JHH = 8.7 Hz, 2H) 














21 4-Me n-Pr 
in CDCl3:  0.95 (t, JHH 
= 7.2 Hz, 3H); 1.65 
(m, 2H); 2.37 (s, 6H); 
3.55 (t, JHH = 7.0 Hz, 
2H); 7.07 (s, 1H); 7.21 
(d, JHH = 7.8 Hz, 2H); 
8.01 (d, JHH = 8.4 Hz, 
2H) 















22 4-N(Me)2 n-Pr 
in CDCl3:  0.95 (t, JHH 
= 7.2 Hz, 3H); 1.65 
(m, 2H); 2.36 (s, 3H); 
3.04 (s, 6H); 3.55 (t, 
JHH = 7.5 Hz, 2H); 
6.70 (d, JHH = 8.7 Hz, 
2H); 7.06 (s, 1H); 8.05 
(d, JHH = 9.3 Hz, 2H) 













134.1 (13);  
84.1 (38) 
 194 
23 4-OH C3CO2H 
in DMSO-d6:  1.67 
(m, 2H); 1.91 (t, JHH = 
7.0 Hz, 2H); 2.34 (s, 
3H); 3.53 (t, JHH = 7.6 
Hz, 2H); 6.77 (d, JHH 
= 8.5 Hz, 2H); 6.83 (s, 
1H); 8.01 (d, JHH = 8.8 
Hz, 2H) 














24 4-OH C5CO2H 
in DMSO-d6:  1.25 
(m, 2H); 1.49 (m, 4H); 
1.94 (t, JHH = 7.0 Hz, 
2H); 2.32 (s, 3H); 3.50 
(t, JHH = 7.9 Hz, 2H); 
6.74 (d, JHH = 8.5 Hz, 
2H); 6.83 (s, 1H); 7.98 
(d, JHH = 8.8 Hz, 2H) 


















in CDCl3:  2.40 (s, 
3H); 3.23 (s, 3H); 7.56 
(m, 3H); 7.87 (m, 2H); 
7.98 (s, 1H); 8.31 (d, 
JHH = 8.4 Hz, 1H); 
8.79 (d, JHH = 7.2 Hz, 
1H) 













26 4-Et Me 
in CDCl3:  1.24 (t, JHH 
= 7.6 Hz, 3H); 2.37 (s, 
3H); 2.67 (q, JHH = 7.8 
Hz, 3H); 3.18 (s, 3H); 
7.10 (s, 1H); 7.25 (d, 
JHH = 9.0 Hz, 2H); 
8.04 (d, JHH = 7.5 Hz, 
2H) 












27 3-Me Me 
in CDCl3:  2.38 (s, 
3H); 2.39 (s, 3H); 3.18 
(s, 3H); 7.08 (s, 1H); 
7.18 (d, JHH = 7.7 Hz, 
1H); 7.30 (t, JHH = 7.7 
Hz, 1H); 7.93 (d, JHH 
= 9.4 Hz, 2H) 















28 2,4-Me Me 
in CDCl3:  2.36 (s, 
3H); 2.37 (s, 3H); 2.43 
(s,3H); 3.18 (s, 3H); 
7.07 (s, 2H); 7.36 (s, 




















in CDCl3:  2.40 (s, 
3H); 3.18 (s, 3H); 7.42 
(s, 1H); 7.54 (d, JHH = 
8.2 Hz, 1H); 7.70 (t of 
d, JHH = 8.2, 1.1 Hz, 
1H); 7.79 (d, JHH = 8.2 
Hz, 1H); 8.10 (d, JHH 
= 8.8 Hz, 1H); 8.17 (d, 
JHH = 8.8 Hz, 1H); 
8.85 (d, JHH = 8.8 Hz, 
1H) 













30 2,5-Me Me 
in CDCl3:  2.32 (s, 
3H); 2.36 (s, 3H); 2.45 
(s,3H); 3.18 (s, 3H); 
7.02 (s, 1H); 7.08 (d, 
JHH = 8.2 Hz, 1H); 
7.37 (s, 1H); 8.53 (d, 
JHH = 7.7 Hz, 1H) 

















in CDCl3:  1.27 (t, JHH 
= 7.1 Hz 3H); 2.40 (s, 
3H); 3.68 (q, d, JHH = 
7.1 Hz, 2H); 7.55 (m, 
3H); 7.86 (m, 2H); 
7.97 (s, 1H); 8.31 (d, 
JHH = 8.2 Hz, 1H); 
8.80 (d, JHH = 8.2 Hz, 
1H) 

















32 4-i-Pr n-Pr 
in CDCl3:  1.12 (t, JHH 
= 7.1 Hz, 3H); 1.41 (s, 
3H); 1.43 (s, 3H); 1.82 
(m, 2H); 2.54 (s, 3H); 
3.09 (m, 1H); 3.72 (t, 
JHH = 7.1 Hz, 2H); 
7.44 (d, JHH = 8.2 Hz, 
2H); 8.22 (d, JHH = 8.2 
Hz, 2H) 














33 4-N(Me)2 n-Bu 
in CDCl3:  0.93 (t, JHH 
= 7.3 Hz, 3H); 1.36 
(m, 2H); 1.56 (m, 2H); 
2.35 (s, 3H); 3.03 (s, 








6H); 3.58 (t, JHH = 7.3 
Hz, 2H); 6.68 (d, JHH 
= 9.1 Hz, 2H); 7.05 (s, 






34 2-CF3 Me 
in CDCl3:  2.36 (s, 
3H); 3.17 (s, 3H); 7.42 
(m, 2H); 7.60 (t, JHH = 
7.7 Hz, 1H); 7.68 (d, 
JHH = 7.7 Hz, 1H); 
8.69 (d, JHH = 8.2 Hz, 
1H) 















in CDCl3:  2.40 (s, 
3H); 3.19 (s, 3H); 7.50 
(m, 2H); 7.85 (m, 3H); 
8.42 (s, 1H); 8.43 (d, 
d, JHH = 7.7 Hz, 1H) 












36 4-N(Et)2 i-Pr 
in CDCl3:  1.17 (t, JHH 
= 7.1 Hz, 6H); 1.44 (s, 
3H); 1.46 (s, 3H); 2.38 
(s, 3H); 3.39 (q, JHH = 
7.1 Hz, 4H); 4.26 (m, 
1H); 6.65 (d, JHH = 8.8 
Hz, 2H); 6.99 (s, 1H); 
8.00 (d, JHH = 8.8 Hz, 
2H) 














37 4-OH EtOH 
in DMSO-d6:  2.36 (s, 
3H); 3.52 (d, JHH = 5.0 
Hz, 3.60 (d, JHH = 5.0 
Hz, 2H); 6.83 (d, JHH 
= 8.8 Hz, 2H); 6.88 (s, 











in acetone-d6: 2.46 (d, 
JHF = 0.6 Hz, 3 H), 
4.59 (tt, JHF = 16.5 Hz, 
2 H), 6.93 (AA′ part 
of AA′BB′ spin 
system, 2 H), 7.02 (s, 
1 H), 8.18 (BB′ part of 









H), 9.06 (br s, 1 H) 
39 4-Et n-Pr 
in CDCl3:  0.93 (t, JHH 
= 7.1 Hz, 3H); 1.22 (t, 
JHH = 7.1 Hz, 3H); 
1.64 (m, 2H); 2.36 (s, 
3H); 2.65 (q, JHH = 7.7 
Hz, 2H); 3.54 (t, JHH = 
7.1 Hz, 2H); 7.07 (s, 
1H); 7.22 (d, JHH = 8.2 
Hz, 2H); 8.03 (d, JHH 
= 8.2 Hz, 2H) 














40 2-Et Me 
in CDCl3:  1.23 (m, 
6H); 2.38 (s, 3H); 2.83 
(q, JHH = 7.1 Hz, 2H), 
3.66 (q, JHH = 7.1 Hz, 
2H); 7.21 (m, 1H); 
7.28 (m, 2H); 7.40 (s, 
1H); 8.57 (m, 1H) 
















41 2-Me n-Pr 
in CDCl3:  0.97 (t, JHH 
= 7.1 Hz, 3H); 1.23 (t, 
JHH = 7.7 Hz, 3H); 
1.67 (m, 2H); 2.38 (s, 
3H); 2.84 (q, JHH = 7.7 
Hz, 2H); 3.57 (t, JHH = 
7.1 Hz, 2H); 7.21 (m, 
1H); 7.28 (m, 2H); 
7.41 (s, 1H); 8.58 (m, 
1H) 
















42 2-Me CH2CF3 
in CDCl3:  2.34 (s, 
3H); 2.49 (s, 3H); 3.79 
(s, 2H); 7.19-7.31 (m, 
3H); 7.43 (s, 1H); 






43 4-OH PrOH 
in DMSO-d6:  1.69 
(pentet, JHH = 6.7 Hz, 
2H); 2.35 (s, 3H); 3.41 
(t, JHH = 6.2 Hz, 2H); 
3.60 (t, JHH = 7.0 Hz, 
2H); 6.80 (d, JHH = 8.5 
Hz, 2H); 6.86 (s, 1H); 
8.05 (d, JHH = 8.5 Hz, 
2H) 










44 2-Et n-Pr 
in CDCl3:  0.97 (t, JHH 
= 7.7 Hz, 3H); 1.23 (t, 
JHH = 7.7 Hz, 3H);1.67 







(m, 2H); 2.38 (s, 3H); 
2.84 (q, JHH = 7.7 Hz, 
2H); 3.57 (t, JHH = 7.1 
Hz, 2H); 7.22 (m, 
1H); 7.28 (m, 2H); 












45 3-NO2 Me 
in CDCl3:  2.37 (s, 
3H); 3.19 (s, 3H); 7.49 
(s, 2H); 7.66 (t, JHH = 
7.7 Hz, 1H); 7.99 (d, 
JHH = 8.2 Hz, 1H); 
8.46 (d, JHH = 7.7 Hz, 
1H) 














46 4-N(Et)2 n-Pr 
in CDCl3:  0.94 (t, JHH 
= 7.1 Hz, 3H); 1.18 (t, 
JHH = 7.1 Hz, 6H); 
1.64 (m, 2H); 2.35 (s, 
3H); 3.40 (q, JHH = 6.6 
Hz, 4H); 3.55 (t, JHH = 
7.7 Hz, 2H); 6.65 (d, 
JHH = 9.3 Hz, 2H); 
7.04 (s, 1H); 8.01 (d, 
JHH = 8.8 Hz, 2H) 















47 2,6-Me Me 
in CDCl3:  2.26 (s, 
6H); 2.30 (s, 3H); 3.18 
(s, 3H); 7.05 (d, JHH = 
7.7 Hz, 2H); 7.13 (t, 
JHH = 8.2 Hz, 1H); 
7.32 (s, 1H) 














48 4-i-Pr Me 
in CDCl3:  1.23 (s, 
3H); 1.25 (s, 3H); 2.35 
(s, 3H); 3.16 (s, 3H); 
7.09 (s, 1H); 7.26 (d, 
JHH = 8.3 Hz, 2H); 







49 4-t-Bu Me 
in CDCl3:  1.32 (s, 
9H); 2.36 (s, 3H); 3.16 
(s, 3H); 7.10 (s, 1H); 
7.43 (d, JHH = 8.2 Hz, 
2H); 8.04 (d, JHH = 8.8 
Hz, 2H) 











50 3-indole Me 
in DMSO-d6:  2.34 (s, 
3H); 3.10 (s, 3H); 7.17 
(m, 2H); 7.30 (s, 1H); 
7.47 (dd, JHH = 7.1, 
1.1 Hz, 1H); 8.20 (d, 
JHH = 7.1 Hz, 1H); 
8.39 (s, 1H); 11.93 (s, 
1H) 












51 2-F n-Pr 
in CDCl3:  0.96 (t, JHH 
= 7.1 Hz, 3H); 1.67 
(m, 2H); 2.38 (s, 3H); 
3.57 (t, JHH = 7.7 Hz, 
3H); 7.41 (s, 1H); 7.43 
(t, JHH = 7.7 Hz, 1H);  
7.61 (t, JHH = 7.7 Hz, 
1H); 7.69 (d, JHH = 7.7 
Hz, 1H); 8.73 (d, JHH 
= 7.7 Hz, 1H) 















52 4-N(Me)2 i-Pr 
in CDCl3:  1.45 (s, 
3H); 1.47 (s, 3H); 2.39 
(s, 3H); 3.03 (s, 6H); 
3.08 (s, 3H); 4.26 (m, 
1H); 6.69 (dd, JHH = 
6.6, 2.2 Hz, 2H); 7.01 
(s, 1H); 8.03 (d, JHH = 
8.8 Hz, 2H) 













53 4-tetralin Me 
in CDCl3:  1.28 (s, 
6H); 1.30 (s, 6H); 1.68 
(s, 4H); 2.36 (s, 3H); 
3.17 (s, 3H); 7.09 (s, 
1H); 7.35 (d, JHH = 8.2 
Hz, 1H); 7.91 (d, JHH 
= 1.7 Hz, 1H); 8.03 
(dd, JHH = 8.2, 1.7 Hz, 
1H) 













54 2-Me Et 
in CDCl3:  1.26 (t, JHH 
= 7.1 Hz, 3H); 2.39 (s, 
3H); 2.48 (s, 3H); 3.67 
(q, JHH = 7.1 Hz, 2H); 
7.21 (m, 1H); 7.26 (m, 
2H); 7.38 (s, 1H); 8.60 
(m, 1H) 















55 4-N(Et)2 n-Pn 
in CDCl3:  0.89 (t, JHH 
= 7.0 Hz, 3H); 1.18 (t, 
JHH = 7.0 Hz, 6H); 







1.33 (m, 4H); 1.61 (m, 
2H); 2.35 (s, 3H); 3.40 
(q, JHH = 7.0 Hz, 4H); 
3.57 (t, JHH = 7.3 Hz, 
2H); 6.65 (d, JHH = 9.1 
Hz, 2H); 7.05 (s, 1H); 









56 Benzyl Me 
in CDCl3:  2.36 (s, 
3H); 3.16 (s, 3H); 7.09 
(s, 1H); 7.39 (m, 3H); 
8.11 (dd, JHH = 8.2, 
2.2 Hz, 2H) 















in CDCl3:  1.49 (t, JHH 
= 6.6 Hz, 3H); 2.34 (s, 
3H); 3.18 (s, 3H); 4.08 
(q, JHH = 7.1 Hz, 2H); 
6.78 (t, JHH = 7.7 Hz, 
1H); 6.91 (d, JHH = 6.0 
Hz, 1H); 6.92 (d, JHH 
= 7.1Hz, 1H); 7.14 (s, 
1H) 














58 4-F Me 
in CDCl3:  2.35 (s, 3 
H), 3.16 (s, 3 H), 7.03 
(s, 1 H), 7.08 (AA′ of 
a AA′BB′X spin 
system, 2 H), 8.12 
(BB′ of a AA′BB′X 
spin system, 2 H) 
in CDCl3:  
15.01, 26.53, 
115.79 (JCF = 
21.8 Hz), 
125.81, 130.43, 
134.10 (JCF = 
9.2 Hz), 162.64, 











in CDCl3:  1.19 (t, JHH 
= 7.1 Hz, 6H); 2.33 (s, 
3H); 3.20 (s, 3H); 3.38 
(q, JHH = 6.6 Hz, 4H); 
6.16 (s, 1H); 6.22 (dd, 
JHH = 8.8, 2.7 Hz, 1H); 
7.12 (s, 1H); 7.11 (d, 
JHH = 8.8 Hz, 1H) 

















in DMSO-d6:  2.33 (s, 
3H); 3.07 (s, 3H); 6.91 
(s, 1H); 7.77 (s, 1H); 





61 2-Et Et in CDCl3:  1.24 (m, in CDCl3:  242.1 (100); 
 201 
6H); 2.38 (s, 3H); 2.83 
(q, JHH = 7.1 Hz, 2H); 
3.66 (q, JHH = 7.1 Hz, 
2H); 7.21 (m, 1H); 
7.28 (m, 2H); 7.40 (s, 














62 3-Me n-Pr 
in DMSO-d6:  0.85 (t, 
JHH = 7.7 Hz, 3H); 
1.56 (m, 2H); 2.32 (s, 
3H); 2.37 (s, 3H); 3.52 
(t, JHH = 7.2 Hz, 2H); 
6.91 (s, 1H); 7.22 (d, 
JHH = 7.2 Hz, 1H); 
7.33 (t, JHH = 7.2 Hz, 
1H); 7.98 (s, 1H); 8.04 
(d, JHH = 7.7 Hz, 1H) 
















63 2-Me n-Bu 
in CDCl3:  0.96 (t, JHH 
= 7.3 Hz, 3H); 1.38 
(sextet, JHH = 7.6 Hz, 
2H); 1.61 (pentet, JHH 
= 7.3 Hz, 2H); 2.38 (s, 
3H); 2.48 (s, 3H); 3.60 
(t, JHH = 7.3 Hz, 2H); 
7.17-7.31(m, 3H); 
7.37 (s, 1H); 8.60 (dd, 
JHH = 6.5, 2.9 Hz, 1H) 












64 2-Me n-Pn 
in CDCl3:  0.90 (t, JHH 
= 6.7 Hz, 3H); 1.33 
(sextet, JHH = 7.3 Hz, 
4H); 1.62 (pentet, JHH 
= 7.3 Hz, 2H); 2.39 (s, 
6H); 3.59 (t, JHH = 7.3 
Hz, 2H); 7.07 (s, 1H); 
7.18 (d, JHH = 7.3 Hz, 
1H); 7.31 (t, JHH = 7.6 
Hz, 1H); 7.92 (s, 1H); 
7.94 (d, JHH = 8.8 Hz, 
1H) 













65 2-Me i-Pr 
in CDCl3:  1.48 (s, 
3H); 1.50 (s, 3H); 2.41 
(s, 3H); 2.47 (s, 3H); 
7.17-7.29 (m, 3H); 












in DMSO-d6:  1.70 
(m, 2H); 1.98 (t, JHH = 
7.1 Hz, 2H); 2.34 (s, 
3H); 3.54 (t, JHH = 7.7 
Hz, 2H); 6.80 (d, JHH 
= 8.8 Hz, 1H); 6.84 (s, 
1H); 7.54 (dd, JHH = 
8.2, 1.7 Hz, 1H); 7.91 
(s, 1H) 














67 4-Me Et 
in CDCl3:  1.24 (t, JHH 
= 7.1 Hz, 3H); 2.37 (s, 
3H); 2.38 (s, 3H); 3.65 
(q, JHH = 7.1 Hz, 2H); 
7.07 (s, 1H); 7.21 (d, 
JHH = 7.7 Hz, 2H); 
8.01 (d, JHH = 8.2 Hz, 
2H) 










68 2,3-OMe C3CO2H 
in DMSO-d6:  1.69 
(m, 2H); 1.92 (t, JHH = 
6.7 Hz, 2H); 2.39 (s, 
3H); 3.55 (t, JHH = 7.3 
Hz, 3H); 3.79 (s, 3H); 
3.82 (s, 3H); 7.11 (s, 
1H); 7.12 (d, JHH = 6.7 
Hz, 1H); 7.19 (s, 1H); 
8.32 (dd, JHH = 7.0, 
2.3 Hz, 1H) 
















69 4-N(Et)2 C3CO2H 
in DMSO-d6:  1.10 (t, 
JHH = 6.4 Hz, 6H); 
1.68 (m, 2H); 1.92 (t, 
JHH = 6.4 Hz, 2H); 
2.34 (s, 3H); 3.53 (t, 
JHH = 7.0 Hz, 2H); 
3.39 (q, JHH = 6.7 Hz, 
4H); 6.69 (d, JHH = 8.8 
Hz, 2H); 6.82 (s, 1H); 
8.02 (d, JHH = 8.5 Hz, 
2H) 













70 4-Cl Me 
in CDCl3:  2.36 (s, 
3H); 3.16 (s, 3H); 7.01 
(s, 1H); 7.36 (d, JHH = 
8.5 Hz, 2H); 8.05 (d, 
JHH = 8.8 Hz, 2H) 








71 3-CF3 n-Pr 
in CDCl3:  0.96 (t, JHH 
= 7.6 Hz, 3H); 1.67 





(sextet, JHH = 7.3 Hz, 
2H); 2.40 (s, 3H); 3.57 
(t, JHH = 7.6 Hz, 2H); 
7.06 (s, 1H); 7.47-7.66 
(m, 2H); 8.28 (d, JHH = 




(JCF = 4.4 Hz), 
128.45 (JCF = 





72 4-CF3 Me 
in CDCl3:  2.36 (s, 
3H); 3.17 (s, 3H); 7.42 
(m, 2H); 7.60 (t, JHH = 
7.7 Hz, 1H); 7.68 (d, 
JHH = 7.7 Hz, 1H); 
8.69 (d, JHH = 8.2 Hz, 
1H) 
in CDCl3:  
15.74, 26.63, 
124.79, 125.36 
(JCF = 4.4 Hz), 
125.47 (JCF = 










in DMSO-d6:  1.67 
(m, 2H); 2.11 (s, 6H); 
2.19 (t, JHH = 6.7 Hz, 
2H); 2.35 (s, 3H); 3.56 
(t, JHH = 7.6 Hz, 2H); 
6.82 (d, JHH = 8.8 Hz, 
2H); 6.87 (s, 1H); 8.07 
(d, JHH = 8.8 Hz, 2H) 











74 3-CF3 Me 
in CDCl3:  2.38 (s, 
3H); 3.17 (s, 3H); 7.05 
(s, 1H); 7.48-7.60 (m, 
2H); 8.26 (d, JHH = 7.6 
Hz, 1H); 8.42 (s, 1H) 




(JCF = 4.4 Hz), 
129.08 (JCF = 







75 2,4-OH C3CO2H 
in DMSO-d6:  1.72 
(m, 2H); 1.99 (t, JHH = 
5.8 Hz, 2H); 2.35 (s, 
3H); 3.56 (t, JHH = 5.8 
Hz, 2H); 6.25 (s 
(broad), 2H); 7.13 (s, 
1H); 7.80 (d, JHH = 7.3 
Hz, 1H) 










76 3,4-OH C3CO2H 
in DMSO-d6:  1.72 






5.8 Hz, 2H); 2.35 (s, 
3H); 3.56 (t, JHH = 5.8 
Hz, 2H); 6.68 (d, JHH 
= 8.2 Hz, 1H); 6.76 (s, 
1H); 7.33 (d, JHH = 7.9 
Hz, 1H); 7.77 (s, 1H) 
completed 
77 2-Cl Me 
in CDCl3:  2.38 (s, 
3H); 3.19 (s, 3H); 7.26 
(t of d, JHH = 2.1, 7.6 
Hz, 1H); 7.33 (t of d, 
JHH = 1.5, 7.6 Hz, 1H); 
7.41 (dd, JHH = 1.5, 
7.9 Hz, 1H); 7.56 (s, 
1H); 8.74 (dd, JHH = 
1.8, 7.6 Hz, 1H) 










78 2-Cl n-Pr 
in CDCl3:  0.97 (t, JHH 
= 7.6 Hz, 3H); 1.67 
(m, 2H); 2.39 (s, 3H); 
3.57 (t, JHH = 7.6 Hz, 
2H); 7.27 (t of d, JHH = 
1.8, 7.6 Hz, 1H); 7.41 
(dd, JHH = 1.8, 7.6 Hz, 
1H); 7.33 (t of d, JHH = 
1.5, 7.3 Hz, 1H); 7.55 
(s, 1H); 8.76 (dd, JHH 
= 1.8, 7.6 Hz, 1H) 











79 4-CF3 n-Pr 
in CDCl3:  0.96 (t, JHH 
= 7.3 Hz, 3H); 1.66 
(m, 2H); 2.40 (s, 3H); 
3.60 (t, JHH = 7.3 Hz, 
2H); 7.05 (s, 1H); 7.64 
(d, JHH = 7.9 Hz, 2H); 
8.22 (d, JHH = 8.2 Hz, 
2H) 












80 3,5-Me Me 
in CDCl3:  2.35 (s, 
6H); 2.38 (s, 3H); 3.17 
(s, 3H); 7.01 (s, 1H); 
7.05 (s, 1H); 7.74 (s, 
2H) 









81 4-tetralin C3CO2H 
in DMSO-d6:  1.24 (s, 
12H); 1.64 (m, 2H); 
1.65 (s, 4H); 1.92 (t, 
JHH = 6.2 Hz, 2H); 
2.38 (s, 3H); 3.55 (t, 
JHH = 7.9 Hz, 2H); 










6.92 (s, 1H); 7.38 (d, 
JHH = 8.2 Hz, 1H); 
8.04 (d, JHH = 7.9 Hz, 







82 Benzyl C3CO2H 
in DMSO-d6:  1.70 
(m, 2H); 1.92 (t, JHH = 
6.7 Hz, 2H); 2.40 (s, 
3H); 3.56 (t, JHH = 8.8 
Hz, 2H); 6.95 (s, 1H); 
7.42 (m, 3H); 8.19 (d, 
JHH = 8.5 Hz, 2H) 
















in DMSO-d6:  1.07 (t, 
JHH = 6.7 Hz, 3H); 
1.09 (t, JHH = 6.7 Hz, 
3H); 1.72 (m, 2H); 
1.95 (t, JHH = 5.9 Hz, 
2H); 2.35 (s, 3H); 3.33 
(q, JHH = 7.3 Hz, 4H); 
3.56 (t, JHH = 7.0 Hz, 
2H); 6.13 (s, 1H); 6.23 
(dd, JHH = 6.7, 2.6 Hz, 
1H); 7.02 (d, JHH = 8.8 
Hz, 1H); 8.10 (s, 1H) 














84 4-N(Me)2 C3CO2H 
in DMSO-d6:  1.67 
(m, 2H); 1.90 (t, JHH = 
6.7 Hz, 2H); 2.35(s, 
3H); 2.99 (s, 6H); 3.53 
(t, JHH = 7.0 Hz, 2H); 
6.73 (d, JHH = 8.8 Hz, 
2H); 6.84 (s, 1H); 8.05 
(d, JHH = 8.8 Hz, 2H) 











85 4-OC6H13 Me 
in CDCl3:  0.90 (t, JHH 
= 7.0 Hz, 3H); 1.34 
(m, 4H); 1.46 (m, 2H); 
1.79 (m, 2H); 2.37 (s, 
3H); 3.18 (s, 3H); 3.99 
(t, JHH = 6.4 Hz, 2H); 
6.92 (d, JHH = 9.1 Hz, 
2H); 7.07 (s, 1H); 8.08 
(d JHH = 8.8 Hz, 2H) 
















in DMSO-d6:  2.14 (s, 
6H); 2.24 (s, 3H); 3.07 





(s, 3H); 6.49 (s, 2H); 














in CDCl3:  1.47 (s, 
18H); 2.22 (s, 3H); 
4.82 (s, 2H); 7.16-7.35 
(m, 6H); 8.08 (s, 2H) 













88 4-OH Benzyl 
in DMSO-d6:  2.34 (s, 
3H); 4.82 (s, 2H); 6.85 
(d, JHH = 8.5 Hz, 2H); 
6.99 (s, 1H); 7.28 (m, 
5H); 8.10 (d, JHH = 8.5 
Hz, 2H) 

















in DMSO-d6:  2.18 (s, 
6H); 2.32 (s, 3H); 3.07 
(s, 3H); 6.80 (s, 1H); 
7.81 (s, 2H) 









90 3-F Me 
in CDCl3:  2.37 (d, 
JHH = 0.6 Hz, 3 H), 
3.17 (s, 3 H), 7.02 (s, 
1 H), 7.00-7.10 (m, 1 
H), 7.30-7.4 (m, 1 H), 
7.70-7.75 (m, 1 H), 
8.00-8.08 (m, 1 H) 
in CDCl3:  
15.67, 26.58, 
116.75 (JCF = 
22.0 Hz), 
118.25 (JCF = 
22.0 Hz), 
125.45, 127.97, 
130.01 (JCF = 
7.7 Hz), 136.20, 
139.51, 162.69 





91 3-OH C3CO2H 
in DMSO-d6:  1.71 
(pentet, JHH = 7.3 Hz, 





2H); 1.99 (t, JHH = 6.7 
Hz, 2H); 2.37 (s, 3H); 
3.55 (t, JHH = 7.3 Hz, 
2H); 6.83 (s, 1H); 6.85 
(d, JHH = 7.9 Hz, 1H); 
7.19 (t, JHH = 7.9 Hz, 
1H); 7.51 (d, JHH = 7.9 









92 4-OC12H25 Me 
in CDCl3:  0.88 (t, JHH 
= 6.7 Hz, 3H); 1.18-
1.39 (m, 18H); 1.45 
(sextet, JHH = 7.9 Hz, 
2H); 1.79 (pentet, JHH 
= 7.9 Hz, 2H); 2.36 (s, 
3H); 3.18 (s, 3H); 3.99 
(t, JHH = 6.5 Hz, 2H); 
6.92 (d, JHH = 8.8 Hz, 
2H); 7.07 (s, 1H); 8.09 
(d, JHH = 8.8 Hz, 2H) 















93 4-OMe Me 
in CDCl3:  2.63 (s, 
3H); 3.17 (s, 3H); 3.84 
(s, 3H); 6.93 (d, JHH = 
9.1 Hz, 2H); 7.07 (s, 
1H); 8.10 (d, JHH = 9.1 
Hz, 2H) 









94 2-OMe Me 
in CDCl3:  2.34 (s, 
3H); 3.15 (s, 3H); 3.86 
(s, 3H); 6.86 (d, JHH = 
8.2 Hz 1H); 7.00 (t, 
JHH = 7.6 Hz, 1H); 
7.32 (t, JHH = 7.00 Hz, 
1H); 7.66 (s, 1H); 8.70 
(dd, JHH = 7.9, 1.8 Hz, 
1H) 












95 4-OMe n-Pr 
in CDCl3:  0.95 (t, JHH 
= 7.6 Hz, 3H); 1.65 
(m, 2H); 2.37 (s, 3H); 
3.55 (t, JHH = 7.6 Hz, 
2H); 3.84 (s, 3H); 6.93 
(d, JHH = 9.1 Hz, 2H); 
7.06 (s, 1H); 8.10 (d, 
JHH = 8.8 Hz, 2H) 













96 4-Cl n-Pr 
in CDCl3:  0.96 (t, JHH 
= 7.3 Hz, 3H); 1.66 
(sextet, JHH = 7.3 Hz, 







2H); 2.38 (s, 3H); 3.56 
(t, JHH = 7.3 Hz, 2H); 
7.04 (s, 1H); 7.10 
(AA′ of a AA′BB′X 
spin system, 2 H), 
8.14 (BB′ of a 
AA′BB′X spin system, 
2 H) 
115.86 (JCF = 
21.0 Hz), 
125.74, 130.57, 
134.12 (JCF = 
8.8 Hz), 162.72, 






97 4-Br Me 
in CDCl3:  2.36 (s, 
3H); 3.17 (s, 3H); 6.99 
(s, 1H); 7.51 (d, JHH = 
8.8 Hz, 2H); 7.98 (d, 
JHH = 8.5 Hz, 2H) 









98 2-OMe n-Pr 
in CDCl3:  0.94 (t, JHH 
= 7.3 Hz, 3H); 1.64 
(m, 2H); 2.36 (s, 3H); 
3.55 (t, JHH = 7.6 Hz, 
2H); 3.86 (s, 3H); 6.87 
(d, JHH = 8.2 Hz, 1H); 
7.01 (t, JHH = 6.7 Hz, 
1H); 7.32 (t, JHH = 6.7 
Hz, 1H); 7.66 (s, 1H); 
8.70 (d, JHH = 7.9 Hz, 
1H) 












99 2-Br Me 
in CDCl3:  2.36 (s, 
3H); 3.18 (s, 3H); 7.17 
(t, JHH = 7.9 Hz, 1H); 
7.36 (t, JHH = 7.9 Hz, 
1H); 7.50 (s, 1H); 7.60 
(d, JHH = 7.9 Hz, 1H); 
8.70 (d, JHH = 7.9 Hz, 
1H) 










100 4-PhC8H17 Me 
in CDCl3:  0.89 (t, JHH 
= 7.0 Hz, 3H); 1.19-
1.42 (m, 10H); 1.60-
1.70 (m, 2H); 2.40 (s, 
3H); 2.65 (t, JHH = 7.9 
Hz, 2H); 3.20 (s, 3H); 
7.15 (s, 1H); 7.28 (d, 
JHH = 6.4 Hz, 4H); 
7.47-7.60 (m, 4H); 
7.66 (d, JHH = 8.2 Hz, 
2H); 8.20 (d, JHH = 8.2 
Hz, 2H) 















101 4-Br n-Pr in CDCl3:  0.95 (t, JHH in CDCl3:   
 209 
= 7.3 Hz, 3H); 1.66 
(sextet, JHH = 7.3 Hz, 
2H); 2.37 (s, 3H); 3.55 
(t, JHH = 7.3 Hz, 2H); 
6.99 (s, 1H); 7.53 (d, 
JHH = 8.5 Hz, 2H); 








102 2-Br n-Pr 
in CDCl3:  0.96 (t, JHH 
= 7.3 Hz, 3H); 1.67 
(sextet, JHH = 7.3 Hz, 
2H); 2.38 (s, 3H); 3.57 
(t, JHH = 7.3 Hz, 2H); 
7.18 (t of d, JHH = 7.9, 
1.8 Hz, 1H); 7.37 (t of 
d, JHH = 7.9, 1.5 Hz, 
1H); 7.61 (dd, JHH = 
8.2, 1.2 Hz, 1H); 7.50 
(s, 1H); 8.72 (dd, JHH 
= 8.2, 1.5 Hz, 1H) 











103 3-F n-Pr 
in CDCl3:  0.96 (t, JHH 
= 7.3 Hz, 3H); 1.67 
(sextet, JHH = 7.3 Hz, 
2H); 2.39 (s, 3H); 3.56 
(t, JHH = 7.3 Hz, 2H); 
7.02 (s, 1H); 7.05 (t of 
d, JHH = 8.2, 2.6 Hz, 
1H); 7.36 (d of t, JHH = 
6.1 Hz, 1H); 7.73 (d, 
JHH = 7.9 Hz, 1H); 
8.05 (ddd, JHH = 10.6, 
2.6, 1.5 Hz, 1H) 
in CDCl3:  
11.16, 15.77, 
22.55, 42.18, 




(JCF = 8.8 Hz), 
136.29, 139.47, 






104 3-Cl Me 
in CDCl3:  2.37 (s, 
3H); 3.16 (s, 3H); 6.98 
(s, 1H); 7.29-7.35 (m, 
2H); 7.87-7.94 (m, 
1H); 8.20 (s, 1H) 










105 3-OMe n-Pr 
in CDCl3:  0.95 (t, JHH 
= 7.6 Hz, 3H); 1.66 
(sextet, JHH = 7.3 Hz, 
2H); 2.38 (s, 3H); 3.56 
(t, JHH = 7.6 Hz, 2H); 
3.85 (s, 3H); 6.93 (dd, 
JHH = 8.2, 2.3 Hz, 1H); 











7.05 (s, 1H); 7.32 (t, 
JHH = 7.9 Hz, 1H); 
7.64 (d, JHH = 7.6 Hz, 
1H); 7.81 (s, 1H) 
159.59, 162.64, 
170.74 
106 Benzyl n-Pr 
in CDCl3:  0.95 (t, JHH 
= 7.6 Hz, 3H); 1.66 
(sextet, JHH = 7.6 Hz, 
2H); 2.38 (s, 3H); 3.56 
(t, JHH = 7.6 Hz, 2H); 
7.09 (s, 1H); 7.32-7.44 
(m, 3H); 8.12 (d, JHH = 
6.2 Hz, 2H) 










107 3-OH C3CO2H 
in DMSO-d6:  1.15-
1.29 (m, 2H); 1.39-
1.57 (m, 4H); 1.93 (t, 
JHH = 7.3 Hz, 2H); 
2.36 (s, 3H); 3.51 (t, 
JHH = 7.6 Hz, 2H); 
6.83 (s, 1H); 6.85 (d, 
JHH = 8.2 Hz, 1H); 
7.19 (t, JHH = 7.9 Hz, 
1H); 7.51 (d, JHH = 7.9 
Hz, 1H); 7.68 (s, 1H) 













108 Benzyl C3CO2H 
in DMSO-d6:  1.23 
(pentet, JHH = 7.0 Hz, 
2H); 1.41-1.57 (m, 
4H); 1.87 (t, JHH = 7.3 
Hz, 2H); 2.38 (s, 3H); 
3.53 (t, JHH = 7.0 Hz, 
2H); 6.96 (s, 1H); 
7.17-7.46 (m, 3H); 
8.20 (d, JHH = 6.4 Hz, 
2H) 












109 4-PhC5H11 Me 
in CDCl3:  0.91 (t, JHH 
= 6.5 Hz, 3H); 1.30-
1.41 (m, 4H); 1.66 
(pentet, JHH = 7.6 Hz, 
2H); 2.39 (s, 3H); 2.65 
(t, JHH = 7.9 Hz, 2H); 
3.19 (s, 3H); 7.14 (s, 
1H); 7.27 (d, JHH = 6.2 
Hz, 2H); 7.56 (d, JHH 
= 8.2 Hz, 2H); 7.65 (d, 
JHH = 8.5 Hz, 2H); 
8.19 (d, JHH = 8.5 Hz, 
2H) 















110 4-i-Pr Me 
in CDCl3:  0.89 (s, 
3H); 0.91 (s, 3H); 1.88 
(septet, JHH = 6.7 Hz, 
1H); 2.37 (s, 3H); 2.50 
(d, JHH = 7.0 Hz, 2H); 
3.18 (s, 3H); 7.10 (s, 
1H); 7.20 (d, JHH = 8.2 
Hz, 2H); 8.04 (d, JHH 
= 8.2 Hz, 2H) 











111 3,4-Me Me 
in CDCl3:  2.29 (s, 
3H); 2.30 (s, 3H); 2.37 
(s, 3H); 3.17 (s, 3H); 
7.07 (s, 1H); 7.18 (d, 
JHH = 8.5 Hz, 1H); 
7.87 (s, 1H); 7.89 (d, 
JHH = 6.2 Hz, 1H) 















in CDCl3:  0.89 (t, JHH 
= 7.0 Hz, 3H); 1.18 (t, 
JHH = 7.0 Hz, 4H); 
1.32 (m, 4H); 1.62 (m, 
2H); 2.33 (s, 3H); 3.37 
(q, JHH = 7.0 Hz, 4H); 
3.59 (t, JHH = 7.3 Hz, 
2H); 6.15 (d, JHH = 2.6 
Hz, 1H); 6.21 (dd, JHH 
= 8.8, 2.3 Hz, 1H); 
7.09 (s, 1H); 7.11 (d, 
JHH = 7.0 Hz, 1H) 





















in CDCl3:  0.86 (t, JHH 
= 6.2 Hz, 3H); 1.18 (t, 
JHH = 7.0 Hz, 6H); 
1.27 (m, 8H); 1.60 (m, 
2H); 2.32 (s, 3H); 3.37 
(q, JHH = 7.0 Hz, 4H); 
3.59 (t, JHH = 7.3 Hz, 
2H); 6.15 (s, 1H); 6.20 
(d, JHH = 9.1 Hz, 1H); 
7.09 (s, 1H); 7.10 (d, 
JHH = 7.3 Hz, 1H) 


















in CDCl3:  0.95 (t, JHH 
= 7.3 Hz, 3H); 1.19 (t, 
JHH = 7.0 Hz, 6H); 
1.66 (m, 2H); 2.33 (s, 
3H); 3.38 (q, JHH = 7.0 
Hz, 4H); 3.58 (t, JHH = 










7.6 Hz, 2H); 6.15 (d, 
JHH = 2.3 Hz, 1H); 
6.21 (dd, JHH = 9.1, 
2.6 Hz, 1H); 7.10 (s, 





115 4-N(Et)2 n-hexyl 
in CDCl3:  0.88 (t, JHH 
= 6.7 Hz, 3H); 1.19 (t, 
JHH = 7.3 Hz, 6H); 
1.30 (m, 6H); 1.60 (m, 
2H); 2.35 (s, 3H); 3.40 
(q, JHH = 7.0 Hz, 4H); 
3.57 (t, JHH = 7.6 Hz, 
2H); 6.65 (d, JHH = 9.1 
Hz, 2H); 7.05 (s, 1H); 
8.02 (d, JHH = 8.8 Hz, 
2H) 

















in CDCl3:  0.86 (t, JHH 
= 6.2 Hz, 3H); 1.17 (t, 
JHH = 7.3 Hz, 4H); 
1.29 (m, 8H); 1.60 (m, 
2H); 2.32 (s, 3H); 3.36 
(q, JHH = 7.0 Hz, 4H); 
3.58 (t, JHH = 7.3 Hz, 
2H); 6.14 (s, 1H); 6.20 
(dd, JHH = 8.8, 2.1 Hz, 
1H); 7.08 (s, 1H); 7.10 
(d,, JHH = 7.6 Hz, 1H) 














117 2-OH n-Pr 
in CDCl3:  0.96 (t, JHH 
= 7.3 Hz, 3H); 1.68 
(sextet, JHH = 7.3 Hz, 
2H); 2.39 (s, 3H); 3.60 
(t, JHH = 7.6 Hz, 2H); 
6.85 (t, JHH = 7.9 Hz, 
1H); 6.95 (d, JHH = 8.2 
Hz, 1H); 7.15 (s, 1H); 
7.27-7.37 (m, 2H) 











118 3-Cl n-Pr 
in CDCl3:  0.96 (t, JHH 
= 7.6 Hz, 3H); 1.66 
(sextet, JHH = 7.3 Hz, 
2H); 2.39 (s, 3H); 3.56 
(t, JHH = 7.3 Hz, 2H); 
6.99 (s, 1H); 7.30-7.36 
(m, 2H); 7.89-7.95 (m, 
1H); 8.22 (s, 1H) 











119 2-OH Dodecyl in CDCl3:  0.87 (t, JHH in CDCl3:   
 213 
4-N(Et)2 = 6.7 Hz, 3H); 1.19 (t, 
JHH = 7.0 Hz, 6H); 
1.24 (m, 18H); 1.61 
(m, 2H); 2.34 (s, 3H); 
3.38 (q, JHH = 7.0 Hz, 
4H); 3.60 (t, JHH = 7.3 
Hz, 2H); 6.16 (s, 1H); 
6.22 (dd, JHH = 8.8, 
2.1 Hz, 1H); 7.11 (s, 


















in CDCl3:  0.86 (t, JHH 
= 6.7 Hz, 3H); 1.18 (t, 
JHH = 7.0 Hz, 6H); 
1.27 (m, 10H); 1.61 
(m, 2H); 2.33 (s, 3H); 
3.37 (q, JHH = 7.0 Hz, 
4H); 3.59 (t, JHH = 7.6 
Hz, 2H); 6.15 (s, 1H); 
6.21 (dd, JHH = 8.8, 
2.1 Hz, 1H); 7.10 (s, 
1H); 7.11 (d, JHH = 7.3 
Hz, 1H) 















121 4-i-Bu C3CO2H 
in CD3OD:  0.90 (s, 
3H); 0.92 (s, 3H); 
1.82-1.96 (m, 3H); 
2.20 (t, JHH = 7.3 Hz, 
2H); 2.44 (s, 3H); 2.51 
(d, JHH = 7.3 Hz, 2H); 
3.67 (t, JHH = 7.6 Hz, 
2H); 7.03 (s, 1H); 7.22 
(d, JHH = 8.2 Hz, 2H); 
8.01 (d, JHH = 7.9 Hz, 
2H) 












122 4-i-Bu n-heptyl 
in CDCl3:  0.74-1.01 
(m, 9H); 1.14-1.41 (m, 
8H); 1.52-1.69 (m, 
2H); 1.87 (septet, JHH 
= 6.7 Hz, 1H);  2.37 
(s, 3H); 2.49 (d, JHH = 
7.0 Hz, 2H); 3.57 (t, 
JHH = 7.0 Hz, 2H); 
7.08 (s, 1H); 7.19 (d, 
JHH = 7.6 Hz, 2H); 
8.03 (d, JHH = 7.6 Hz, 
















123 3,4-Me C3CO2H 
in CD3OD:  1.89 
(pentet, JHH = 7.3 Hz, 
2H); 2.21 (t, JHH = 7.3 
Hz, 2H); 2.29 (s, 6H); 
2.43 (s, 3H); 3.66 (t, 
JHH = 7.3 Hz, 2H); 
6.98 (s, 1H); 7.17 (d, 
JHH = 7.6 Hz, 1H); 
7.80 (d, JHH = 7.9 Hz, 
1H); 7.85 (s, 1H) 













124 3-pyridyl Me 
in CDCl3:  2.36 (s, 
3H); 3.16 (s, 3H); 7.02 
(s, 1H); 7.32 (dd, JHH 
= 7.9, 4.7 Hz, 8.53 
(dd, JHH = 5.0, 1.5 Hz, 
1H); 8.66 (d of t, JHH = 
8.2, 1.8 Hz, 1H); 9.01 
(dd, JHH = 2.3 Hz, 1H) 










125 3-Br n-Pr 
in CDCl3:  0.95 (t, JHH 
= 7.3 Hz, 3H); 1.66 
(sextet, JHH = 7.3 Hz, 
2H); 2.39 (s, 3H); 3.56 
(t, JHH = 7.6 Hz, 2H); 
6.97 (s, 1H); 7.27 (t, 
JHH = 7.9 Hz, 1H); 
7.48 (d, JHH = 7.9 Hz, 
1H); 7.99 (d, JHH = 7.6 
Hz, 1H); 8.35 (s, 1H) 












126 2,4-Cl Me 
in CDCl3:  2.36 (s, 
3H); 3.17 (s, 3H); 7.28 
(d, JHH = 8.5 Hz, 1H); 
7.41 (s, 1H); 7.43 (s, 
1H); 8.75 (d, JHH = 8.5 
Hz, 1H) 










127 2-OH Me 
in CDCl3:  2.36 (s, 
3H); 3.11 (s, 3H); 6.86 
(t, JHH = 7.0 Hz, 1H); 
6.87 (d, JHH = 8.5 Hz, 
1H); 7.24 (s, 1H); 7.27 
(t of d, JHH = 7.0, 1.8 
Hz, 1H); 8.17 (dd, JHH 
= 7.9, 1.8 Hz, 1H) 










128 3-Br Me 
in CDCl3:  2.38 (s, 
3H); 3.18 (s, 3H); 6.98 





(s, 1H); 7.27 (t, JHH = 
7.9 Hz, 1H); 7.48 (d, 
JHH = 7.9 Hz, 1H); 
7.98 (d, JHH = 7.9 Hz, 







129 4-PhC3H7 Me 
in CDCl3:  0.98 (t, JHH 
= 7.3 Hz, 3H); 1.69 
(sextet, JHH = 7.6 Hz, 
2H); 2.39 (s, 3H); 2.64 
(t, JHH = 7.9 Hz, 2H); 
3.19 (s, 3H); 7.15 (s, 
1H); 7.28 (d, JHH = 8.2 
Hz, 1H); 7.56 (d, JHH 
= 8.2 Hz, 1H); 7.65 (d, 
JHH = 8.5 Hz, 1H); 
8.19 (d, JHH = 8.5 Hz, 
1H) 
















in CDCl3:  0.94 (t, JHH 
= 7.3 Hz, 3H); 1.46 (s, 
18H); 1.65 (sextet, JHH 
= 7.6 Hz, 2H); 2.35 (s, 
3H); 3.55 (t, JHH = 7.3 
Hz, 2H); 7.06 (s, 1H); 
8.05 (s, 2H) 















in CDCl3:  0.89 (t, JHH 
= 6.7 Hz, 3H); 1.25-
1.38 (m, 4H); 1.46 (s, 
18H); 1.61 (pentet, 
JHH = 7.0 Hz, 2H); 
2.36 (s, 3H); 3.58 (t, 
JHH = 7.3 Hz, 2H); 
7.06 (s, 1H); 8.06 (s, 
2H) 
















in CDCl3:  0.87 (t, JHH 
= 7.0 Hz, 3H); 1.22-
1.35 (m, 6H); 1.46 (s, 
18H); 1.54-1.65 (m, 
2H); 2.35 (s, 3H); 3.57 
( t, JHH = 7.3 Hz, 2H); 
7.06 (s, 1H); 8.05 (s, 
2H) 













133 4-OMe EtOH 
in CDCl3:  2.36 (s, 
3H); 3.72 (d, JHH = 4.7 





Hz, 2H); 3.79 (d, JHH 
= 5.3 Hz, 2H); 3.85 (s, 
3H); 6.94 (d, JHH = 9.1 
Hz, 2H); 7.02 (s, 1H); 








134 3,4-OMe n-Pr 
in CDCl3:  0.94 (t, JHH 
= 7.3 Hz, 3H); 1.64 
(sextet, JHH = 7.6 Hz, 
2H); 2.36 (s, 3H); 3.55 
(t, JHH = 7.6 Hz, 2H); 
3.91 (s, 3H); 3.94 (s, 
3H); 6.88 (d, JHH = 8.5 
Hz, 1H); 7.03 (s, 1H); 
7.52 (dd, JHH = 8.2, 
1.8 Hz, 1H); 8.03 (s, 
1H) 
















in CDCl3:  1.45 (t, JHH 
= 7.0 Hz, 3H); 2.22 (s, 
3H); 4.09 (q, JHH = 7.0 
Hz, 2H); 6.78 (t, JHH = 
7.9 Hz, 1H); 6.90 (dd, 
JHH = 8.2, 1.2 Hz, 1H); 
6.94-7.04 (m, 3H); 
7.13 (dd, JHH = 8.2, 
1.2 Hz, 1H); 7.16 (s, 
1H); 7.28 (t of d, JHH = 
8.2, 1.5 Hz, 1H) 

















in DMSO-d6:  2.17 (s, 
6H); 2.36 (s, 3H); 2.38 
(t, JHH = 6.4 Hz, 2H); 
3.63 (t, JHH = 6.4 Hz, 
2H); 6.83 (d, JHH = 8.8 
Hz, 2H); 6.87 (s, 1H0; 
8.06 (d, JHH = 8.8 Hz, 
2H) 













in DMSO-d6:  2.17 (s, 
6H); 2.39 (s, 3H); 3.64 
(t, JHH = 6.2 Hz, 4H); 
6.82 (dd, JHH = 8.2, 
1.8 Hz, 1H); 6.85 (s, 
1H); 7.23 (t, JHH = 7.6 
Hz, 1H); 7.53 (d, JHH 
= 7.9 Hz, 1H); 7.72 (s, 
1H) 











138 2-OH Me in CDCl3:  2.34 (s, in CDCl3:  Analysis 
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3H); 2.76 (s, 3H); 3.20 
(s, 3H); 6.97 (t, JHH = 
7.9 Hz, 1H); 7.03 (d, 
JHH = 8.2 Hz, 1H); 
7.32 (t, JHH = 8.2 Hz, 











139 4-N(Et)2 C2-sym 
in CDCl3:  1.19 (t, JHH 
= 7.3 Hz, 6H); 2.19 (s, 
3H); 3.41 (q, JHH = 7.0 
Hz, 4H); 3.87 (s, 2H); 
6.67 (d, JHH = 9.1 Hz, 
2H); 7.08 (s, 1H); 8.03 
(d, JHH = 9.1 Hz, 2H) 













in CDCl3:  2.27 (s, 
6H); 2.41 (s, 3H); 2.49 
(t, JHH = 6.7 Hz, 2H); 
3.68 (t, JHH = 6.7 Hz, 
2H); 7.08 (s, 1H); 
7.31-7.46 (m, 3H); 
8.10 (d, JHH = 7.6 Hz, 
2H) 














in CDCl3:  1.47 (s, 
18H); 2.38 (s, 3H); 
3.72-3.82 (m, 4H); 
7.07 (s, 1H); 8.05 (s, 
2H) 














in CDCl3:  0.96 (t, JHH 
= 7.3 Hz, 3H); 1.67 
(sextet, JHH = 7.6 Hz, 
2H); 2.37 (s, 3H); 3.59 
(t, JHH = 7.6 Hz, 2H); 
3.82 (s, 3H); 6.42-6.49 
(m, 2H); 7.12 (s, 1H); 
7.20 (d, JHH = 9.3 Hz, 
1H) 











143 2,4-Cl n-Pr 
in CDCl3:  0.96 (t, JHH 
= 7.3 Hz, 3H); 1.66 
(sextet, JHH = 7.3 Hz, 
2H); 2.38 (s, 3H); 3.57 
(t, JHH = 7.3 Hz, 2H); 
7.30 (d, JHH = 7.9 Hz, 
1H); 7.43 (s, 1H); 7.45 
(s, 1H); 8.78 (d, JHH = 












8.5 Hz, 1H) 
144 4-N(Et)2 C4-sym 
in CDCl3:  1.19 (t, JHH 
= 7.0 Hz, 3H); 1.60-
1.72 (m, 2H); 2.35 (s, 
3H); 3.40 (q, JHH = 7.0 
Hz, 2H); 3.61-3.74 
(m, 2H); 6.67 (d, JHH = 
9.1 Hz, 2H); 7.05 (s, 
1H); 8.02 (d, JHH = 9.1 
Hz, 2H) 














in CDCl3:  2.35 (s, 
3H); 3.20 (s, 3H); 3.82 
(s, 3H); 6.41-6.47 (m, 
2H), 7.13 (s, 1H); 7.20 
(d, JHH = 9.4 Hz, 1H) 










146 Piperonal Me 
in CDCl3:  2.35 (s, 
3H); 3.17 (s, 3H); 6.00 
(s, 2H); 6.83 (d, JHH = 
8.2 Hz, 1H); 7.01 (s, 
1H); 7.41 (dd, JHH = 
8.2, 1.8 Hz, 1H); 7.98 
(d, JHH = 1.8 Hz, 1H) 










147 2-CF3 n-Pr 
in CDCl3:  0.96 (t, JHH 
= 7.3 Hz, 3H); 1.67 
(sextet, JHH = 7.6 Hz, 
2H); 2.38 (s, 3H); 3.57 
(t, JHH = 7.6 Hz, 2H); 
7.40-7.47 (m, 2H); 
7.61 (t, JHH = 8.2 Hz, 
1H); 7.70 (d, JHH = 7.9 
Hz, 1H); 8.75 (t, JHH = 
7.9 Hz, 1H) 
in CDCl3:  
11.20, 15.59, 
22.55, 42.26, 
121.16 (JCF = 
4.4 Hz), 122.33, 
125.88 (JCF = 








148 4-OH Allyl 
in CDCl3:  2.32 (s, 
3H); 4.32 (d, JHH = 5.3 
Hz, 2H); 5.12 (d, JHH 
= 9.6 Hz, 1H); 5.20 (d, 
JHH = 9.6 Hz, 1H); 
5.73-5.88 (m, 1H); 
6.83 (d, JHH = 8.8 Hz, 
2H); 7.10 (s, 1H); 7.65 
(d, JHH = 8.8 Hz, 2H) 










149 2,5-OMe n-Pr 
in CDCl3:  0.94 (t, JHH 
= 7.6 Hz, 3H); 1.65 





(sextet, JHH = 7.3 Hz, 
2H); 2.35 (s, 3H); 3.55 
(t, JHH = 7.3 Hz, 2H); 
3.82 (s, 3H); 3.83 (s, 
3H); 6.82 (s, 1H); 6.88 
(d, JHH = 2.9 Hz, 1H); 
7.61 (s, 1H); 8.42 (d, 









150 4-N(Me)2 PrOH 
in CDCl3:  1.77 
(pentet, JHH = 7.6 Hz, 
2H); 2.35 (s, 3H); 3.03 
(s, 6H); 3.55 (t, JHH = 
5.6 Hz, 2H); 3.75 (t, 
JHH = 6.2 Hz, 2H); 
6.68 (d, JHH = 8.8 Hz, 
2H); 7.09 (s, 1H); 8.05 
(d, JHH = 9.1 Hz, 2H) 















in CDCl3:  2.38 (s, 
3H); 3.11 (s, 3H); 6.76 
(dd, JHH = 8.5, 2.9 Hz, 
1H); 7.10 (s, 1H); 7.49 
(d, JHH = 8.5 Hz, 1H); 
8.29 (d, JHH = 3.2 Hz, 






152 4-OH 2-heptyl 
in CDCl3:  0.88 (t, JHH 
= 6.7 Hz, 3H); 0.92 (d, 
JHH = 7.3 Hz, 3H); 
1.19-1.38 (m, 8H); 
1.68 (sextet, JHH = 6.2 
Hz, 1H); 2.37 (s, 3H); 
3.49 (d, JHH = 7.3 Hz, 
2H); 6.84 (d, JHH = 8.8 
Hz, 2H); 7.09 (s, 1H); 
7.98 (d, JHH = 8.8 Hz, 
2H) 













153 4-Ph Me 
in CDCl3:  2.40 (s, 
3H); 3.20 (s, 3H); 7.15 
(s, 1H); 7.39 (d, JHH = 
7.3 Hz, 1H); 7.46 (t, 
JHH = 7.6 Hz, 2H); 
7.65 (t, JHH = 7.0 Hz, 
4H); 8.20 (d, JHH = 8.2 
Hz, 2H) 











154 4-OMe Allyl 
in CDCl3:  2.33 (s, 
3H); 3.84 (s, 3H); 4.23 
(d, JHH = 4.7 Hz, 2H); 







5.09-5.22 (m, 2H); 
5.74-5.92 (m, 1H); 
6.94 (d, JHH = 8.5 Hz, 
2H); 7.09 (s, 1H); 8.11 










in CDCl3:  1.82 
(pentet, JHH = 5.3 Hz, 
2H); 2.38 (s, 3H); 3.58 
(t, JHH = 5.6 Hz, 2H); 
3.79 (d, JHH = 5.9 Hz, 
2H); 3.82 (s, 3H); 
6.42-6.46 (m, 2H); 
7.15 (s, 1H); 7.19 (d, 
JHH = 9.4 Hz, 1H) 












156 4-N(Me)2 2-heptyl 
in CDCl3:  0.80-0.92 
(m, 6H); 1.17-1.37 (m, 
8H); 1.67 (sextet, JHH 
= 6.2 Hz, 1H); 2.35 (s, 
3H); 3.02 (s, 6H); 3.46 
(d, JHH = 8.8 Hz, 3H); 
6.69 (d, JHH = 9.1 Hz, 
2H); 7.05 (s, 1H); 8.05 
(d, JHH = 8.8 Hz, 2H) 













157 4-OC4H9 Me 
in CDCl3:  0.97 (t, JHH 
= 7.3 Hz, 3H); 1.49 
(sextet, JHH = 7.6 Hz, 
2H); 1.77 (pentet, JHH 
= 7.9 Hz, 2H); 2.36 (s, 
3H); 3.17 (s, 3H); 4.00 
(t, JHH = 6.4 Hz, 2H); 
6.92 (d, JHH = 9.1 Hz, 
2H); 7.07 (s, 1H); 8.08 
(d, JHH = 8.8 Hz, 2H) 














in CDCl3:  2.26 (s, 
6H); 2.37 (s, 3H); 2.47 
(t, JHH = 6.7 Hz, 2H); 
3.02 (s, 6H); 3.66 (t, 
JHH = 7.0 Hz, 2H); 
6.68 (d, JHH = 9.1 Hz, 
2H); 7.04 (s, 1H); 8.03 
(d, JHH = 9.1 Hz, 2H) 










159 4-N(Me)2 C2CN 
in CDCl3:  2.45 (s, 
3H); 2.76 (t, JHH = 6.4 
Hz, 2H); 3.06 (s, 6H); 
3.88 (t, JHH = 6.4 Hz, 








2H); 6.70 (d, JHH = 9.1 
Hz, 2H); 7.09 (s, 1H); 










in CDCl3:  1.20 (t, JHH 
= 7.0 Hz, 3H); 2.20 (s, 
3H); 3.40 (q, JHH = 7.0 
Hz, 2H); 3.93 (s, 2H); 
6.16 (s, 1H); 6.23 (dd, 
JHH = 8.8 Hz, 1H); 
7.12 (d, JHH = 9.1 Hz, 






161 4-Me C2H4CN 
in CDCl3:  2.38 (s, 
3H); 2.47 (s, 3H); 2.76 
(t, JHH = 6.4 Hz, 2H); 
3.88 (t, JHH = 6.4 Hz, 
2H); 7.11 (s, 1H); 7.23 
(d, JHH = 8.2 Hz, 2H); 
8.03 (d, JHH = 8.2 Hz, 
2H) 











162 2-Indole n-Pn 
in CDCl3:  0.86 (t, JHH 
= 7.3 Hz, 3H); 1.17-
1.35 (m, 4H); 1.54 
(pentet, JHH = 7.0 Hz, 
2H); 2.35 (s, 3H); 3.54 
(t, JHH = 7.3 Hz, 2H); 
7.15 (t, JHH = 7.0 Hz, 
1H); 7.21 (t, JHH = 7.0 
Hz, 1H); 7.32 (s, 1H); 
7.48 (d, JHH = 7.0 Hz, 
1H); 8.21 (d, JHH = 8.2 
Hz, 1H); 8.41 (s, 1H) 













163 3-OH 2-heptyl 
in CDCl3:  0.85 -0.93 
(m, 6H); 1.19-1.37 (m, 
8H); 1.67 (sextet, JHH 
= 6.0 Hz, 1H); 2.34 (s, 
3H); 3.47 (d, JHH = 7.9 
Hz, 2H); 6.85 (dd, JHH 
= 8.2, 2.6 Hz, 1H); 
7.10 (s, 1H); 7.23 (t, 
JHH = 7.9 Hz, 1H); 
7.45 (d, JHH = 7.6 Hz, 
1H); 7.78 (s, 1H) 














164 3-OH 3-Pn 
in CDCl3:  0.87 (t, JHH 
= 7.3 Hz, 6H); 1.58-
1.66 (m, 1H); 1.69-







1.82 (m, 2H); 1.92-
2.11 (m, 2H); 2.34 (s, 
3H); 6.85 (d, JHH = 8.2 
Hz, 1H); 7.03 (s, 1H); 
7.22 (t, JHH = 7.6 Hz, 
1H); 7.48 (d, JHH = 7.9 










in CDCl3:  1.82 
(pentet, JHH = 7.3 Hz, 
2H); 2.22 (s, 6H); 2.32 
(t, JHH = 7.3 Hz, 2H); 
2.36 (s, 3H); 3.66 (t, 
JHH = 7.0 Hz, 2H); 
7.21-7.25 (m, 2H); 
7.39 (dd, JHH = 5.9, 
3.2 Hz, 1H); 7.55 (s, 
1H); 7.94 (dd, JHH = 
6.7, 2.6 Hz, 1H); 8.45 
(s, 1H) 













166 4-N(Me)2 EtOH 
in CDCl3:  2.32 (s, 
3H); 3.03 (s, 6H); 3.69 
(d, JHH = 5.0 Hz, 2H); 
3.75 (d, JHH = 4.4 Hz, 
2H); 6.68 (d, JHH = 9.1 
Hz, 2H); 7.01 (s, 1H); 
8.01 (d, JHH = 8.8 Hz, 
2H)  










167 4-N(Et)2 C6-sym 
in CDCl3:  1.18 (t, JHH 
= 7.0 Hz, 3H); 1.32-
1.42 (m, 2H); 1.57-.71 
(m. 2H); 2.34 (s, 3H); 
3.40 (t, JHH = 7.0 Hz, 
2H); 3.57 (t, JHH = 7.3 
Hz, 2H); 6.65 (d, JHH 
= 9.1 Hz, 2H); 7.04 (s, 
1H); 8.02 (d, JHH = 9.1 
Hz, 2H) 











168 2-Indole n-Pr 
in CDCl3:  0.96 (t, JHH 
= 7.6 Hz, 3H); 1.67 
(sextet, JHH = 7.3 Hz, 
2H); 2.36 (s, 3H); 3.57 
(t, JHH = 7.3 Hz, 2H); 
7.21-7.25 (m, 2H); 
7.39 (dd, JHH = 7.6, 
2.3 Hz, 1H); 7.56 (s, 
1H); 7.94 (dd, JHH = 













6.7, 3.2 Hz, 1H); 8.45 
(s, 1H) 








170 4-CN PrOH 
in CDCl3:  1.83 
(pentet, JHH = 5.3 Hz, 
2H); 2.43 (s, 3H); 3.61 
(t, JHH = 5.8 Hz, 2H); 
3.79 (t, JHH = 6.4 Hz, 
2H); 7.03 (s, 1H); 7.68 
(d, JHH = 8.5 Hz, 2H); 
8.22 (d, JHH = 8.2 Hz, 
2H) 






























symmetry_cell_setting              monoclinic 
symmetry_space_group_name_H-M    'P 21/c' 
 
cell_length_a                    7.173(4) 
cell_length_b                    7.902(3) 
cell_length_c                    22.746(9) 
cell_angle_alpha                 90.00 
cell_angle_beta                  96.44(3) 
cell_angle_gamma                 90.00 
cell_volume                      1281.13 
 
 
Spatial Coordinates of 2,3-OMe/Me 
 
C1  C  0.70223(18)   0.38143(17)   0.04495(5) 
C2  C  0.46737(18)   0.46825(16)   0.09518(5) 
C3  C  0.62756(17)   0.59036(16)   0.09871(5) 
C4  C  0.62572(17)   0.73869(16)   0.12816(5) 
H4A  H  0.5153   0.7618   0.1462 
 225 
C5  C  0.77205(17)   0.86844(16)   0.13582(5) 
C6  C  0.95567(18)   0.84070(17)   0.12127(6) 
H6A  H  0.9877   0.7351   0.1052 
C7  C  1.08863(18)   0.96676(17)   0.13036(6) 
H7A  H  1.2126   0.9453   0.1214 
C8  C  1.04561(17)   1.12474(17)   0.15240(5) 
H8A  H  1.1383   1.2110   0.1572 
C9  C  0.86583(17)   1.15502(16)   0.16725(5) 
C10  C  0.72992(17)   1.02594(16)   0.16002(5) 
C11  C  0.8052(2)   0.26679(19)   0.00827(6) 
H11A  H  0.9272   0.3167   0.0028 
H11B  H  0.7322   0.2508   -0.0304 
H11C  H  0.8244   0.1571   0.0282 
C12  C  0.4113(2)   0.19228(17)   0.04154(6) 
H12A  H  0.2920   0.1983   0.0586 
H12B  H  0.4789   0.0896   0.0555 
H12C  H  0.3868   0.1894   -0.0017 
C13  C  0.95038(19)   1.42981(17)   0.20406(6) 
H13A  H  0.8937   1.5316   0.2191 
H13B  H  1.0106   1.4587   0.1688 
H13C  H  1.0444   1.3844   0.2346 
C14  C  0.5370(2)   1.0677(2)   0.23624(6) 
H14A  H  0.4063   1.0890   0.2428 
H14B  H  0.6160   1.1608   0.2530 
H14C  H  0.5793   0.9613   0.2555 
N1  N  0.76716(15)   0.52530(14)   0.06632(5) 
N2  N  0.52462(15)   0.34052(14)   0.05963(5) 
O1  O  0.31945(13)   0.47427(13)   0.11679(4) 
O2  O  0.80757(12)   1.30513(11)   0.18904(4) 
O3  O  0.55066(12)   1.05584(12)   0.17407(4) 
 
Bond Angles of 2,3-OMe/Me 
Number Atom1  Atom2  Atom3  Angle 
1  C11  C1  N1  124.3(1) 
2  C11  C1  N2  121.4(1) 
3  N1  C1  N2  114.3(1) 
4  C3  C2  N2  103.0(1) 
5  C3  C2  O1  130.6(1) 
6  N2  C2  O1  126.3(1) 
7  C2  C3  C4  122.4(1) 
8  C2  C3  N1  108.9(1) 
9  C4  C3  N1  128.6(1) 
10  C3  C4  H4A  115.9(1) 
11  C3  C4  C5  128.3(1) 
12  H4A  C4  C5  115.8(1) 
13  C4  C5  C6  122.6(1) 
 226 
14  C4  C5  C10  118.9(1) 
15  C6  C5  C10  118.4(1) 
16  C5  C6  H6A  120.0(1) 
17  C5  C6  C7  120.1(1) 
18  H6A  C6  C7  120.0(1) 
19  C6  C7  H7A  119.2(1) 
20  C6  C7  C8  121.6(1) 
21  H7A  C7  C8  119.2(1) 
22  C7  C8  H8A  120.3(1) 
23  C7  C8  C9  119.4(1) 
24  H8A  C8  C9  120.3(1) 
25  C8  C9  C10  119.7(1) 
26  C8  C9  O2  124.5(1) 
27  C10  C9  O2  115.8(1) 
28  C5  C10  C9  120.7(1) 
29  C5  C10  O3  119.3(1) 
30  C9  C10  O3  120.0(1) 
31  C1  C11  H11A  109.5(1) 
32  C1  C11  H11B  109.5(1) 
33  C1  C11  H11C  109.4(1) 
34  H11A  C11  H11B  109.4(1) 
35  H11A  C11  H11C  109.5(1) 
36  H11B  C11  H11C  109.5(1) 
37  H12A  C12  H12B  109.5(1) 
38  H12A  C12  H12C  109.4(1) 
39  H12A  C12  N2  109.5(1) 
40  H12B  C12  H12C  109.4(1) 
41  H12B  C12  N2  109.5(1) 
42  H12C  C12  N2  109.5(1) 
43  H13A  C13  H13B  109.4(1) 
44  H13A  C13  H13C  109.4(1) 
45  H13A  C13  O2  109.5(1) 
46  H13B  C13  H13C  109.5(1) 
47  H13B  C13  O2  109.5(1) 
48  H13C  C13  O2  109.5(1) 
49  H14A  C14  H14B  109.5(1) 
50  H14A  C14  H14C  109.4(1) 
51  H14A  C14  O3  109.5(1) 
52  H14B  C14  H14C  109.5(1) 
53  H14B  C14  O3  109.4(1) 
54  H14C  C14  O3  109.5(1) 
55  C1  N1  C3  105.6(1) 
56  C1  N2  C2  108.1(1) 
57  C1  N2  C12  128.0(1) 
58  C2  N2  C12  123.9(1) 
59  C9  O2  C13  116.3(1) 
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60  C10  O3  C14  114.1(1) 
 
Bond Lengths of 2,3-OMe/Me 
 
Number Atom1  Atom2  Type  Length  
1  C1  C11  Unknown 1.483(2)  
2  C1  N1  Unknown 1.302(2)  
3  C1  N2  Unknown 1.391(2)  
4  C2  C3  Unknown 1.496(2)  
5  C2  N2  Unknown 1.384(2)  
6  C2  O1  Unknown 1.219(2)  
7  C3  C4  Unknown 1.351(2)  
8  C3  N1  Unknown 1.405(2)  
9  C4  H4A  Unknown 0.950(1)  
10  C4  C5  Unknown 1.464(2)  
11  C5  C6  Unknown 1.411(2)  
12  C5  C10  Unknown 1.407(2)  
13  C6  H6A  Unknown 0.949(1)  
14  C6  C7  Unknown 1.379(2)  
15  C7  H7A  Unknown 0.950(1)  
16  C7  C8  Unknown 1.393(2)  
17  C8  H8A  Unknown 0.950(1)  
18  C8  C9  Unknown 1.390(2)  
19  C9  C10  Unknown 1.408(2)  
20  C9  O2  Unknown 1.369(2)  
21  C10  O3  Unknown 1.380(2)  
22  C11  H11A  Unknown 0.980(2)  
23  C11  H11B  Unknown 0.980(1)  
24  C11  H11C  Unknown 0.981(1)  
25  C12  H12A  Unknown 0.980(2)  
26  C12  H12B  Unknown 0.980(1)  
27  C12  H12C  Unknown 0.980(1)  
28  C12  N2  Unknown 1.458(2)  
29  C13  H13A  Unknown 0.980(1)  
30  C13  H13B  Unknown 0.980(1) 
31  C13  H13C  Unknown 0.980(1)  
32  C13  O2  Unknown 1.435(2)  
33  C14  H14A  Unknown 0.980(2) 
34  C14  H14B  Unknown 0.979(2)  
35  C14  H14C  Unknown 0.980(2)  
















cell_length_a                    27.8365(7)  
cell_length_b                    27.8365(7)  
cell_length_c                    8.2402(5)  
cell_angle_alpha                 90.00  
cell_angle_beta                  90.00  
cell_angle_gamma                 120.00  
cell_volume                      5529.6(4)  
cell_formula_units_Z             18  
cell_measurement_temperature     173(2)  
cell_measurement_reflns_used     4505  
cell_measurement_theta_min       3.18  
cell_measurement_theta_max       65.54  
   
exptl_crystal_description        rod  
exptl_crystal_colour             colorless  
exptl_crystal_size_max           0.41  
exptl_crystal_size_mid           0.15  
exptl_crystal_size_min           0.14  
exptl_crystal_density_meas       ?  
exptl_crystal_density_diffrn     1.234  
exptl_crystal_density_method     'not measured'  
exptl_crystal_F_000              2196  
exptl_absorpt_coefficient_mu     0.625  
exptl_absorpt_correction_type    multi-scan  
exptl_absorpt_correction_T_min   0.7838  
exptl_absorpt_correction_T_max   0.9176  
exptl_absorpt_process_details    SADABS  
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Spatial Coordinates of 2,3-OMe/Me 
 
C1  C  0.70223(18)   0.38143(17)   0.04495(5) 
C2  C  0.46737(18)   0.46825(16)   0.09518(5) 
C3  C  0.62756(17)   0.59036(16)   0.09871(5) 
C4  C  0.62572(17)   0.73869(16)   0.12816(5) 
H4A  H  0.5153   0.7618   0.1462 
C5  C  0.77205(17)   0.86844(16)   0.13582(5) 
C6  C  0.95567(18)   0.84070(17)   0.12127(6) 
H6A  H  0.9877   0.7351   0.1052 
C7  C  1.08863(18)   0.96676(17)   0.13036(6) 
H7A  H  1.2126   0.9453   0.1214 
C8  C  1.04561(17)   1.12474(17)   0.15240(5) 
H8A  H  1.1383   1.2110   0.1572 
C9  C  0.86583(17)   1.15502(16)   0.16725(5) 
C10  C  0.72992(17)   1.02594(16)   0.16002(5) 
C11  C  0.8052(2)   0.26679(19)   0.00827(6) 
H11A  H  0.9272   0.3167   0.0028 
H11B  H  0.7322   0.2508   -0.0304 
H11C  H  0.8244   0.1571   0.0282 
C12  C  0.4113(2)   0.19228(17)   0.04154(6) 
H12A  H  0.2920   0.1983   0.0586 
H12B  H  0.4789   0.0896   0.0555 
H12C  H  0.3868   0.1894   -0.0017 
C13  C  0.95038(19)   1.42981(17)   0.20406(6) 
H13A  H  0.8937   1.5316   0.2191 
H13B  H  1.0106   1.4587   0.1688 
H13C  H  1.0444   1.3844   0.2346 
C14  C  0.5370(2)   1.0677(2)   0.23624(6) 
H14A  H  0.4063   1.0890   0.2428 
H14B  H  0.6160   1.1608   0.2530 
H14C  H  0.5793   0.9613   0.2555 
N1  N  0.76716(15)   0.52530(14)   0.06632(5) 
N2  N  0.52462(15)   0.34052(14)   0.05963(5) 
O1  O  0.31945(13)   0.47427(13)   0.11679(4) 
O2  O  0.80757(12)   1.30513(11)   0.18904(4) 
O3  O  0.55066(12)   1.05584(12)   0.17407(4) 
 
Bond Angles of 2,3-OMe/Me 
 
Number Atom1  Atom2  Atom3  Angle 
1  C11  C1  N1  124.3(1) 
2  C11  C1  N2  121.4(1) 
3  N1  C1  N2  114.3(1) 
4  C3  C2  N2  103.0(1) 
5  C3  C2  O1  130.6(1) 
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6  N2  C2  O1  126.3(1) 
7  C2  C3  C4  122.4(1) 
8  C2  C3  N1  108.9(1) 
9  C4  C3  N1  128.6(1) 
10  C3  C4  H4A  115.9(1) 
11  C3  C4  C5  128.3(1) 
12  H4A  C4  C5  115.8(1) 
13  C4  C5  C6  122.6(1) 
14  C4  C5  C10  118.9(1) 
15  C6  C5  C10  118.4(1) 
16  C5  C6  H6A  120.0(1) 
17  C5  C6  C7  120.1(1) 
18  H6A  C6  C7  120.0(1) 
19  C6  C7  H7A  119.2(1) 
20  C6  C7  C8  121.6(1) 
21  H7A  C7  C8  119.2(1) 
22  C7  C8  H8A  120.3(1) 
23  C7  C8  C9  119.4(1) 
24  H8A  C8  C9  120.3(1) 
25  C8  C9  C10  119.7(1) 
26  C8  C9  O2  124.5(1) 
27  C10  C9  O2  115.8(1) 
28  C5  C10  C9  120.7(1) 
29  C5  C10  O3  119.3(1) 
30  C9  C10  O3  120.0(1) 
31  C1  C11  H11A  109.5(1) 
32  C1  C11  H11B  109.5(1) 
33  C1  C11  H11C  109.4(1) 
34  H11A  C11  H11B  109.4(1) 
35  H11A  C11  H11C  109.5(1) 
36  H11B  C11  H11C  109.5(1) 
37  H12A  C12  H12B  109.5(1) 
38  H12A  C12  H12C  109.4(1) 
39  H12A  C12  N2  109.5(1) 
40  H12B  C12  H12C  109.4(1) 
41  H12B  C12  N2  109.5(1) 
42  H12C  C12  N2  109.5(1) 
43  H13A  C13  H13B  109.4(1) 
44  H13A  C13  H13C  109.4(1) 
45  H13A  C13  O2  109.5(1) 
46  H13B  C13  H13C  109.5(1) 
47  H13B  C13  O2  109.5(1) 
48  H13C  C13  O2  109.5(1) 
49  H14A  C14  H14B  109.5(1) 
50  H14A  C14  H14C  109.4(1) 
51  H14A  C14  O3  109.5(1) 
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52  H14B  C14  H14C  109.5(1) 
53  H14B  C14  O3  109.4(1) 
54  H14C  C14  O3  109.5(1) 
55  C1  N1  C3  105.6(1) 
56  C1  N2  C2  108.1(1) 
57  C1  N2  C12  128.0(1) 
58  C2  N2  C12  123.9(1) 
59  C9  O2  C13  116.3(1) 
60  C10  O3  C14  114.1(1) 
 
Bond Lengths of 2,3-OMe/Me 
 
Number Atom1  Atom2  Type  Length  
1  C1  C11  Unknown 1.483(2)  
2  C1  N1  Unknown 1.302(2)  
3  C1  N2  Unknown 1.391(2)  
4  C2  C3  Unknown 1.496(2)  
5  C2  N2  Unknown 1.384(2)  
6  C2  O1  Unknown 1.219(2)  
7  C3  C4  Unknown 1.351(2)  
8  C3  N1  Unknown 1.405(2)  
9  C4  H4A  Unknown 0.950(1)  
10  C4  C5  Unknown 1.464(2)  
11  C5  C6  Unknown 1.411(2)  
12  C5  C10  Unknown 1.407(2)  
13  C6  H6A  Unknown 0.949(1)  
14  C6  C7  Unknown 1.379(2)  
15  C7  H7A  Unknown 0.950(1)  
16  C7  C8  Unknown 1.393(2)  
17  C8  H8A  Unknown 0.950(1)  
18  C8  C9  Unknown 1.390(2)  
19  C9  C10  Unknown 1.408(2)  
20  C9  O2  Unknown 1.369(2)  















cell_length_a                    7.4859(7)  
cell_length_b                    21.6997(17)  
cell_length_c                    8.0387(7)  
cell_angle_alpha                 90.00  
cell_angle_beta                  110.755(5)  
cell_angle_gamma                 90.00  
cell_volume                      1221.08(18)  
cell_formula_units_Z             4  
cell_measurement_temperature     173(2)  
cell_measurement_reflns_used     3594  
cell_measurement_theta_min       4.07  
cell_measurement_theta_max       65.33  
   
exptl_crystal_description        plate  
exptl_crystal_colour             colourless  
exptl_crystal_size_max           0.31  
exptl_crystal_size_mid           0.26  
exptl_crystal_size_min           0.15  
exptl_crystal_density_meas       ?  
exptl_crystal_density_diffrn     1.242  
exptl_crystal_density_method     'not measured'  
exptl_crystal_F_000              488  
exptl_absorpt_coefficient_mu     0.629  
exptl_absorpt_correction_type    multi-scan  
exptl_absorpt_correction_T_min   0.8290  
exptl_absorpt_correction_T_max   0.9116  
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exptl_absorpt_process_details    SADABS  
  
diffrn_ambient_temperature       173(2)  
diffrn_radiation_wavelength      1.54178  
diffrn_radiation_type            CuK\a  
diffrn_radiation_source          'fine-focus sealed tube'  
diffrn_radiation_monochromator   graphite  
diffrn_measurement_device_type   'CCD area detector'  
diffrn_measurement_method        'phi and omega scans'  
diffrn_detector_area_resol_mean  ?  
diffrn_reflns_number             9487  
diffrn_reflns_av_R_equivalents   0.0344  
diffrn_reflns_av_sigmaI/netI     0.0265  
diffrn_reflns_limit_h_min        -8  
diffrn_reflns_limit_h_max        8  
diffrn_reflns_limit_k_min        -25  
diffrn_reflns_limit_k_max        24  
diffrn_reflns_limit_l_min        -9  
diffrn_reflns_limit_l_max        9  
diffrn_reflns_theta_min          4.07  
diffrn_reflns_theta_max          65.76  
reflns_number_total              2000  
reflns_number_gt                 1718  
reflns_threshold_expression      >2sigma(I)  
 
Spatial Coordinates of 2,5-Me/Me 
C1  C  0.3109(3)  0.46573(9) 0.2565(3)     
C2  C  0.6310(3)  0.45991(9)  0.3567(3)   
C3 C  0.5555(3)  0.51468(9)  0.2399(2)   
C4  C  0.6749(3)  0.55591(9)  0.2084(2)   
H4A  H  0.8070  0.5467  0.2623   
C5  C  0.6307(3)  0.61272(8)  0.1035(2)   
C6  C  0.4432(3)  0.62977(9)  0.0040(3)   
H6A  H  0.3414  0.6040  0.0062   
C7  C  0.4003(3)  0.68335(9)  -0.0983(3)   
C8  C  0.5503(3)  0.72121(9)  -0.0963(3)   
H8A  H  0.5246  0.7585  -0.1623   
C9  C  0.7377(3)  0.70505(9)  0.0012(3)   
H9A  H  0.8380  0.7316  -0.0005   
C10  C  0.7831(3)  0.65125(9)  0.1013(3)   
C11  C  0.1143(3)  0.44677(11)  0.2348(3)   
H11A  H  0.0231  0.4760  0.1562   
H11B  H  0.0996  0.4464  0.3512   
H11C  H  0.0897  0.4054  0.1825  
C12  C  0.4690(4)  0.37499(9)  0.4587(3)   
H12A  H  0.6013  0.3621  0.5216   
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H12B  H  0.4011  0.3428  0.3746   
H12C  H  0.4056  0.3818  0.5449   
C13  C  0.1970(4)  0.69889(11)  -0.2107(4)   
H13A  H  0.1113  0.6671  -0.1949   
H13B  H  0.1846  0.7007  -0.3362   
H13C  H  0.1630  0.7390  -0.1742   
C14  C  0.9896(4)  0.63544(11)  0.2009(4)   
H14A  H  1.0714  0.6678  0.1816   
H14B  H  1.0199  0.5960  0.1576   
H14C  H  1.0117  0.6322  0.3283   
N1  N  0.3552(3)  0.51433(7)  0.1835(2)   
N2  N  0.4675(3)  0.43194(7)  0.3622(2)   
O1  O  0.7948(2)  0.44221(7)  0.4315(2)   
 
Bond Lengths of 2,5-Me/Me 
Number Atom1  Atom2  Atom3  Angle 
1  C1  C11  Unknown  1.478(3)  
2  C1  N1  Unknown  1.306(3)  
3  C1  N2  Unknown  1.388(3)  
4  C2  C3  Unknown  1.496(3)  
5  C2  N2  Unknown  1.381(3)  
6  C2  O1  Unknown  1.221(2)  
7  C3  C4  Unknown  1.351(3)  
8  C3  N1  Unknown  1.404(3)  
9  C4  H4A  Unknown  0.950(2)  
10  C4  C5  Unknown  1.464(2)  
11  C5  C6  Unknown  1.397(3)  
12  C5  C10  Unknown  1.420(3)  
13  C6  H6A  Unknown  0.950(2)  
14  C6  C7  Unknown  1.394(3)  
15  C7  C8  Unknown  1.387(3)  
16  C7  C13  Unknown  1.507(3)  
17  C8  H8A  Unknown  0.949(2)  
18  C8  C9  Unknown  1.388(3)  
19  C9  H9A  Unknown  0.950(2)  
20  C9  C10  Unknown  1.390(3)  
21  C10  C14  Unknown  1.507(3)  
22  C11  H11A  Unknown  0.981(2)  
23  C11  H11B  Unknown  0.980(3)  
24  C11  H11C  Unknown  0.981(2)  
25  C12  H12A  Unknown  0.980(3)  
26  C12  H12B  Unknown  0.980(2)  
27  C12  H12C  Unknown  0.980(3)  
28  C12  N2  Unknown  1.457(3)  
29  C13  H13A  Unknown  0.980(3)  
30  C13  H13B  Unknown  0.981(3)  
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31  C13  H13C  Unknown  0.980(3)  
32  C14  H14A  Unknown  0.980(3)  
33  C14  H14B  Unknown  0.980(3)  
34  C14  H14C  Unknown  0.980(3)  
  
Bond Angles of 2,5-Me/Me 
 
Number Atom1  Atom2  Type  Length  
1  C11  C1  N1  124.9(2) 
2  C11  C1 N2 121.0(2) 
3  N1  C1 N2 114.1(2) 
4  C3  C2 N2 103.1(2) 
5  C3  C2 O1 130.5(2) 
6  N2  C2 O1 126.4(2) 
7  C2  C3 C4 121.1(2) 
8  C2  C3 N1 108.7(2) 
9  C4  C3 N1 130.2(2) 
10  C3  C4 H4A 115.2(2) 
11  C3  C4 C5 129.5(2) 
12  H4A  C4 C5 115.2(2) 
13  C4  C5 C6 121.9(2) 
14  C4  C5 C10 119.0(2) 
15  C6  C5 C10 119.1(2) 
16  C5  C6 H6A 118.9(2) 
17  C5  C6 C7 122.2(2) 
18  H6A  C6 C7 118.9(2) 
19  C6  C7 C8 118.1(2) 
20  C6  C7 C13 120.8(2) 
21  C8  C7 C13 121.1(2) 
22  C7  C8 H8A 119.7(2) 
23  C7  C8 C9 120.6(2) 
24  H8A  C8 C9 119.7(2) 
25  C8  C9 H9A 119.0(2) 
26  C8  C9 C10 122.0(2) 
27  H9A  C9 C10 119.0(2) 
28  C5  C10 C9 118.0(2) 
29  C5  C10 C14 122.5(2) 
30  C9  C10 C14 119.5(2) 
31  C1  C11 H11A 109.4(2) 
32  C1  C11 H11B 109.5(2) 
33  C1  C11 H11C 109.5(2) 
34  H11A  C11 H11B 109.4(2) 
35  H11A  C11 H11C 109.5(2) 
36  H11B  C11 H11C 109.5(2) 
37  H12A  C12 H12B 109.6(2) 
38  H12A  C12 H12C 109.4(2) 
39  H12A  C12 N2 109.4(2) 
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40  H12B  C12 H12C 109.4(2) 
41  H12B  C12 N2 109.5(2) 
42  H12C  C12 N2 109.5(2) 
43  C7  C13 H13A 109.4(2) 
44  C7  C13 H13B 109.5(2) 
45  C7  C13 H13C 109.5(2) 
46  H13A  C13 H13B 109.5(3) 
47  H13A  C13 H13C 109.6(3) 
48  H13B  C13 H13C 109.4(3) 
49  C10  C14 H14A 109.5(2) 
50  C10  C14 H14B 109.4(2) 
51  C10  C14 H14C 109.4(2) 
52  H14A  C14 H14B 109.5(3) 
53  H14A  C14 H14C 109.5(3) 
54  H14B  C14H14C 109.5(3) 
55  C1  N1 C3 105.8(2) 
56  C1  N2 C2 108.3(2) 
57  C1  N2 C12 128.3(2) 














cell_length_a                    7.6089(3)  
cell_length_b                    7.1163(3)  
cell_length_c                    22.9767(8)  
cell_angle_alpha                 90.00  
cell_angle_beta                  98.190(2)  
cell_angle_gamma                 90.00  
cell_volume                      1231.44(8)  
cell_formula_units_Z             4  
cell_measurement_temperature     173(2)  
cell_measurement_reflns_used     2443  
cell_measurement_theta_min       5.92  
cell_measurement_theta_max       65.36  
   
exptl_crystal_description        rod  
exptl_crystal_colour             colourless  
exptl_crystal_size_max           0.24  
exptl_crystal_size_mid           0.11  
exptl_crystal_size_min           0.09  
exptl_crystal_density_meas       ?  
exptl_crystal_density_diffrn     1.350  
exptl_crystal_density_method     'not measured'  
exptl_crystal_F_000              528  
exptl_absorpt_coefficient_mu     0.681  
exptl_absorpt_correction_type    multi-scan  
exptl_absorpt_correction_T_min   0.8536  
exptl_absorpt_correction_T_max   0.9412  
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exptl_absorpt_process_details    SADABS  
   
diffrn_ambient_temperature       173(2)  
diffrn_radiation_wavelength      1.54178  
diffrn_radiation_type            CuK\a  
diffrn_radiation_source          'fine-focus sealed tube'  
diffrn_radiation_monochromator   graphite  
diffrn_measurement_device_type   'CCD area detector'  
diffrn_measurement_method        'phi and omega scans'  
diffrn_detector_area_resol_mean  ?  
diffrn_standards_number          ?  
diffrn_standards_interval_count  ?  
diffrn_standards_interval_time   ?  
diffrn_standards_decay_%         ?  
diffrn_reflns_number             8270  
diffrn_reflns_av_R_equivalents   0.0448  
diffrn_reflns_av_sigmaI/netI     0.0861  
diffrn_reflns_limit_h_min        -8  
diffrn_reflns_limit_h_max        9  
diffrn_reflns_limit_k_min        -6  
diffrn_reflns_limit_k_max        8  
diffrn_reflns_limit_l_min        -27  
diffrn_reflns_limit_l_max        27  
diffrn_reflns_theta_min          3.89  
diffrn_reflns_theta_max          66.28  
reflns_number_total              2069  
reflns_number_gt                 1524  
reflns_threshold_expression      >2sigma(I)  
 
 
Spatial Coordinates of 2-naphthyl/Me 
C1  C  0.6086(3) 0.8372(3) 1.09078(9)  
C2  C  0.6902(3) 0.5570(3) 1.12979(9)  
C3  C  0.7069(3) 0.5690(3) 1.06587(9)  
C4  C  0.7665(3) 0.4244(3) 1.03695(9)   
H4A  H  0.7963      0.3159      1.0604  
C5  C  0.7934(3) 0.4047(3) 0.97562(9)  
C6  C  0.7646(3) 0.5537(3) 0.93418(10)  
H6A  H  0.7237 0.6720 0.9460.  
C7  C  0.7953(3) 0.5284(4) 0.87775(10)  
H7A  H  0.7745 0.6297 0.8507  
C8  C  0.8570(3) 0.3561(4) 0.85843(9)  
C9  C  0.8934(3) 0.3251(4) 0.79993(10)  
H9A  H  0.8763 0.4245 0.7721  
C10  C  0.9523(3) 0.1546(4) 0.78340(10)  
H10A  H  0.9766 0.1369 0.7443  
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C11  C  0.9772(3) 0.0056(4) 0.82366(11)  
H11A  H  1.0175 -0.1127 0.8117  
C12  C  0.9438(3) 0.0300(4) 0.88029(10)  
H12A  H  0.9609 -0.0720 0.9072  
C13  C  0.8843(3) 0.2043(4) 0.89907(10)  
C14  C  0.8503(3) 0.2344(3) 0.95732(9)  
H14A  H  0.8674 0.1335 0.9846. .  
C15  C  0.5399(3) 1.0323(3) 1.09047(10)  
H15A  H  0.5334 1.0850 1.0508  
H15B  H  0.6197 1.1091 1.1181  
H15C  H  0.4211 1.0317 1.1023  
C16  C  0.5948(3) 0.7918(4) 1.20005(10)  
H16A  H  0.5520 0.9219 1.1978  
H16B  H  0.7050 0.7841 1.2278  
H16C  H  0.5048 0.7103 1.2135  
N1  N  0.6531(2) 0.7494(3) 1.04531(8)  
N2  N  0.6283(2) 0.7310(3) 1.14215(8)  
O1  O  0.7219(2) 0.4263(2) 1.16457(6)   
 
Bond Angles of 2-naphthyl/Me 
Number Atom1 Atom2 Atom3 Angle 
 
1  C15 C1 N1 125.2(2) 
2  C15 C1 N2 120.5(2) 
3  N1 C1 N2 114.3(2) 
4  C3 C2 N2 103.4(2) 
5  C3 C2 O1 130.3(2) 
6  N2 C2 O1 126.3(2) 
7  C2 C3 C4 121.7(2) 
8  C2 C3 N1 108.7(2) 
9  C4 C3 N1 129.6(2) 
10  C3 C4 H4A 114.4(2) 
11  C3 C4 C5 131.1(2) 
12  H4A C4 C5 114.5(2) 
13  C4 C5 C6 123.1(2) 
14  C4 C5 C14 118.3(2) 
15  C6 C5 C14 118.6(2) 
16  C5 C6 H6A 119.7(2) 
17  C5 C6 C7 120.6(2) 
18  H6A C6 C7 119.8(2) 
19  C6 C7 H7A 119.2(2) 
20  C6 C7 C8 121.7(2) 
21  H7A C7 C8 119.1(2) 
22  C7 C8 C9 123.4(2) 
23  C7 C8 C13 118.6(2) 
24  C9 C8 C13 118.1(2) 
25  C8 C9 H9A 119.5(2) 
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26  C8 C9 C10 121.0(2) 
27  H9A C9 C10 119.5(2) 
28  C9 C10 H10A 119.7(2) 
29  C9 C10 C11 120.5(2) 
30  H10A C10 C11 119.8(2) 
31  C10 C11 H11A 119.9(2) 
32  C10 C11 C12 120.3(2) 
33  H11A C11 C12 119.8(2) 
34  C11 C12 H12A 119.6(2) 
35  C11 C12 C13 120.9(2) 
36  H12A C12 C13 119.6(2) 
37  C8 C13 C12 119.4(2) 
38  C8 C13 C14 118.4(2) 
39  C12 C13 C14 122.2(2) 
40  C5 C14 C13 122.1(2) 
41  C5 C14 H14A 119.0(2) 
42  C13 C14 H14A 118.9(2) 
43  C1 C15 H15A 109.5(2) 
44  C1 C15 H15B 109.5(2) 
45  C1 C15 H15C 109.4(2) 
46  H15A C15 H15B 109.5(2) 
47  H15A C15 H15C 109.5(2) 
48  H15B C15 H15C 109.5(2) 
49  H16A C16 H16B 109.5(2) 
50  H16A C16 H16C 109.5(2) 
51  H16A C16 N2 109.4(2) 
52  H16B C16 H16C 109.5(2) 
53  H16B C16 N2 109.5(2) 
54  H16C C16 N2 109.5(2) 
55  C1 N1 C3 105.3(2) 
56  C1 N2 C2 108.3(2) 
57  C1 N2 C16 127.0(2) 
58  C2 N2 C16 124.7(2) 
 
Bond Lengths of 2,3-OMe/Me 
 
Number Atom1 Atom2 Type  Length  
1  C1 C15 Unknown 1.483(3)  
2  C1 N1 Unknown 1.303(3)  
3  C1 N2 Unknown 1.392(3)  
4  C2 C3 Unknown 1.495(3)  
5  C2 N2 Unknown 1.369(3)  
6  C2 O1 Unknown 1.228(3)  
7  C3 C4 Unknown 1.339(3)  
8  C3 N1 Unknown 1.408(3)  
9  C4 H4A Unknown 0.950(2)  
10  C4 C5 Unknown 1.459(3)  
 241 
11  C5 C6 Unknown 1.421(3)  
12  C5 C14 Unknown 1.373(3)  
13  C6 H6A Unknown 0.950(2)  
14  C6 C7 Unknown 1.362(3)  
15  C7 H7A Unknown 0.950(3)  
16  C7 C8 Unknown 1.407(4)  
17  C8 C9 Unknown 1.428(3)  
18  C8 C13 Unknown 1.424(4)  
19  C9 H9A Unknown 0.950(3)  
20  C9 C10 Unknown 1.366(4)  
21  C10 H10A Unknown 0.951(2)  
22  C10 C11 Unknown 1.402(4)  
23  C11 H11A Unknown 0.950(3)  
24  C11 C12 Unknown 1.372(4)  
25  C12 H12A Unknown 0.950(3)  
26  C12 C13 Unknown 1.409(4)  
27  C13 C14 Unknown 1.415(3)  
28  C14 H14A Unknown 0.950(2)  
29  C15 H15A Unknown 0.980(2)  
30  C15 H15B Unknown 0.980(2)  
31  C15 H15C Unknown 0.980(2)  
32  C16 H16A Unknown 0.980(3)  
33  C16 H16B Unknown 0.980(2)  
34  C16 H16C Unknown 0.980(3)  















cell_length_a                    16.109(4)  
cell_length_b                    17.406(5)  
cell_length_c                    7.1321(19)  
cell_angle_alpha                 90.00  
cell_angle_beta                  90.00  
cell_angle_gamma                 90.00  
cell_volume                      1999.8(9)  
cell_formula_units_Z             8  
cell_measurement_temperature     172(2)  
cell_measurement_reflns_used     6737  
cell_measurement_theta_min       2.34  
cell_measurement_theta_max       29.15  
   
exptl_crystal_description        needle  
exptl_crystal_colour             yellow  
exptl_crystal_size_max           0.37  
exptl_crystal_size_mid           0.14  
exptl_crystal_size_min           0.12  
exptl_crystal_density_meas       ?  
exptl_crystal_density_diffrn     1.337  
exptl_crystal_density_method     'not measured'  
exptl_crystal_F_000              848  
exptl_absorpt_coefficient_mu     0.090  
exptl_absorpt_correction_type    multi-scan  
exptl_absorpt_correction_T_min   0.9675  
exptl_absorpt_correction_T_max   0.9893  
exptl_absorpt_process_details    SADABS  
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diffrn_ambient_temperature       172(2)  
diffrn_radiation_wavelength      0.71073  
diffrn_radiation_type            MoK\a  
diffrn_radiation_source          'fine-focus sealed tube'  
diffrn_radiation_monochromator   graphite  
diffrn_measurement_device_type   'CCD area detector'  
diffrn_measurement_method        'phi and omega scans'  
diffrn_detector_area_resol_mean  ?  
diffrn_reflns_number             35200  
diffrn_reflns_av_R_equivalents   0.0490  
diffrn_reflns_av_sigmaI/netI     0.0257  
diffrn_reflns_limit_h_min        -22  
diffrn_reflns_limit_h_max        23  
diffrn_reflns_limit_k_min        -23  
diffrn_reflns_limit_k_max        23  
diffrn_reflns_limit_l_min        -9  
diffrn_reflns_limit_l_max        9  
diffrn_reflns_theta_min          1.72  
diffrn_reflns_theta_max          30.55  
reflns_number_total              2959  
reflns_number_gt                 2221  
reflns_threshold_expression      >2sigma(I)  
 
Spatial Coordinates of 2-pyridyl/Me 
 
C1  C  -0.01029(7) 0.32163(7) 0.61845(17)  
C2  C  -0.07978(7) 0.21371(7) 0.68824(18)  
C3  C  0.00561(7) 0.19872(6) 0.61530(16)  
C4  C  0.03445(7) 0.12693(7) 0.58573(17)  
H4  H  -0.0035 0.0865 0.6120.  
C5  C  0.11619(7) 0.10308(6) 0.51871(17).  
C6  C  0.18355(8) 0.15341(7) 0.50145(18).  
H6  H  0.1770 0.2066 0.5273  
C7  C  0.25997(8) 0.12449(7) 0.4460(2).  
H7  H  0.3070 0.1572 0.4362  
C8  C  0.26630(8) 0.04704(7) 0.40531(19).  
H8  H  0.3178 0.0255 0.3670.  
C9  C  0.19630(7) 0.00137(7) 0.42143(19).  
H9  H  0.2010 -0.0514 0.3896  
C10  C  -0.15946(9) 0.33647(8) 0.7319(2). .  
H10A  H  -0.2027 0.3013 0.7764  
H10B  H  -0.1792 0.3636 0.6201.  
H10C  H  -0.1465 0.3738 0.8304.  
C11  C  0.00107(8) 0.40579(7) 0.5925(2).  
H11A  H  0.0570 0.4159 0.5442.  
H11B  H  -0.0061 0.4319 0.7131.  
H11C  H  -0.0402 0.4250 0.5030.  
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N1  N  0.04459(6) 0.26938(5) 0.57851(15)  
N2  N  -0.08510(6) 0.29293(6) 0.68555(16)  
N3  N  0.12247(6) 0.02737(6) 0.47928(16).  
O1  O  -0.13382(5) 0.16958(5) 0.74147(14)  
 
Bond Lengths of 2-pyridyl/Me 
 
Number Atom1 Atom2 Atom3  Angle 
1  C1 C11 Unknown 1.488(2)  
2  C1 N1 Unknown 1.300(2)  
3  C1 N2 Unknown 1.390(2)  
4  C2 C3 Unknown 1.494(2)  
5  C2 N2 Unknown 1.382(2)  
6  C2 O1 Unknown 1.221(1)  
7  C3 C4 Unknown 1.350(2)  
8  C3 N1 Unknown 1.406(1)  
9  C4 H4 Unknown 0.951(1)  
10  C4 C5 Unknown 1.461(2)  
11  C5 C6 Unknown 1.400(2)  
12  C5 N3 Unknown 1.351(2)  
13  C6 H6 Unknown 0.950(1)  
14  C6 C7 Unknown 1.388(2)  
15  C7 H7 Unknown 0.950(1)  
16  C7 C8 Unknown 1.383(2)  
17  C8 H8 Unknown 0.951(1)  
18  C8 C9 Unknown 1.384(2)  
19  C9 H9 Unknown 0.949(1)  
20  C9 N3 Unknown 1.338(2)  
21  C10 H10A Unknown 0.980(1)  
22  C10 H10B Unknown 0.980(1)  
23  C10 H10C Unknown 0.979(1)  
24  C10 N2 Unknown 1.456(2)  
25  C11 H11A Unknown 0.981(1)  
26  C11 H11B Unknown 0.980(1)  
27  C11 H11C Unknown 0.980(1)  
 
Bond Angles of 2-pyridyl/Me 
 
Number Atom1 Atom2 Type Length  
1  C11 C1 N1 125.3(1) 
2  C11 C1 N2 120.2(1) 
3  N1 C1 N2 114.4(1) 
4  C3 C2 N2 103.1(1) 
5  C3 C2 O1 130.9(1) 
6  N2 C2 O1 126.0(1) 
7  C2 C3 C4 122.2(1) 
8  C2 C3 N1 108.88(9) 
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9  C4 C3 N1 128.8(1) 
10  C3 C4 H4 115.7(1) 
11  C3 C4 C5 128.6(1) 
12  H4 C4 C5 115.7(1) 
13  C4 C5 C6 123.3(1) 
14  C4 C5 N3 114.4(1) 
15  C6 C5 N3 122.3(1) 
16  C5 C6 H6 120.4(1) 
17  C5 C6 C7 119.1(1) 
18  H6 C6 C7 120.5(1) 
19  C6 C7 H7 120.7(1) 
20  C6 C7 C8 118.6(1) 
21  H7 C7 C8 120.7(1) 
22  C7 C8 H8 120.6(1) 
23  C7 C8 C9 118.8(1) 
24  H8 C8 C9 120.5(1) 
25  C8 C9 H9 118.1(1) 
26  C8 C9 N3 123.7(1) 
27  H9 C9 N3 118.2(1) 
28  H10A C10 H10B 109.5(1) 
29  H10A C10 H10C 109.5(1) 
30  H10A C10 N2 109.5(1) 
31  H10B C10 H10C 109.5(1) 
32  H10B C10 N2 109.5(1) 
33  H10C C10 N2 109.4(1) 
34  C1 C11 H11A 109.5(1) 
35  C1 C11 H11B 109.5(1) 
36  C1 C11 H11C 109.5(1) 
37  H11A C11 H11B 109.5(1) 
38  H11A C11 H11C 109.5(1) 
39  H11B C11 H11C 109.5(1) 
40  C1 N1 C3 105.5(1) 
41  C1 N2 C2 108.0(1) 
42  C1 N2 C10 127.2(1) 
43  C2 N2 C10 124.6(1) 
44  C5 N3 C9 117.4(1) 
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cell_length_a                    7.6811(13)  
cell_length_b                    8.0170(12)  
cell_length_c                    23.929(4)  
cell_angle_alpha                 90.00  
cell_angle_beta                  90.00  
cell_angle_gamma                 90.00  
cell_volume                      1473.5(4)  
cell_formula_units_Z             4  
cell_measurement_temperature     173(2)  
cell_measurement_reflns_used     821  
cell_measurement_theta_min       3.69  
cell_measurement_theta_max       44.87  
   
exptl_crystal_description        rod  
exptl_crystal_colour             yellow  
exptl_crystal_size_max           0.31  
exptl_crystal_size_mid           0.07  
exptl_crystal_size_min           0.06  
exptl_crystal_density_meas       ?  
exptl_crystal_density_diffrn     1.309  
exptl_crystal_density_method     'not measured'  
exptl_crystal_F_000              616  
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exptl_absorpt_coefficient_mu     0.793  
exptl_absorpt_correction_type    multi-scan  
exptl_absorpt_correction_T_min   0.7911  
exptl_absorpt_correction_T_max   0.9517  
exptl_absorpt_process_details    ?  
   
diffrn_ambient_temperature       173(2)  
diffrn_radiation_wavelength      1.54178  
diffrn_radiation_type            CuK\a  
diffrn_radiation_source          'fine-focus sealed tube'  
diffrn_radiation_monochromator   graphite  
diffrn_measurement_device_type   'CCD area detector'  
diffrn_measurement_method        'phi and omega scans'  
diffrn_detector_area_resol_mean  ?  
diffrn_reflns_number             6727  
diffrn_reflns_av_R_equivalents   0.1040  
diffrn_reflns_av_sigmaI/netI     0.1439  
diffrn_reflns_limit_h_min        -8  
diffrn_reflns_limit_h_max        6  
diffrn_reflns_limit_k_min        -9  
diffrn_reflns_limit_k_max        7  
diffrn_reflns_limit_l_min        -28  
diffrn_reflns_limit_l_max        25  
diffrn_reflns_theta_min          3.69  
diffrn_reflns_theta_max          67.53  
reflns_number_total              2077  
reflns_number_gt                 869  
reflns_threshold_expression      >2sigma(I)  
 
Spatial Coordinates of 3,4,5-OMe/Me 
C1   C  1.078(2) 0.2955(15) 0.0778(6)  
C2   C  1.0355(18) 0.2198(15) 0.1661(7)  
C3   C  0.8955(17) 0.3211(14) 0.1432(5).  
C4   C  0.7563(18) 0.3694(15) 0.1739(5)  
H4A  H  0.7568 0.3322 0.2116  
C5   C  0.6083(18) 0.4678(14) 0.1583(5).  
C6   C  0.5832(18) 0.5511(14) 0.1071(4)  
H6A   H  0.6699 0.5422 0.0790.  
C7   C  0.4379(19) 0.6443(14) 0.0968(5)  
C8   C  0.2966(19) 0.6483(16) 0.1349(5).  
C9   C  0.3215(17) 0.5703(14) 0.1859(4)  
H9A   H  0.2334 0.5781 0.2137  
C10   C  0.474(2) 0.4797(15) 0.1976(5)  
C11   C  1.1809(16) 0.3044(16) 0.0216(4)  
H11A   H  1.1146 0.3706 -0.0055.  
H11B   H  1.1980 0.1915 0.0069  
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H11C   H  1.2943 0.3569 0.0280.  
C12   C  1.3210(16) 0.1216(14) 0.1248(5)  
H12A   H  1.3801 0.1277 0.0886  
H12B   H  1.3022 0.0044 0.1348  
H12C   H  1.3932 0.1752 0.1534  
C13   C  0.5498(15) 0.7289(18) 0.0070(5)  
H13A   H  0.5145 0.7912 -0.0263.  
H13B   H  0.5789 0.6140 -0.0034  
H13C   H  0.6519 0.7823 0.0238 0.137.  
C14   C  0.0233(16) 0.7646(15) 0.1560(4)  
H14A   H  -0.0667 0.8359 0.1396 0.119  
H14B   H  0.0672 0.8162 0.1904 0.119  
H14C   H  -0.0265 0.6551 0.1648  
C15   C  0.3421(17) 0.4006(15) 0.2879(5)  
H15A   H  0.3771 0.3417 0.3220  
H15B   H  0.2433 0.3428 0.2707  
H15C   H  0.3082 0.5151 0.2973  
N1   N  0.9316(16) 0.3700(12) 0.0865(4)  
N2   N  1.1523(14) 0.2076(12) 0.1212(5)  
O1   O  1.0578(11) 0.1555(10) 0.2117(4)  
O2   O  0.4080(11) 0.7276(10) 0.0471(3)  
O3   O  0.1662(11) 0.7444(10) 0.1163(3)  
O4   O  0.4887(12) 0.4039(10) 0.2485(3).  
 
Bond Angles of 3,4,5-OMe/Me 
Number Atom1 Atom2 Atom3 Angle 
1  C11 C1 N1 124(1) 
2  C11 C1 N2 118(1) 
3  N1 C1 N2 118(1) 
4  C3 C2 N2 103(1) 
5  C3 C2 O1 133(1) 
6  N2 C2 O1 124(1) 
7  C2 C3 C4 123(1) 
8  C2 C3 N1 111(1) 
9  C4 C3 N1 126(1) 
10  C3 C4 H4A 115(1) 
11  C3 C4 C5 130(1) 
12  H4A C4 C5 115(1) 
13  C4 C5 C6 127(1) 
14  C4 C5 C10 117(1) 
15  C6 C5 C10 117(1) 
16  C5 C6 H6A 119(1) 
17  C5 C6 C7 122(1) 
18  H6A C6 C7 119(1) 
19  C6 C7 C8 121(1) 
20  C6 C7 O2 124(1) 
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21  C8 C7 O2 115(1) 
22  C7 C8 C9 117(1) 
23  C7 C8 O3 112(1) 
24  C9 C8 O3 131(1) 
25  C8 C9 H9A 119(1) 
26  C8 C9 C10 122(1) 
27  H9A C9 C10 119(1) 
28  C5 C10 C9 121(1) 
29  C5 C10 O4 121(1) 
30  C9 C10 O4 118(1) 
31  C1 C11 H11A 109(1) 
32  C1 C11 H11B 110(1) 
33  C1 C11 H11C 110(1) 
34  H11A C11 H11B 109(1) 
35  H11A C11 H11C 109(1) 
36  H11B C11 H11C 110(1) 
37  H12A C12 H12B 109(1) 
38  H12A C12 H12C 109(1) 
39  H12A C12 N2 109(1) 
40  H12B C12 H12C 109(1) 
41  H12B C12 N2 110(1) 
42  H12C C12 N2 110(1) 
43  H13A C13 H13B 110(1) 
44  H13A C13 H13C 109(1) 
45  H13A C13 O2 110(1) 
46  H13B C13 H13C 109(1) 
47  H13B C13 O2 109(1) 
48  H13C C13 O2 109(1) 
49  H14A C14 H14B 109(1) 
50  H14A C14 H14C 109(1) 
51  H14A C14 O3 110(1) 
52  H14B C14 H14C 109(1) 
53  H14B C14 O3 110(1) 
54  H14C C14 O3 109(1) 
55  H15A C15 H15B 110(1) 
56  H15A C15 H15C 109(1) 
57  H15A C15 O4 109(1) 
58  H15B C15 H15C 109(1) 
59  H15B C15 O4 109(1) 
60  H15C C15 O4 110(1) 
61  C1 N1 C3 101(1) 
62  C1 N2 C2 106(1) 
63  C1 N2 C12 130(1) 
64  C2 N2 C12 123(1) 
65  C7 O2 C13 116.6(9) 
66  C8 O3 C14 114.2(9) 
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Bond Lengths of 3,4,5-OMe/Me 
 
Number Atom1 Atom2 Type  Length  
1  C1 C11 Unknown 1.56(2) 
2  C1 N1 Unknown 1.29(2) 
3  C1 N2 Unknown 1.38(2) 
4  C2 C3 Unknown 1.45(2) 
5  C2 N2 Unknown 1.40(2) 
6  C2 O1 Unknown 1.22(2) 
7  C3 C4 Unknown 1.35(2) 
8  C3 N1 Unknown 1.44(2) 
9  C4 H4A Unknown 0.95(1) 
10  C4 C5 Unknown 1.43(2) 
11  C5 C6 Unknown 1.41(2) 
12  C5 C10 Unknown 1.40(2) 
13  C6 H6A Unknown 0.95(1) 
14  C6 C7 Unknown 1.37(2) 
15  C7 C8 Unknown 1.42(2) 
16  C7 O2 Unknown 1.38(1) 
17  C8 C9 Unknown 1.38(2) 
18  C8 O3 Unknown 1.34(2) 
19  C9 H9A Unknown 0.95(1) 
20  C9 C10 Unknown 1.41(2) 
21  C10 O4 Unknown 1.37(1) 
22  C11 H11A Unknown 0.98(1) 
23  C11 H11B Unknown 0.98(1) 
24  C11 H11C Unknown 0.98(1) 
25  C12 H12A Unknown 0.98(1) 
26  C12 H12B Unknown 0.98(1) 
27  C12 H12C Unknown 0.98(1) 
28  C12 N2 Unknown 1.47(2) 
29  C13 H13A Unknown 0.98(1) 
30  C13 H13B Unknown 0.98(1) 
31  C13 H13C Unknown 0.98(1) 
32  C13 O2 Unknown 1.45(1) 
33  C14 H14A Unknown 0.98(1) 
34  C14 H14B Unknown 0.98(1) 
35  C14 H14C Unknown 0.98(1) 
36  C14 O3 Unknown 1.46(1) 
37  C15 H15A Unknown 0.98(1) 
38  C15 H15B Unknown 0.98(1) 
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39  C15 H15C Unknown 0.98(1) 
40  C15 O4 Unknown 1.47(2) 
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cell_length_a                    13.4980(7)  
cell_length_b                    11.2673(7)  
cell_length_c                    9.8819(6)  
cell_angle_alpha                 90.00  
cell_angle_beta                  102.138(3)  
cell_angle_gamma                 90.00  
cell_volume                      1469.30(15)  
cell_formula_units_Z             4  
cell_measurement_temperature     173(2)  
cell_measurement_reflns_used     4815  
cell_measurement_theta_min       3.35  
cell_measurement_theta_max       65.80  
   
exptl_crystal_description        irreg  
exptl_crystal_colour             orange  
exptl_crystal_size_max           0.32  
exptl_crystal_size_mid           0.29  
exptl_crystal_size_min           0.24  
exptl_crystal_density_meas       ?  
exptl_crystal_density_diffrn     1.227  
exptl_crystal_density_method     'not measured'  
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exptl_crystal_F_000              584  
exptl_absorpt_coefficient_mu     0.619  
exptl_absorpt_correction_type    multi-scan  
exptl_absorpt_correction_T_min   0.8264  
exptl_absorpt_correction_T_max   0.8656  
exptl_absorpt_process_details    SADABS  
   
diffrn_ambient_temperature       173(2)  
diffrn_radiation_wavelength      1.54178  
diffrn_radiation_type            CuK\a  
diffrn_radiation_source          'fine-focus sealed tube'  
diffrn_radiation_monochromator   graphite  
diffrn_measurement_device_type   'CCD area detector'  
diffrn_measurement_method        'phi and omega scans'  
diffrn_detector_area_resol_mean  ?  
diffrn_standards_number          ?  
diffrn_standards_interval_count  ?  
diffrn_standards_interval_time   ?  
diffrn_standards_decay_%         ?  
diffrn_reflns_number             10750  
diffrn_reflns_av_R_equivalents   0.0161  
diffrn_reflns_av_sigmaI/netI     0.0118  
diffrn_reflns_limit_h_min        -16  
diffrn_reflns_limit_h_max        15  
diffrn_reflns_limit_k_min        -10  
diffrn_reflns_limit_k_max        12  
diffrn_reflns_limit_l_min        -11  
diffrn_reflns_limit_l_max        11  
diffrn_reflns_theta_min          3.35  
diffrn_reflns_theta_max          66.27  
reflns_number_total              2372  
reflns_number_gt                 2138  
reflns_threshold_expression      >2sigma(I)  
 
Spatial Coordinates of 4-(Et)2/Me 
C1   C  0.0568(2) 0.9485(3) -0.1516(3)  
C2   C  0.0106(2) 0.8047(3) -0.0209(3)  
C3   C  0.1168(2) 0.8409(3) 0.0281(3)  
C4   C  0.1774(2) 0.7916(3) 0.1406(3)  
H4A   H  0.1460 0.7307 0.1831  
C5   C  0.2809(2) 0.8149(3) 0.2071(3). .  
C6   C  0.3407(3) 0.9051(3) 0.1671(4)  
H6A   H  0.3133 0.9524 0.0885.  
C7   C  0.4375(3) 0.9266(3) 0.2388(4)  
H7A   H  0.4757 0.9883 0.2087  
C8   C  0.4819(3) 0.8589(4) 0.3567(4)  
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C9   C  0.4233(3) 0.7642(4) 0.3921(4)  
H9A   H  0.4518 0.7129 0.4665  
C10   C  0.3262(3) 0.7454(3) 0.3208(4)  
H10A   H  0.2880 0.6829 0.3495  
C11   C  0.0446(3) 1.0345(3) -0.2677(4)  
H11A   H  0.1084 1.0771 -0.2636  
H11B   H  -0.0090 1.0914 -0.2603  
H11C   H  0.0261 0.9919 -0.3559  
C12   C  -0.1257(3) 0.8755(4) -0.2165(4)  
H12A   H  -0.1316 0.9343 -0.2908  
H12B   H  -0.1735 0.8950 -0.1576  
H12C   H  -0.1412 0.7965 -0.2567  
C13   C  0.6192(4) 0.8121(5) 0.5607(6)  
H13A   H  0.6701 0.8591 0.6257  
H13B   H  0.5645 0.7894 0.6086  
C14   C  0.6660(4) 0.7067(5) 0.5189(8)  
H14A   H  0.6947 0.6592 0.6008  
H14B   H  0.7199 0.7297 0.4715  
H14C   H  0.6149 0.6598 0.4560  
C15   C  0.6345(4) 0.9853(5) 0.3925(8)  
H15A   H  0.6289 0.9795 0.2912  
H15B   H  0.5999 1.0596 0.4095  
C16   C  0.7344(4) 0.9989(6) 0.4507(9)  
H16A   H  0.7616 1.0665 0.4077  
H16B   H  0.7712 0.9267 0.4361  
H16C   H  0.7423 1.0134 0.5502  
N1   N  0.1399(2) 0.9310(2) -0.0603(3)  
N2   N  -0.0230(2) 0.8766(3) -0.1337(3)  
N3   N  0.5756(3) 0.8857(4) 0.4334(4)  
O1   O  -0.04115(18) 0.7300(2) 0.0234(2) 
 
Bond Angles of 4-(Et)2/Me 
Number Atom1 Atom2 Atom3 Angle 
1  C11 C1 N1 125.1(3) 
2  C11 C1 N2 121.1(3) 
3  N1 C1 N2 113.8(3) 
4  C3 C2 N2 103.6(3) 
5  C3 C2 O1 131.2(3) 
6  N2 C2 O1 125.1(3) 
7  C2 C3 C4 122.4(3) 
8  C2 C3 N1 108.8(3) 
9  C4 C3 N1 128.9(3) 
10  C3 C4 H4A 114.3(3) 
11  C3 C4 C5 131.5(3) 
12  H4A C4 C5 114.3(3) 
13  C4 C5 C6 124.3(3) 
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14  C4 C5 C10 118.9(3) 
15  C6 C5 C10 116.8(3) 
16  C5 C6 H6A 119.2(4) 
17  C5 C6 C7 121.6(3) 
18  H6A C6 C7 119.2(4) 
19  C6 C7 H7A 119.3(4) 
20  C6 C7 C8 121.5(4) 
21  H7A C7 C8 119.2(4) 
22  C7 C8 C9 116.6(4) 
23  C7 C8 N3 121.4(4) 
24  C9 C8 N3 122.0(4) 
25  C8 C9 H9A 119.6(4) 
26  C8 C9 C10 120.9(4) 
27  H9A C9 C10 119.5(4) 
28  C5 C10 C9 122.4(3) 
29  C5 C10 H10A 118.7(4) 
30  C9 C10 H10A 118.8(4) 
31  C1 C11 H11A 109.5(3) 
32  C1 C11 H11B 109.4(3) 
33  C1 C11 H11C 109.5(3) 
34  H11A C11 H11B 109.4(4) 
35  H11A C11 H11C 109.5(4) 
36  H11B C11 H11C 109.4(4) 
37  H12A C12 H12B 109.5(4) 
38  H12A C12 H12C 109.5(4) 
39  H12A C12 N2 109.5(4) 
40  H12B C12 H12C 109.5(4) 
41  H12B C12 N2 109.4(4) 
42  H12C C12 N2 109.5(4) 
43  H13A C13 H13B 108.3(5) 
44  H13A C13 C14 109.9(5) 
45  H13A C13 N3 109.9(5) 
46  H13B C13 C14 109.8(5) 
47  H13B C13 N3 109.8(5) 
48  C14 C13 N3 109.2(5) 
49  C13 C14 H14A 109.5(6) 
50  C13 C14 H14B 109.4(6) 
51  C13 C14 H14C 109.4(6) 
52  H14A C14 H14B 109.6(6) 
53  H14A C14 H14C 109.4(6) 
54  H14B C14 H14C 109.5(6) 
55  H15A C15 H15B 106.8(6) 
56  H15A C15 C16 107.1(6) 
57  H15A C15 N3 107.2(5) 
58  H15B C15 C16 107.1(6) 
59  H15B C15 N3 107.2(5) 
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60  C16 C15 N3 120.8(6) 
61  C15 C16 H16A 109.4(6) 
62  C15 C16 H16B 109.4(6) 
63  C15 C16 H16C 109.4(6) 
64  H16A C16 H16B 109.5(7) 
65  H16A C16 H16C 109.5(7) 
66  H16B C16 H16C 109.5(7) 
67  C1 N1 C3 105.5(3) 
68  C1 N2 C2 108.3(3) 
69  C1 N2 C12 127.3(3) 
70  C2 N2 C12 124.3(3) 
71  C8 N3 C13 119.5(4) 
72  C8 N3 C15 120.3(4) 
73  C13 N3 C15 120.2(4) 
 
Bond Lengths of 4-(Et)2/Me 
 
Number Atom1 Atom2 Type  Length  
1  C1 C11 Unknown 1.484(5)  
2  C1 N1 Unknown 1.298(4)  
3  C1 N2 Unknown 1.389(4)  
4  C2 C3 Unknown 1.471(4)  
5  C2 N2 Unknown 1.375(4)  
6  C2 O1 Unknown 1.231(4)  
7  C3 C4 Unknown 1.353(4)  
8  C3 N1 Unknown 1.416(4)  
9  C4 H4A Unknown 0.950(3)  
10  C4 C5 Unknown 1.438(4)  
11  C5 C6 Unknown 1.405(5)  
12  C5 C10 Unknown 1.400(5)  
13  C6 H6A Unknown 0.950(4)  
14  C6 C7 Unknown 1.371(5)  
15  C7 H7A Unknown 0.950(4)  
16  C7 C8 Unknown 1.416(5)  
17  C8 C9 Unknown 1.415(6)  
18  C8 N3 Unknown 1.365(5)  
19  C9 H9A Unknown 0.951(4)  
20  C9 C10 Unknown 1.368(5)  
21  C10 H10A Unknown 0.951(4)  
22  C11 H11A Unknown 0.979(4)  
23  C11 H11B Unknown 0.981(4)  
24  C11 H11C Unknown 0.980(4)  
25  C12 H12A Unknown 0.980(4)  
26  C12 H12B Unknown 0.980(4)  
27  C12 H12C Unknown 0.979(4)  
28  C12 N2 Unknown 1.454(4)  
29  C13 H13A Unknown 0.990(5)  
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30  C13 H13B Unknown 0.991(6)  
31  C13 C14 Unknown 1.446(8)  
32  C13 N3 Unknown 1.518(7)  
33  C14 H14A Unknown 0.980(7)  
34  C14 H14B Unknown 0.979(7)  
35  C14 H14C Unknown 0.980(6)  
36  C15 H15A Unknown 0.990(8)  
37  C15 H15B Unknown 0.990(6)  
38  C15 C16 Unknown 1.359(7)  
39  C15 N3 Unknown 1.480(8)  
40  C16 H16A Unknown 0.980(7)  
41  C16 H16B Unknown 0.980(7)  















cell_length_a                    7.0520(12)  
cell_length_b                    12.411(3)  
cell_length_c                    14.761(4)  
cell_angle_alpha                 90.00  
cell_angle_beta                  97.434(12)  
cell_angle_gamma                 90.00  
cell_volume                      1281.0(5)  
cell_formula_units_Z             4  
cell_measurement_temperature     173(2)  
cell_measurement_reflns_used     183  
cell_measurement_theta_min       6.65  
cell_measurement_theta_max       41.64  
   
exptl_crystal_description        rod  
exptl_crystal_colour             yellow  
exptl_crystal_size_max           0.21  
exptl_crystal_size_mid           0.08  
exptl_crystal_size_min           0.06  
exptl_crystal_density_meas       ?  
exptl_crystal_density_diffrn     1.262  
exptl_crystal_density_method     'not measured'  
exptl_crystal_F_000              520  
exptl_absorpt_coefficient_mu     0.653  
exptl_absorpt_correction_type    multi-scan  
exptl_absorpt_correction_T_min   0.8750  
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exptl_absorpt_correction_T_max   0.9618  
exptl_absorpt_process_details    ?   
  
diffrn_ambient_temperature       173(2)  
diffrn_radiation_wavelength      1.54178  
diffrn_radiation_type            CuK\a  
diffrn_radiation_source          'fine-focus sealed tube'  
diffrn_radiation_monochromator   graphite  
diffrn_measurement_device_type   'CCD area detector'  
diffrn_measurement_method        'phi and omega scans'  
diffrn_detector_area_resol_mean  ?  
diffrn_reflns_number             7921  
diffrn_reflns_av_R_equivalents   0.1907  
diffrn_reflns_av_sigmaI/netI     0.1938  
diffrn_reflns_limit_h_min        -8  
diffrn_reflns_limit_h_max        7  
diffrn_reflns_limit_k_min        -12  
diffrn_reflns_limit_k_max        12  
diffrn_reflns_limit_l_min        -16  
diffrn_reflns_limit_l_max        16  
diffrn_reflns_theta_min          4.67  
diffrn_reflns_theta_max          62.38  
reflns_number_total              1854  
reflns_number_gt                 725  
reflns_threshold_expression      >2sigma(I)  
 
Spatial Coordinates of 4-N(Me)2/Me 
 
C1   C  0.6254(10) 0.6435(7) 0.6066(7)  
C2   C  0.6306(10) 0.8221(9) 0.6058(6)  
C3   C  0.6290(10) 0.7780(8) 0.5148(6)  
C4   C  0.6272(10) 0.8402(7) 0.4402(6)   
H4A  H  0.6243 0.9154 0.4519   
C5   C  0.6288(10) 0.8125(7) 0.3453(6)   
C6   C  0.6429(10) 0.7055(7) 0.3134(6)   
H6A   H  0.6555 0.6479 0.3561   
C7   C  0.6388(10) 0.6832(7) 0.2216(6)   
H7A   H  0.6449 0.6104 0.2023  
C8   C  0.6258(10) 0.7654(8) 0.1566(6)  
C9   C  0.6156(10) 0.8717(8) 0.1868(6)   
H9A   H  0.6087 0.9294 0.1441   
C10   C  0.6155(10) 0.8930(7) 0.2784(6)   
H10A   H  0.6059 0.9659 0.2970   
C11   C  0.6185(11) 0.5345(7) 0.6467(5)   
H11A   H  0.6146 0.5406 0.7126   
H11B   H  0.7325 0.4939 0.6356   
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H11C   H  0.5038 0.4969 0.6183   
C12   C  0.6305(11) 0.7369(7) 0.7605(5)   
H12A   H  0.6280 0.6634 0.7847   
H12B   H  0.5180 0.7765 0.7750   
H12C   H  0.7468 0.7735 0.7882   
C13   C  0.6244(12) 0.6318(7) 0.0334(5)   
H13A   H  0.6311 0.5826 0.0856   
H13B   H  0.7356 0.6204 0.0010 
H13C   H  0.5070 0.6179 -0.0082   
C14   C  0.6149(12) 0.8287(7) -0.0024(5)   
H14A   H  0.6144 0.8989 0.0280   
H14B   H  0.4978 0.8209 -0.0456   
H14C   H  0.7265 0.8238 -0.0355   
N1   N  0.6270(9) 0.6638(6) 0.5203(5)   
N2   N  0.6286(8) 0.7327(7) 0.6621(4)   
N3   N  0.6238(10) 0.7431(6) 0.0658(5)  
O1   O  0.6333(8) 0.9164(5) 0.6334(4)  
  
Bond Angles of 4-N(Me)2/Me 
 
Number Atom1 Atom2 Atom3 Angle 
1  C11 C1 N1 125.0(8) 
2  C11 C1 N2 119.8(7) 
3  N1 C1 N2 115.2(8) 
4  C3 C2 N2 104.7(7) 
5  C3 C2 O1 131.3(8) 
6  N2 C2 O1 124.0(8) 
7  C2 C3 C4 122.7(8) 
8  C2 C3 N1 108.8(7) 
9  C4 C3 N1 128.4(8) 
10  C3 C4 H4A 114.4(8) 
11  C3 C4 C5 131.1(8) 
12  H4A C4 C5 114.4(8) 
13  C4 C5 C6 123.7(7) 
14  C4 C5 C10 120.4(7) 
15  C6 C5 C10 115.8(7) 
16  C5 C6 H6A 119.3(8) 
17  C5 C6 C7 121.4(8) 
18  H6A C6 C7 119.3(8) 
19  C6 C7 H7A 119.3(8) 
20  C6 C7 C8 121.3(8) 
21  H7A C7 C8 119.4(8) 
22  C7 C8 C9 118.2(8) 
23  C7 C8 N3 121.2(8) 
24  C9 C8 N3 120.6(8) 
25  C8 C9 H9A 120.0(8) 
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26  C8 C9 C10 120.1(8) 
27  H9A C9 C10 120.0(8) 
28  C5 C10 C9 123.2(8) 
29  C5 C10 H10A 118.5(8) 
30  C9 C10 H10A 118.4(8) 
31  C1 C11 H11A 109.5(7) 
32  C1 C11 H11B 109.4(7) 
33  C1 C11 H11C 109.4(7) 
34  H11A C11 H11B 109.6(8) 
35  H11A C11 H11C 109.5(8) 
36  H11B C11 H11C 109.5(8) 
37  H12A C12 H12B 109.5(8) 
38  H12A C12 H12C 109.4(8) 
39  H12A C12 N2 109.4(7) 
40  H12B C12 H12C 109.5(8) 
41  H12B C12 N2 109.5(7) 
42  H12C C12 N2 109.5(7) 
43  H13A C13 H13B 109.5(8) 
44  H13A C13 H13C 109.5(8) 
45  H13A C13 N3 109.5(7) 
46  H13B C13 H13C 109.5(8) 
47  H13B C13 N3 109.4(7) 
48  H13C C13 N3 109.5(7) 
49  H14A C14 H14B 109.4(8) 
50  H14A C14 H14C 109.5(8) 
51  H14A C14 N3 109.5(7) 
52  H14B C14 H14C 109.4(8) 
53  H14B C14 N3 109.5(7) 
54  H14C C14 N3 109.4(7) 
55  C1 N1 C3 104.5(7) 
56  C1 N2 C2 106.7(7) 
57  C1 N2 C12 128.5(7) 
58  C2 N2 C12 124.8(7) 
59  C8 N3 C13 120.8(7) 
60  C8 N3 C14 121.5(7) 
61  C13 N3 C14 117.6(7) 
 
Bond Lengths of 4-N(Me)2/Me 
 
Number Atom1 Atom2 Type  Length  
1  C1 C11 Unknown 1.48(1) 
2  C1 N1 Unknown 1.30(1) 
3  C1 N2 Unknown 1.38(1) 
4  C2 C3 Unknown 1.45(1) 
5  C2 N2 Unknown 1.39(1) 
6  C2 O1 Unknown 1.24(1) 
7  C3 C4 Unknown 1.34(1) 
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8  C3 N1 Unknown 1.42(1) 
9  C4 H4A Unknown 0.950(9) 
10  C4 C5 Unknown 1.44(1) 
11  C5 C6 Unknown 1.42(1) 
12  C5 C10 Unknown 1.40(1) 
13  C6 H6A Unknown 0.950(9) 
14  C6 C7 Unknown 1.38(1) n 
15  C7 H7A Unknown 0.950(9) 
16  C7 C8 Unknown 1.40(1) 
17  C8 C9 Unknown 1.40(1) 
18  C8 N3 Unknown 1.37(1) 
19  C9 H9A Unknown 0.951(9)  
20  C9 C10 Unknown 1.38(1) 
21  C10 H10A Unknown 0.950(9) 
22  C11 H11A Unknown 0.980(7) 
23  C11 H11B Unknown 0.980(8) 
24  C11 H11C Unknown 0.980(8) 
25  C12 H12A Unknown 0.981(9) 
26  C12 H12B Unknown 0.980(8) 
27  C12 H12C Unknown 0.979(8) 
28  C12 N2 Unknown 1.45(1) 
29  C13 H13A Unknown 0.979(8) 
30  C13 H13B Unknown 0.980(9) 
31  C13 H13C Unknown 0.980(8) 
32  C13 N3 Unknown 1.46(1) 
33  C14 H14A Unknown 0.980(8) 
34  C14 H14B Unknown 0.981(8) 
35  C14 H14C Unknown 0.980(9) 














cell_length_a                    7.0404(8) 
cell_length_b                    7.2141(7) 
cell_length_c                    11.4902(11) 
cell_angle_alpha                 74.020(6) 
cell_angle_beta                  80.942(6) 
cell_angle_gamma                 75.193(4) 
cell_volume                      540.02(10) 
cell_formula_units_Z             2 
cell_measurement_temperature     293(2) 
  
exptl_crystal_description        'prism' 
exptl_crystal_colour             'colorless' 
exptl_crystal_size_max           0.310 
exptl_crystal_size_mid           0.100 
exptl_crystal_size_min           0.065 
exptl_crystal_density_meas       ? 
exptl_crystal_density_diffrn     1.330 
exptl_crystal_density_method     'not measured' 
exptl_crystal_F_000              228 
exptl_absorpt_coefficient_mu     0.092 
exptl_absorpt_correction_type    'sphere' 
exptl_absorpt_correction_T_min   0.9719 
exptl_absorpt_correction_T_max   0.9945 
exptl_absorpt_process_details     'SADABS (Sheldrick, 1996)' 
  
diffrn_ambient_temperature       293(2) 
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diffrn_radiation_wavelength      0.71073 
diffrn_radiation_type            MoK\a 
diffrn_radiation_source          'rotating anode' 
diffrn_radiation_monochromator   'multilayer confocal TXS mirror' 
diffrn_measurement_device_type   'Bruker SMART APEX2 diffractometer' 
diffrn_measurement_method          '\w scans'  
diffrn_detector_area_resol_mean  ? 
diffrn_standards_number          ? 
diffrn_standards_interval_count  ? 
diffrn_standards_interval_time   ? 
diffrn_standards_decay_%         ? 
diffrn_reflns_number             7058 
diffrn_reflns_av_R_equivalents   0.0287 
diffrn_reflns_av_sigmaI/netI     0.0306 
diffrn_reflns_limit_h_min        -7 
diffrn_reflns_limit_h_max        8 
diffrn_reflns_limit_k_min        -8 
diffrn_reflns_limit_k_max        8 
diffrn_reflns_limit_l_min        -13 
diffrn_reflns_limit_l_max        13 
diffrn_reflns_theta_min          1.85 
diffrn_reflns_theta_max          25.00 
reflns_number_total              1905 
reflns_number_gt                 1250 
reflns_threshold_expression      >2sigma(I) 
 
Spatial Coordinates of 3-OH/Me 
H7  H  0.228(4) 0.888(4) -0.050(2)  
H15  H  -0.165(4) 0.788(4) 0.333(3)  
C2  C  0.1352(4) 0.7605(4) 0.1804(3)  
H2  H  0.0278 0.8285 0.1361  
C1  C  0.3245(4) 0.7380(4) 0.1207(3)  
N10  N  0.6940(4) 0.8605(4) -0.2653(2)  
C7  C  0.3448(4) 0.8198(4) -0.0100(3)  
O16  O  0.3608(4) 0.9895(4) -0.2786(2)  
C8  C  0.5071(4) 0.8153(4) -0.0897(3)  
C3  C  0.1035(5) 0.6836(4) 0.3045(3)  
C6  C  0.4826(5) 0.6351(5) 0.1890(3)  
H6  H  0.6108 0.6182 0.1516  
C9  C  0.4995(5) 0.9045(5) -0.2199(3)  
O15  O  -0.0783(4) 0.6989(4) 0.3652(2)  
N12  N  0.7061(4) 0.7279(3) -0.0663(2)  
C4  C  0.2624(5) 0.5822(5) 0.3693(3)  
H4  H  0.2430 0.5292 0.4526  
C5  C  0.4486(5) 0.5588(5) 0.3118(3)  
H5  H  0.5549 0.4897 0.3568  
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C11  C  0.8058(4) 0.7575(5) -0.1709(3)  
C14  C  1.0221(5) 0.6868(6) -0.1914(4)  
H14A  H  1.0734 0.6102 -0.1159  
H14B  H  1.0822 0.7982 -0.2229  
H14C  H  1.0511 0.6062 -0.2487  
C13  C  0.7601(6) 0.9168(6) -0.3948(3)  
H13A  H  0.8579 0.9933 -0.4065  
H13B  H  0.6497 0.9942 -0.4392  
H13C  H  0.8160 0.7998 -0.4238. 
 
Bond Angles of 3-OH/Me 
Number Atom1 Atom2 Atom3 Angle 
1  H2 C2 C1 119.4(3) 
2  H2 C2 C3 119.3(3) 
3  C1 C2 C3 121.3(3) 
4  C2 C1 C7 117.9(3) 
5  C2 C1 C6 118.2(3) 
6  C7 C1 C6 123.9(3) 
7  C9 N10 C11 108.7(3) 
8  C9 N10 C13 123.2(3) 
9  C11 N10 C13 128.1(3) 
10  H7 C7 C1 118(2) 
11  H7 C7 C8 111(2) 
12  C1 C7 C8 130.3(3) 
13  C7 C8 C9 122.8(3) 
14  C7 C8 N12 128.3(3) 
15  C9 C8 N12 108.9(3) 
16  C2 C3 O15 123.0(3) 
17  C2 C3 C4 119.1(3) 
18  O15 C3 C4 117.9(3) 
19  C1 C6 H6 120.1(3) 
20  C1 C6 C5 119.8(3) 
21  H6 C6 C5 120.1(4) 
22  N10 C9 O16 126.2(3) 
23  N10 C9 C8 103.0(3) 
24  O16 C9 C8 130.7(3) 
25  H15 O15 C3 116(2) 
26  C8 N12 C11 105.2(3) 
27  C3 C4 H4 119.9(3) 
28  C3 C4 C5 120.2(3) 
29  H4 C4 C5 119.9(4) 
30  C6 C5 C4 121.4(3) 
31  C6 C5 H5 119.3(3) 
32  C4 C5 H5 119.3(3) 
33  N10 C11 N12 114.1(3) 
34  N10 C11 C14 121.4(3) 
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35  N12 C11 C14 124.4(3) 
36  C11 C14 H14A 109.5(4) 
37  C11 C14 H14B 109.5(4) 
38  C11 C14 H14C 109.5(4) 
39  H14A C14 H14B 109.4(4) 
40  H14A C14 H14C 109.5(4) 
41  H14B C14 H14C 109.5(4) 
42  N10 C13 H13A 109.5(3) 
43  N10 C13 H13B 109.5(3) 
44  N10 C13 H13C 109.5(3) 
45  H13A C13 H13B 109.4(4) 
46  H13A C13 H13C 109.5(4) 
47  H13B C13 H13C 109.4(4) 
  
Bond Lengths of 3-OH/Me 
 
Number Atom1 Atom2 Type  Length  
1  H7 C7 Unknown 0.96(3) 
2  H15 O15 Unknown 0.81(3) 
3  C2 H2 Unknown 0.930(3)  
4  C2 C1 Unknown 1.391(4)  
5  C2 C3 Unknown 1.385(4)  
6  C1 C7 Unknown 1.453(4)  
7  C1 C6 Unknown 1.392(4)  
8  N10 C9 Unknown 1.376(4)  
9  N10 C11 Unknown 1.369(4)  
10  N10 C13 Unknown 1.463(4)  
11  C7 C8 Unknown 1.347(4)  
12  O16 C9 Unknown 1.208(4)  
13  C8 C9 Unknown 1.460(5)  
14  C8 N12 Unknown 1.417(4)  
15  C3 O15 Unknown 1.351(4)  
16  C3 C4 Unknown 1.373(5)  
17  C6 H6 Unknown 0.930(3)  
18  C6 C5 Unknown 1.373(4)  
19  N12 C11 Unknown 1.285(4)  
20  C4 H4 Unknown 0.930(3)  
21  C4 C5 Unknown 1.363(5)  
22  C5 H5 Unknown 0.930(3)  
23  C11 C14 Unknown 1.480(4)  
24  C14 H14A Unknown 0.960(4)  
25  C14 H14B Unknown 0.960(4)  
26  C14 H14C Unknown 0.960(5)  
27  C13 H13A Unknown 0.960(5)  
28  C13 H13B Unknown 0.960(4)  
29  C13 H13C Unknown 0.960(4)  
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cell_length_a                    7.12770(10) 
cell_length_b                    11.2873(2) 
cell_length_c                    13.6337(2) 
cell_angle_alpha                 90.00 
cell_angle_beta                  105.1860(10) 
cell_angle_gamma                 90.00 
cell_volume                      1058.56(3) 
cell_formula_units_Z             4 
cell_measurement_temperature     293(2) 
cell_measurement_reflns_used     6195 
cell_measurement_theta_min       2.38 
cell_measurement_theta_max       26.83 
  
exptl_crystal_description       'Columnar' 
exptl_crystal_colour             'yellow' 
exptl_crystal_size_max           0.275 
exptl_crystal_size_mid           0.055 
exptl_crystal_size_min           0.045 
exptl_crystal_density_meas       ? 
exptl_crystal_density_diffrn     1.369 
exptl_crystal_density_method     'not measured' 
exptl_crystal_F_000              456 
exptl_absorpt_coefficient_mu     0.101 
exptl_absorpt_correction_type    'sphere' 
exptl_absorpt_correction_T_min   ? 
exptl_absorpt_correction_T_max   ? 
exptl_absorpt_process_details     'SADABS (Sheldrick, 1996)' 
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Twinned structure; the ratio of one of the components 
is 62.5%. Solvent: hexane  
 
  
diffrn_ambient_temperature       293(2) 
diffrn_radiation_wavelength      0.71073 
diffrn_radiation_type            MoK\a 
diffrn_radiation_source          'rotating anode' 
diffrn_radiation_monochromator   'multilayer confocal TXS mirror' 
diffrn_measurement_device_type   'Bruker SMART APEX2 diffractometer' 
diffrn_measurement_method          '\w scans'  
diffrn_detector_area_resol_mean  ? 
diffrn_standards_number          ? 
diffrn_standards_interval_count  ? 
diffrn_standards_interval_time   ? 
diffrn_standards_decay_%         ? 
diffrn_reflns_number             15287 
diffrn_reflns_av_R_equivalents   0.0263 
diffrn_reflns_av_sigmaI/netI     0.0205 
diffrn_reflns_limit_h_min        -9 
diffrn_reflns_limit_h_max        9 
diffrn_reflns_limit_k_min        -14 
diffrn_reflns_limit_k_max        14 
diffrn_reflns_limit_l_min        -17 
diffrn_reflns_limit_l_max        17 
diffrn_reflns_theta_min          1.55 
diffrn_reflns_theta_max          27.50 
reflns_number_total              2466 
reflns_number_gt                 2012 
reflns_threshold_expression      >2sigma(I) 
 
Spatial Coordinates of 2-F/Me 
F1  F  0.2546(3) 0.19120(13) 0.48356(12)  
O1  O  0.1474(3) 0.53757(16) 0.25452(12)  
N10  N  0.1714(3) 0.71227(15) 0.34443(13)  
N12  N  0.2458(3) 0.64829(16) 0.50538(13)  
C2  C  0.2931(4) 0.2550(2) 0.56969(18)  
C3  C  0.3361(4) 0.1940(2) 0.6611(2)  
H3  H  0.3382 0.1116 0.6622  
C4  C  0.3751(5) 0.2568(3) 0.7487(2)  
H4  H  0.4043 0.2168 0.8105  
C5  C  0.3724(4) 0.3810(3) 0.74798(19)  
H5  H  0.4006 0.4239 0.8083  
C6  C  0.3264(4) 0.4381(2) 0.65467(17)  
H6  H  0.3226 0.5205 0.6535  
C1  C  0.2862(3) 0.37818(18) 0.56401(15)  
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C7  C  0.2389(3) 0.43420(17) 0.46444(15)  
H7  H  0.2163 0.3825 0.4095  
C8  C  0.2232(3) 0.55031(18) 0.44033(15)  
C9  C  0.1750(4) 0.59137(19) 0.33385(16)  
C11  C  0.2125(4) 0.7402(2) 0.44552(17)  
C13  C  0.1276(5) 0.7916(3) 0.2572(2)  
H13 C  0.0547 0.7497 0.1983  
H13B  H  0.2467 0.8201 0.2454  
H13A  H  0.0525 0.8575 0.2705  
C14  C  0.2196(5) 0.8645(2) 0.4809(2)  
H14A  H  0.2249 0.8659 0.5520  
H14C  H  0.1054 0.9057 0.4434  
H14B  H  0.3331 0.9026 0.4703. 
 
Bond Angles of 2-F/Me 
Number Atom1 Atom2 Atom3 Angle 
1  C11 C1 N1 124.9(2) 
2  C11 C1 N2 121.0(2) 
3  N1 C1 N2 114.1(2) 
4  C3 C2 N2 103.1(2) 
5  C3 C2 O1 130.5(2) 
6  N2 C2 O1 126.4(2) 
7  C2 C3 C4 121.1(2) 
8  C2 C3 N1 108.7(2) 
9  C4 C3 N1 130.2(2) 
10  C3 C4 H4A 115.2(2) 
11  C3 C4 C5 129.5(2) 
12  H4A C4 C5 115.2(2) 
13  C4 C5 C6 121.9(2) 
14  C4 C5 C10 119.0(2) 
15  C6 C5 C10 119.1(2) 
16  C5 C6 H6A 118.9(2) 
17  C5 C6 C7 122.2(2) 
18  H6A C6 C7 118.9(2) 
19  C6 C7 C8 118.1(2) 
20  C6 C7 C13 120.8(2) 
21  C8 C7 C13 121.1(2) 
22  C7 C8 H8A 119.7(2) 
23  C7 C8 C9 120.6(2) 
24  H8A C8 C9 119.7(2) 
25  C8 C9 H9A 119.0(2) 
26  C8 C9 C10 122.0(2) 
27  H9A C9 C10 119.0(2) 
28  C5 C10 C9 118.0(2) 
29  C5 C10 C14 122.5(2) 
30  C9 C10 C14 119.5(2) 
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31  C1 C11 H11A 109.4(2) 
32  C1 C11 H11B 109.5(2) 
33  C1 C11 H11C 109.5(2) 
34  H11A C11 H11B 109.4(2) 
35  H11A C11 H11C 109.5(2) 
36  H11B C11 H11C 109.5(2) 
37  H12A C12 H12B 109.6(2) 
38  H12A C12 H12C 109.4(2) 
39  H12A C12 N2 109.4(2) 
40  H12B C12 H12C 109.4(2) 
41  H12B C12 N2 109.5(2) 
42  H12C C12 N2 109.5(2) 
43  C7 C13 H13A 109.4(2) 
44  C7 C13 H13B 109.5(2) 
45  C7 C13 H13C 109.5(2) 
46  H13A C13 H13B 109.5(3) 
47  H13A C13 H13C 109.6(3) 
48  H13B C13 H13C 109.4(3) 
49  C10 C14 H14A 109.5(2) 
50  C10 C14 H14B 109.4(2) 
51  C10 C14 H14C 109.4(2) 
52  H14A C14 H14B 109.5(3) 
53  H14A C14 H14C 109.5(3) 
54  H14B C14 H14C 109.5(3) 
55  C1 N1 C3 105.8(2) 
56  C1 N2 C2 108.3(2) 
57  C1 N2 C12 128.3(2) 
58  C2 N2 C12 123.4(2) 
 
Bond Lengths of 2-F/Me 
 
Number Atom1 Atom2 Type  Length  
1  F1 C2 Unknown 1.343(3)  
2  O1 C9 Unknown 1.211(3)  
3  N10 C9 Unknown 1.373(3)  
4  N10 C11 Unknown 1.369(3)  
5  N10 C13 Unknown 1.456(3)  
6  N12 C8 Unknown 1.400(3)  
7  N12 C11 Unknown 1.303(3)  
8  C2 C3 Unknown 1.386(3)  
9  C2 C1 Unknown 1.393(3)  
10  C3 H3 Unknown 0.930(2)  
11  C3 C4 Unknown 1.354(4)  
12  C4 H4 Unknown 0.930(3)  
13  C4 C5 Unknown 1.402(5)  
14  C5 H5 Unknown 0.930(3)  
15  C5 C6 Unknown 1.387(4)  
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16  C6 H6 Unknown 0.930(2)  
17  C6 C1 Unknown 1.372(3)  
18  C1 C7 Unknown 1.455(3)  
19  C7 H7 Unknown 0.930(2)  
20  C7 C8 Unknown 1.349(3)  
21  C8 C9 Unknown 1.476(3)  
22  C11 C14 Unknown 1.480(3)  
23  C13 H13C Unknown 0.959(3)  
24  C13 H13B Unknown 0.960(4)  
25  C13 H13A Unknown 0.961(4)  
26  C14 H14A Unknown 0.960(3)  
27  C14 H14C Unknown 0.960(3)  
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